Category: Articles

Medical Innovation And The Fight Against Amputation

Many specialists unite with one goal: preventing amputation. When podiatrists encounter patients that may lose a leg from peripheral arterial disease (PAD), vascular treatment is an urgent need. But, the question may arise: “Why doesn’t the vascular community seem to agree on how to best intervene?” … A July 2015 research paper compared the primary and secondary outcomes of angioplasty versus open vascular surgery.1 The research found both treatments equally effective in amputation prevention, improving the quality of life and life expectancy of patients with critical limb ischemia (CLI), but that endovascular treatment offered additional benefits of lower cost, lower complication rates, and easier recoveries. The study also showed a lower 30-day mortality rate for angioplasty. The article summary stated, “Based on these results it is suggested that angioplasty should be considered as the first choice for feasible CLI patients.” … read more

Response to: Remote Diabetic Foot Temperature Monitoring for Early Detection of Diabetic Foot Ulcers

A Cost-Effectiveness Analysis
We read with pleasure the recent article in your journal on the cost-effectiveness of remote diabetic foot temperature monitoring by Brooks et al.1 Diabetic foot ulcers pose a major healthcare burden, and insight into cost-effectiveness of treatments in this field is scarce, especially in preventing foot ulcers.2 Studies with original data are clearly preferred to inform clinicians, researchers and policy-makers on the potential cost-savings and health gains of preventative interventions. But modelling analyses such as by Brooks et al can provide relevant insights … For modelling analyses to be meaningful, assumptions must be based on both published evidence and clinical reasoning, and must be reasonable and logical. For a cost-effectiveness analysis on remote foot temperature monitoring, two assumptions are key … read more

BHU scientists find cure for chronic wounds. Here’s how they managed it

The team led by Prof Gopal Nath of the department of Microbiology said that wounds that took months and years to heal, could now be cured in days or months
A team of scientists from the Banaras Hindu University (BHU) have found a cure for those suffering from chronic wounds, particularly with diabetic foot ulcers. The team led by Prof Gopal Nath of the department of Microbiology, Institute of Medical Sciences, said that wounds that took months and years to heal, could now be cured in days or months. The findings of study have been published in the National Centre for Biotechnology Information, National Institutes of Health, US … read more

How TWC and Wound Clinics Will Evolve in 2022

Wound care continues to evolve as care expands beyond the wound clinic. As we move to 2022, Today’s Wound Clinic Clinical Editor Caroline E. Fife, MD, FAAFP, CWS, FUHM, and Managing Editor Brian McCurdy discuss meeting the challenges and how TWC will continue evolving in its digital format … watch video

Effectiveness of negative pressure wound therapy with instillation and dwelling after stoma closure

a retrospective and propensity score matching analysis
The use of temporary diverting stoma has become more common in low colorectal anastomosis to reduce anastomotic complications. Surgical site infection (SSI) at the stoma closure site has been one of the most frequent postoperative complications. The aim of this study was to compare the short-term outcomes between conventional primary suture closure and negative pressure wound therapy with instillation and dwelling (NPWTi-d) therapy following purse-string suturing, using propensity score matching analysis. We retrospectively evaluated the medical records of 107 patients who underwent stoma closure between January 2016 and October 2020. The primary outcome was the proportion of SSI. The secondary outcome was the day of postoperative length of stay. Propensity score matching with one-to-one match was performed for reducing treatment selection bias … read more

Survey on Wound Hygiene

An article in the Journal of Wound Care surveyed participants on awareness, implementation, barriers, and outcomes of wound hygiene.

Data from a survey created to better understand wound care awareness, implementation, barriers, and outcomes was recently published in the Journal of Wound Care. The survey, which was created by the Journal of Wound Care projects team with consultation from ConvaTech, was 26 questions long and featured a variety of multiple and open-ended questions. It was sent out by email and online, being open for a little over 12 weeks. Nonprobability sampling was used and authors of the survey reviewed the outputs to help analyze the data with the support of a medical writer … read more

Case Study – Diabetic Foot Abscess and Sepsis: Amputation or Limb Salvage?

A 48-year-old Type II insulin dependent diabetic male presented in the acute care setting with sepsis due to an abscess of the right foot involving bone and deep soft tissue structures of the midfoot. The wound and associated sepsis made limb loss and/or mortality a pressing concern. Options were primary limb amputation versus an attempt at limb salvage … In addition to his diabetes, past medical history included chronic kidney disease stage 3, sleep apnea with continuous positive airway pressure dependence, peripheral neuropathy, hyperlipidemia, hypertension, hypothyroid, morbid obesity, Moya disease, and secondary renal hyperparathyroidism … read more

EXPLAINED: Barrier Products

Barrier products, such as skin barrier films, are designed to protect the skin by minimising its exposure to excessive moisture and irritants. These may be topical preparations (available in a spray, foam applicator or wipe format) that can be applied to the skin without stinging, and dry quickly to create a breathable and transparent film. They provide a protective water-repellent barrier against irritants and harmful bodily substances, such as urine and faeces … Barrier films will not affect dressing application and are simple for both healthcare providers and patients/carers to use. Sterile products are particularly useful as they can be used on both intact and injured skin and are recommended for use in patients with a high risk of infection … read more

Wound Care Evidence Summit 2022

The Summit will provide a critically needed multi-disciplinary meeting for payers, government agency policymakers, prominent researchers, wound care medical specialty societies, patient and clinical associations, wound care clinics and manufacturers to address the shared goals of:

  • Addressing the current state of wound care research and clinical trial design
  • Exploring solutions to address the limitations in the wound care evidence-base
  • Communicating with payer medical directors on the development of coverage policies and the use of clinical practice guidelines in coverage decisionmaking
  • Defining “next steps” to actualize solutions
  • Participating in a uniquely intimate gathering of leading decisionmakers

read more

How Are Wound Clinics Coping With Omicron?

At wound clinics, physicians and staff have dealt with a lot over the past two years while the pandemic has raged. First, they were in the trenches as COVID-19 arose and hospitals were swamped, with many patients on ventilators. Even after many were vaccinated, the Delta variant caused another surge. Now, the Omicron variant is spreading quickly, with physicians facing an even more contagious version of the disease … “It still feels like the hits just keep on coming and we are not out of it yet,” says Caroline E. Fife, MD, FAAFP, CWS, FUHM. “Omicron is spreading so fast it’s mind blowing.” … The transmissibility of Omicron is a concern, as evidenced by what experts are seeing in data, according to Dr. Fife … read more

A Human Fibroblast-Derived Growth Factor Preparation in the Management of a Chronic Surgical Wound

in a Diabetic Patient: A Case Report
The surgical treatment of choice for ischaemic heart disease is Coronary Artery Bypass Grafting (CABG). The Great Saphenous Vein (GSV) is the most frequently used conduit for CABG, and the technique for harvesting the GSV entails a long open skin incision, usually comprising the entire leg. The vast proportion of patients experience leg wounds as opposed to sternal wounds. The rate of great saphenous vein harvest site infections (GSVHSI) is reported to be between 1% and 24%. Risk factors associated with GSVHSI include peripheral vascular disease, diabetes mellitus, smoking, obesity, and chronic renal failure. It is well a recognized fact that one of the most significant challenges to wound healing is infection, leading to a poor prognosis and increased morbidity.4 Hence, although rare, complications arising from the great saphenous vein harvest site may require surgical debridement leading to a delay in recovery and may negatively impact the patient … read more

Scientists Find Cure For Diabetic Foot Ulcers

Cure For Diabetic Foot Ulcers: People with diabetes, often struggle with diabetic foot ulcers, but not anymore. A team of scientists from the Banaras Hindu University (BHU) have found a cure. The findings of the study were published in the National Centre for Biotechnology Information, National Institutes of Health, US. The team led by Prof Gopal Nath of the department of Microbiology, Institute of Medical Sciences, said that wounds that took months and years to heal, could now be cured in days or months … read more

Nanoparticles Improve Immunosuppression, Could Boost Diabetes Treatment

Islet transplantation has emerged over the past few decades as a potential cure for type 1 diabetes. However, transplantation efforts have faced setbacks as the immune system continues to eventually reject new islets. Current immunosuppressive drugs offer inadequate protection for transplanted cells and tissues and are plagued by undesirable side effects … read more

Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence (DFU Biofilm)

Diabetic foot ulcers (DFU) are one of the most common reasons for hospitalization of diabetic patients and frequently results in amputation of lower limbs. Of the one million people who undergo non-traumatic leg amputations annually worldwide, 75% are performed on people who have type 2 diabetes (T2DM). The risk of death at 10 years for a diabetic with DFU is twice as high as the risk for a patient without a DFU. The rate of amputation in patients with DFU is 38.4%4. Infection is a common (>50%) complication of DFU. Emerging evidence underscores the significant risk that biofilm infection poses to the non-healing DFU. Biofilms are estimated to account for 60% of chronic wound infections. In the biofilm form, bacteria are in a dormant metabolic state. Thus, standard clinical techniques like the colony forming unit (CFU) assay to detect infection may not detect biofilm infection. Thus, biofilm infection may be viewed as a silent maleficent threat in wound care … read more

The healing of bilateral chronic VLUs using medical grade honey in an end of life patient with polymorbidity

Palliative care provides holistic, person-centred care by managing symptoms, preventing suffering by treating pain and other problems, and providing physical, psychosocial and spiritual support (Chaplin, 2004; Grocott and Gray, 2010; Dale and Emmons, 2014). Palliative wound care should focus upon relieving wound-related suffering and improving the quality of life of patients and their families when facing life-threatening illness (Grocott and Gray, 2010; Dale and Emmons, 2014). Patients requiring palliative wound care can present with any type of wound, particularly those common in older people, such as venous leg ulcers (VLUs), pressure ulcers, diabetic foot ulcers and malignant wounds … read more

New Clinical Study Finds MolecuLight i:X® Point-of-Care Imaging Improved Sensitivity

of Detecting Bacterial Burden in Surgical Site Wounds by 11-Fold

Authors Suggest that Fluorescence Imaging of Bacterial Burden is Positioned to Change
Contemporary Paradigms of Post-Surgical Wound Management

TORONTOJan. 18, 2022 /PRNewswire/ – MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced the publication of  “Uncovering the high prevalence of bacterial burden in surgical site wounds with point-of-care fluorescence imaging1 in International Wound Journal. The publication reports on the results of an analysis of 58 imaged and biopsied surgical site wounds from the 350-patient multi-centre FLAAG (fluorescence imaging assessment and guidance) clinical trial2.

Key findings of the study include:

  • 76% of surgical sites that reach the stage of referral to a wound specialist had clinically significant bacterial loads (104 to 109 CFU/g), however only 6.8% exhibited symptoms of infection, resulting in delayed infection management.
  • Point-of-care fluorescence imaging (using the MolecuLight i:X device) for detecting high bacterial loads improved sensitivity by 5.7-fold compared to clinical signs and symptoms alone.
  • Clinician experience with fluorescence imaging and interpretation (>200 imaging sessions) increased sensitivity of fluorescence imaging to 11.3-fold higher than clinical signs and symptoms alone, and accuracy to 2.6-fold higher.

The incidence of surgical wound complications, including surgical site infections (“SSI”), continue to rise and the development of an SSI is associated with a marked increase in morbidity, a 2-to 11-fold increase in mortality rate, and prolonged hospital stays3. Approximately 2-5% of surgical wounds in the US develop an SSI7-10 at an annual cost of up to $10 billion4-7. This includes extended hospital stays, readmissions, and more resources required to manage complications.

“While early identification and management of high bacterial burden is critical for the prevention of surgical site infections, this study shows that pathogenic bacterial burden is present in most (>75%) surgical wounds that are referred to a wound specialist, but is largely asymptomatic and therefore goes undetected, delaying bacterial management strategies”, says lead author Associate Professor Sandy-Hodgetts, Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University & Senior Research Fellow, School of Biomedical Sciences, University of Western Australia and the Founder and inaugural President of the International Surgical Wound Complications Advisory Panel (ISWCAP). “Due to its ability to quickly and reliably detect bacterial burden at the point-of-care, fluorescence imaging using the MolecuLight device is positioned to change contemporary paradigms of post-surgical wound management”.

These findings are part of an important initiative by the International Surgical Wound Complications Advisory Panel (ISWCAP) to study surgical site infections on a global scale and highlight the need for more objective diagnostic techniques to support the early and accurate detection of clinically concerning bacterial burden in surgical wounds. The authors note that this is the first study reporting the use of an advanced diagnostic device for the visualisation and diagnosis of bacterial burden in surgical wounds.

“MolecuLight fluorescence imaging technology allows clinicians to see into the wound. The point-of-care imaging device enables clinicians to detect and manage elevated levels of bacteria to inform our decision-making,” says Dr. Thomas Serena, the publication’s contributing author, Founder and Medical Director of The SerenaGroup®, and Vice President of ISWCAP.  “Management of bacterial burden should always begin with wound hygiene strategies (e.g., cleansing, debridement), and only escalate to antibiotics when essential.”

References:

Sandy Hodgetts, K. et al., Int Wound J. 2021;1–11

2 L. Le, Advances in Wound Care, 25 Sep 2020

3Hatch MD et al. J Shoulder Elbow Surg. 2017;26(3):472-477

4 Badia JM, et al. J Hosp Infect. 2017;96(1):1-15

5 McLaws ML et al. J Hosp Infect. 2003;53(4):259-267

6 Sullivan E et al. Surg Infect (Larchmt). 2017;18(4):451-454

Ban KA et al. J Am Coll Surg. 2017;224(1):59-74

8 Berrios-Torres SI et al. JAMA Surg. 2017;152(8):784-791

9 Institute CPS. Canadian Surgical Site Infection Prevention Audit. 2016

10 Si D et al. BMC Infect Dis. 2014;14:318

 

About MolecuLight Inc.

MolecuLight Inc. is a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i: and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden (when used with clinical signs and symptoms) and for digital wound measurement. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

Coverage, Payment, and the Impact of Advocacy

Decisions about which wound care products and services are (or are not) covered under Medicare are made at the national level by the CMS or regionally by Medicare contractors that each make local coverage determinations (LCDs) for the parts of the country they cover. The impact of these policies is significant. If something is not covered by Medicare, you cannot be reimbursed for it. As a result, many clinical treatment decisions are guided by Medicare coverage decisions rather than best clinical practices … read more

Utilizing Disposable, Mechanical NPWT Devices to Aid Wound Management at Home: Cost Savings Considerations

In this clinical case presentation, Dr. Napolitano describes 3 cases using mechanically powered, disposable negative pressure wound therapy. The cases covered in this presentation include an open wound after hematoma excision, Charcot foot deformity presenting with a diabetic foot ulcer, and an open wound after ankle fusion surgery. Data from this poster were presented at the SAWC Fall in Las Vegas, Nevada (October 29-31, 2021) … read more

Nutrition Interventions in Adults with Diabetic Foot Ulcers

  • Diabetic foot ulcers (DFU) are chronic wounds in the foot or feet associated with neuropathy and/or peripheral artery disease (PAD) of the lower limb in patients with diabetes mellitus.
  • Reports from the Centers for Disease Control and Prevention show that in the United States there are nearly one in four adults living with diabetes, which indicates that a large number of Americans are at risk of DFU.
  • DFUs will develop in up to 34% of patients with diabetes at some time in their lives, and of those, approximately 15%–25% will require an amputation.
  • Moderate or severe malnutrition has been identified in over half of patients with DFU, and malnutrition in DFU is correlated with increased lower-extremity amputation.

read more

Necrotizing Soft Tissue Infection of the Forearms in a Patient Using Intravenous Heroin

Case Report of Advanced Wound Management Improving Dressing Tolerance and Expediting Skin Graft
Necrotizing soft tissue infection (NSTI) is rare and characterized by rapid onset and spread of inflammation and necrosis. The infection starts within the fascia but can rapidly progress to include musculature, subcutaneous fat, and overlying skin. Its presentation is considered a surgical emergency. Persons who use intravenous or subcutaneous opioids are at higher risk of NSTIs. PURPOSE: The purpose of this case report is to describe the positive clinical outcome after consulting with wound specialists and using a dressing regimen to expedite more rapid wound healing, shortened time to skin graft, and improved pain tolerance in a patient with a history of intravenous and subcutaneous heroin use. CASE REPORT: The patient presented with an NSTI that required extensive debridement of the bilateral upper extremities. The acute surgical wound service was consulted. A dressing regimen consisting of hypochlorous acid–preserved wound cleansing, followed by carboxymethylcellulose fiber with 1.2% ionic silver covered by hydrocellular foam… read more

Diabetic Foot Surgery: An Overview

Procedures have assumed an increasingly important role in patient care
During their lifetime, up to 30% of people with diabetes will develop a foot ulcer. Diabetes-related foot ulcers and lower extremity amputations result in a major burden for patients, their family, and the healthcare system. Interest in this complex and challenging specialty has been growing and, in recent decades, there has been acceptance of a shift towards operative correction of diabetic foot deformities. Surgical management of diabetic foot deformities has now become an integral part of the overall care … read more

Maceration Mitigation: Recognition, Prevention, and Management of Overhydrated Wounds

Maceration is a common clinical complication that poses challenges in chronic wound treatment.1 Excessive moisture can be trapped on the wound surface, especially when occlusive dressings are overused or when nonbreathable cover dressings are applied for extended periods. Maceration as part of the broader umbrella of moisture-associated skin damage (MASD) occurs as a cascade of events that stem from an impaired microclimate and increased humidity on the wound’s surface. The increased moisture level causes overhydration and the stratum corneum to swell, resulting in decreased tensile strength of this epidermal layer … read more

ESVS publishes 2022 guidelines on management of chronic venous disease of the lower limb

The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower limb to update its 2015 recommendations. The document, authored by Marianne G De Maeseneer (Erasmus Medical Centre, Rotterdam, The Netherlands) and colleagues, was published online ahead of print in the European Journal of Vascular and Endovascular Surgery (EJVES) … read more

New method may help make immunomodulation more effective in individuals with Type 1 diabetes

Pancreatic islets control insulin production when blood sugar levels change, and in Type 1 diabetes, the body’s immune system attacks and destroys such insulin-producing cells. Islet transplantation has emerged over the past few decades as a potential cure for Type 1 diabetes. With healthy transplanted islets, Type 1 diabetes patients may no longer need insulin injections, but transplantation efforts have faced setbacks as the immune system continues to eventually reject new islets… “At my past program, I worked on wound healing for diabetic foot ulcers, which are a complication of Type 1 diabetes,” Burke said. “As someone who’s 26, I never really want to get there, so I felt like a better strategy would be to focus on how we can treat diabetes now in a more succinct way that mimics the natural occurrences of the pancreas in a non-diabetic person.” … read more

India uses 4D bioprinting for diabetic foot ulcer management

Indian pharmaceutical firm Alkem Laboratories has announced to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU). The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter half of 2022 post regulatory approval … This advanced technology for DFU management has a high scope of preventing amputations in diabetic patients. This technology will be available at affordable rates to Indian patients at a time when there is no definitive treatment for DFU in India … read more


LinkedIn:
Alkem Laboratories

LimFlow System a ‘cost-effective and high-value alternative’ to traditional therapies

Percutaneous Deep Vein Arterialisation (pDVA) with the LimFlow System offers a cost-effective and high-value alternative to traditional therapies or amputation, according to a recent study published in the Journal of Critical Limb Ischemia … Peter Schneider, professor of surgery at the University of California (San Francisco, USA) and co-author of the published article, said: “The cost-effectiveness analysis builds on recently published 12-month data from the PROMISE I study by showing that pDVA with the LimFlow System can be a high-value therapy alternative to the status quo for no-option CLTI patients … “This research highlights the health economic benefits of reducing amputations and the need to offer patients a better alternative worldwide.” … read more


LinkedIn:
LimFlow SA

Healogics Launches Healing Can’t Wait Program For 2022

JACKSONVILLE, Fla., Jan. 13, 2022 /PRNewswire/ — Healogics®, the nation’s leading provider of world-class wound care, is announcing their “Healing Can’t Wait” program for the millions of people struggling with a non-healing wound. Chronic wounds affect seven million Americans, limiting their quality of life, as well as life expectancy … With the 2022 Healing Can’t Wait program, Healogics looks to address the significant increase in amputations observed in recent years due to the impact of COVID-19 on patient treatment schedules. It is critical that patients understand the urgency and importance of treatment. Through the 2022 Healing Can’t Wait program and resources, Healogics Wound Care Centers will focus on educating the underserved chronic wound population … “Treatment delays and the staggering increase in amputations drive us to work even harder to improve awareness and access to advanced wound care. Any untreated wound is at risk for complications such as infection, hospitalization or amputation,” explains David Bassin, Chief Executive Officer of Healogics. “This is why the Healogics Healing Can’t Wait program is so critical.” … People living with diabetes, heart disease or peripheral artery disease (PAD) are at an even greater risk for health complications that stem from an untreated wound … read more


LinkedIn:
Healogics, Inc.

Intensive glycemic control may prevent diabetic foot ulcers

medwireNews: Early intensive glycemic control may reduce the long-term risk for foot ulcers in people with type 1 diabetes, suggest data from the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) study … The DCCT included 1408 people with type 1 diabetes who completed an average of 6.5 years of intensive (target glycated hemoglobin [HbA1c] <6.05% [42.6 mmol/mol]) or conventional (no specific glycemic target) diabetes treatment and subsequently underwent 23 years of follow-up in the EDIC study … During this period, 195 participants developed at least one diabetic foot ulcer (48 people had multiple events) and 36 needed lower extremity amputation … read more

Cryotherapy Treatment of Cutaneous Kaposi Sarcoma in a Patient With B-Cell Chronic Lymphocytic Leukemia

A Case Report and Short Review of the Literature
Kaposi sarcoma (KS) is a low-grade mesenchymal tumor involving the blood and the lymphatic vessels that primarily effaces the skin and is mediated by human herpesvirus-8 (HHV-8) in more than 90% of patients. There are 4 distinct types of KS. Compared with the classic and AIDS-related variants, chronic lymphocytic leukemia (CLL) associated with KS is a relatively rare clinical condition; thus, only a few cases have been reported. Case Report. This report presents a case study of an 87-year-old patient with B-cell CLL and cutaneous KS managed with cryotherapy, along with a short review of the literature. Conclusions. Considering that the method is relatively simple and with few adverse effects, cryotherapy may represent a simple and safe treatment method for cutaneous KS. However, more studies should be conducted … read more

Silver in Wound Care: Clinical Outcomes | webinar

Thursday, January 27, 2022

Health care professionals should consider silver nanoparticle dressings to decrease healing times and improve the quality of life of their patients.

Registrants attending this session will learn:

  • The history of silver usage
  • The problem of antimicrobial resistance
  • Indications and contraindications for the use of medicinal silver
  • Variations of medical silver in dressings and their clinical outcomes

read more

Technology in Wound Care | webinar

On Wednesday, January 19 at 8:00 PM ET, AAWC will host “Technology in Wound Care,” a webinar presented by Olamide Alabi, MD, RPVI, FACS. Dr. Alabi is an Assistant Professor of Surgery, Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Emory University School of Medicine. She was also the keynote speaker at our 2021 Pressure Ulcer Summit.

register

Kathleen D. Schaum, MS, Named World Expert in Reimbursement Health Insurance

Congratulations to TWC’s own Kathleen D. Schaum, MS, who recently received recognition as an Expertscape World Expert in Reimbursement Health Insurance.

Expertscape tweeted the news on Dec. 12 as part of International Universal Health Coverage Day. Expertscape ranks and lists the world’s top experts in Clinical and Research Medicine and calls itself “the objective, current, global resource for patients and referring physicians.” … read more

All Edema Is Lymphedema: Progressing Lymphedema and Wound Management to an Integrated Model of Care

Chronic edema affects millions of people in the United States and worldwide. Edema can result from a variety of diseases, trauma, medications, and other contributing factors; however, all edema is related to lymphatic fluid dysregulation. Additionally, lymphatic impairment and integumentary dysfunction are interrelated, leading to complex clinical presentations that require an integrated medical model of care to maximize outcomes. PURPOSE: This narrative review article will highlight the current evidence that details lymphatic physiology, fluid regulation by the endothelial glycocalyx layer, and the interconnectedness of the vascular and integumentary systems leading to a paradigm shift in our understanding of edema, lymphedema, and chronic wounds. Traditional pedagogy remains siloed with respect to the body systems, whereas current evidence indicates a certain interdependence, particularly between and among the venous, lymphatic, and integumentary systems … read more


LinkedIn:
Wound Management & Prevention

Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation

Delayed wound healing can cause significant issues for immobile and ageing individuals as well as those living with co-morbid conditions such as diabetes, cardiovascular disease, and cancer. These delays increase a patient’s risk for infection and, in severe cases, can result in the formation of chronic, non-healing ulcers (e.g., diabetic foot ulcers, surgical site infections, pressure ulcers and venous leg ulcers). Chronic wounds are very difficult and expensive to treat and there is an urgent need to develop more effective therapeutics that restore healing processes. Sustained innate immune activation and inflammation are common features observed across most chronic wound types. However, the factors driving this activation remain incompletely understood. Emerging evidence suggests that the composition and structure of the wound microbiome may play a central role in driving this dysregulated activation but the cellular and molecular mechanisms underlying these processes require further investigation. In this review, we will discuss the current literature on: 1) how bacterial populations and biofilms contribute to chronic wound formation … read more

Maceration Mitigation: Recognition, Prevention, and Management of Overhydrated Wounds

Maceration is a common clinical complication that poses challenges in chronic wound treatment.1 Excessive moisture can be trapped on the wound surface, especially when occlusive dressings are overused or when nonbreathable cover dressings are applied for extended periods. Maceration as part of the broader umbrella of moisture-associated skin damage (MASD) occurs as a cascade of events that stem from an impaired microclimate and … read more


LinkedIn:
Alex M. Aningalan
WoundSource

Limb Loss… Who Is Really to Blame?

The Patient? The Physician? The System?—Part 1
The discipline of limb preservation and salvage has spawned extraordinary innovations in both scientific and clinical applications, offering new hope for those seeking the benefits of the burgeoning state-of-the-art lower extremity amputation prevention platforms. Wound treatment complexes are flourishing as well as access to them; research studies abound; extensive data is amassed; myriad public relations campaigns stimulate public awareness; training programs … read more

Optimising wound care through patient engagement

Patient engagement is a crucial and timely topic, both in terms of wound healing (and, in some cases, symptom management), and in improving individuals’ experiences of the process. This document aims to provide clear guidance in listening and engaging with individuals, and thus optimising the care experience for all key stakeholders, of which the patient is the most important. The document was developed with input from both healthcare professionals and individuals using healthcare services Kathleen D. Schaum … read more


LinkedIn:
Wounds International

Have You Revised Your EHR Screens/Templates and Charging System?

At the 2021 SAWC Fall a team (medical director, program director, and clinical nurse manager) from a hospital owned outpatient wound/ulcer management provider-based department (PBD) asked many questions after my main session reimbursement presentation and during my interactive reimbursement session post-conference … When I returned to my office the next week, this same team called me and requested teleconsultation services as soon as possible … As a reimbursement consultant … read more


LinkedIn:
Kathleen D. Schaum
Today’s Wound Clinic

Single cell transcriptomic landscape of diabetic foot ulcers

Diabetic foot ulceration (DFU) is a devastating complication of diabetes whose pathogenesis remains incompletely understood. Here, we profile 174,962 single cells from the foot, forearm, and peripheral blood mononuclear cells using single-cell RNA sequencing. Our analysis shows enrichment of a unique population of fibroblasts overexpressing MMP1, MMP3, MMP11, HIF1A, CHI3L1, and TNFAIP6 and increased M1 macrophage polarization in the DFU patients with healing wounds. Further, analysis of spatially separated samples from the same patient and spatial transcriptomics reveal preferential localization of these healing associated fibroblasts toward the wound bed as compared to the wound edge or unwounded skin … read more

Healthy.io achieves HITRUST CSF® certification for Information Security

BOSTON, Jan. 11, 2022 /PRNewswire/ — Healthy.io, the global leader in transforming the smartphone camera into a medical device, today announced its at-home Minuteful Kidney test and Minuteful for Wound services have earned Certified status for information security by HITRUST, which follows a standardized framework to measure HIPAA compliance … HITRUST CSF Certified status demonstrates that Healthy.io has met key federal and state regulations and industry-defined requirements and is appropriately managing risk. This achievement places Healthy.io in an elite group of organizations worldwide that has earned this certification … Healthy.io’s business case is simple: smartphone-powered technology can help health systems and insurance providers improve patient health, reduce costs across the healthcare system, and improve access to care. Early results are tremendous: In the US, health plans can more than double their current adherence rates.  A recent rollout in the United Kingdom showed that Healthy.io test kits raised test adherence from 0% to 50% among patients who had not done a urine test for kidney disease in the previous year … read more


LinkedIn:
Healthy.io

Is Your Wound Bioburdened? Case 2

• 50-year-old male with morbid obesity visiting the outpatient wound care center for bilateral lower extremity wounds and lymphedema. Click here for a photo.
• The wound on his leg was present for several months and previously treated with broad spectrum oral antibiotics for cellulitis. Click here for photo.
• Pain, odor and erythema detected from wound, prompting the clinician to perform a fluorescence scan. Click here for photo

read more


LinkedIn:
Today’s Wound Clinic

2021 Prime Minister’s prize for improving the repair of human tissue, a beacon for wound research in Australia

The broad purpose of laboratory-based wound research is to obtain a scientific understanding of the mechanistic processes that underpin normal and abnormal wound healing. Translation of this knowledge can lead to the development of new tools, technologies, therapeutics diagnostics and sensors that ultimately will lead to improved wound management and patient care. While this process may seem far removed from the day-to-day challenge of dealing with patients with impaired healing, occasionally we see breakthroughs and achievements that encourage both researchers and clinicians alike … read more

Effective Wound Management For Arterial Ulcers

Lower extremity ulcers are a common occurrence in individuals aged over 60. A combination of risk factors and disease processes in these individuals impact the wound healing stages, which leads to the development of chronic, non-healing ulcers. Arterial ulcers account for 8-10% of all lower extremity ulcers. However, the prevalence might be significantly underreported due to the failure to recognize the etiology of leg ulcers. Wound care specialists need to be aware of the differences between arterial ulcers and other ulcer types to provide effective wound care … read more

Wound Week 2022 – February 24-27, 2022 Philadelphia, PA

Wound Week™ 2022 is an innovative, unparalleled educational opportunity that will feature superior content delivered by multidisciplinary faculty with true clinical expertise. This conference will allow clinician driven training and education in wound care, vascular and hyperbaric medicine. In addition to education and training, this meeting will offer unmatched clinician networking … brochure (PDF)

Can Smartphone Apps Enrich Wound Care?

Access to healthcare has enhanced by leaps and bounds with the arrival of mobile technology The most interesting trends in the healthcare industry now comprise flexible and efficient wound care, among others. Extensive smartphone penetrations, along with cost-effective internet connectivity, have committed to taking wound care to the next level. Today, one can have the greatest of wound care facilities through smartphone apps. Traditionally, the healthcare industry had to offer services at dedicated wound care facilities. This required an appropriately-skilled workforce, maintenance of facilities, and important overheads, which occurred in higher costs for patients. With smartphone apps, many of these difficulties have been overcome … read more

Survey on Wound Hygiene

An article in the Journal of Wound Care surveyed participants on awareness, implementation, barriers, and outcomes of wound hygiene
Data from a survey created to better understand wound care awareness, implementation, barriers, and outcomes was recently published in the Journal of Wound Care. The survey, which was created by the Journal of Wound Care projects team with consultation from ConvaTech, was 26 questions long and featured a variety of multiple and open-ended questions. It was sent out by email and online, being open for a little over 12 weeks. Nonprobability sampling was used and authors of the survey reviewed the outputs to help analyze the data with the support of a medical writer … read more

CPD Accredited 5th International Conference on Wound Care, Tissue Repair and Regenerative Medicine

Paris, France – April 15-16, 2022

This year with the refreshing theme on “Emerging and Innovative Approaches for Wound Healing and Tissue Regeneration”.

 

Wound Care Congress is all set to bring together the eminent scholars from the wound care and tissue regeneration community presenting the unsurpassed opportunities to present and explore the future wound healing and tissue science medicine.

 

Witness the gathering the world-leading and renowned academicians, business delegates, principal investigators, nurses, homeopathists, researchers, students to witness the futuristic ideologies put forth by the experts.

 

This integrative 2-day event deliberates the new strategies, convictions that will impact the process of your professional development. Join us with your research and business tactics which will direct to the optimistic approach to the advancements of the future wound care & tissue regeneration.

 

Connect with us to Socialize, Interact, Network, and Collaborate at Wound Care Conference 2022.

 

read more

Embedding Predictive Analytics Into Your Wound Care Workflow | Webinar

This webinar, presented by Matt Berezo, Joshua Budman, Abbey Cooper, and Cathy Thomas Hess will discuss how wound care-specific analytics can impact a practice’s workflow. Specifically, the presenters will discuss several clinical analytics models, how they are validated, and how clinicians can use them to improve their clinical and operational outcomes … register

A systematic review of multidisciplinary teams to reduce major amputations for patients with DFUs

Multiple single-center studies have reported significant reductions in major amputations among patients with diabetic foot ulcers after initiation of multidisciplinary teams. The purpose of this study was to assess the association between multidisciplinary teams (ie, two or more types of clinicians working together) and the risk of major amputation and to compile descriptions of these diverse teams … read more

THE JWC WUWHS AWARDS ARE OPEN FOR ENTRY

The awards are ‘The Olympics of Wound Care’ and will culminate in an evening which will celebrate excellence in practicing research internally. This will be the first celebration of its kind in the UAE, recognising the fantastic work clinicians in the world and across the region have undertaken. There will be fourteen categories covering a range of wild therapy areas.

Nominations are open to individuals, teams, organisations, societies, companies, charities, and government organisations whose work has made a huge impact based on work carried out over the last year.

The deadline has been extended! You have until the 17th of January to enter … read more

Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers

improves patient outcomes vs standard of care: Results of a prospective randomized controlled multi-center clinical trial

 

The prevalence of diabetes in the United States continues to rise, with the disease now affecting 34.2 million, with an estimated additional 84 million at risk of progressing to diabetes in the coming years.1 The lifetime incidence of DFUs among diabetics is 19% to 34%, with recurrent ulceration reported as approximately 40% at 1 year and 60% at 3 years.2 Management is challenging and associated with substantial socio-economic burden approaching $40 billion annually in direct costs.3 Approximately 70% of DFUs resolve with standard wound care therapies. However, the natural healing cascade is arrested in the remaining 30%, which ultimately become chronic wounds.4, 5 Patients with chronic wounds typically suffer loss of function, recurrent infection, and significant morbidity.6 Amputations are reported in up to 20% of cases with an associated mortality of 70% at 5 years post-amputation … read more

New Level-1 Evidence Finds Geistlich Derma-Gide® Closes Significantly More Diabetic Foot Ulcers

in Appreciably Shorter Time and at Lower Costs

 

Demonstrates Superiority Compared to Standard of Care in Prospective, Randomized Controlled Trial
PRINCETON, N.J.–(BUSINESS WIRE)–The Geistlich Medical business unit of Geistlich Pharma AG, a family owned, Swiss-based global leader in regenerative solutions, is proud to announce the results from their clinical study of the Geistlich Derma-Gide® Advanced Wound Matrix. The study, “Use of a Purified Reconstituted Bilayer Matrix (PRBM) in the Management of Chronic Diabetic Foot Ulcers Improves Patient Outcomes vs Standard of Care – Results of a Prospective Randomized Controlled Multi-Center Clinical Trial,” was peer-reviewed and published in the International Wound Journal – Wiley Online Library … The paper was authored by David G. Armstrong, DPM, MD, PhD; Dennis P. Orgill, MD, PhD; Robert D. Galiano, MD; Paul M. Glat, MD; Jarrod P. Kaufman, MD; Marissa J. Carter, MA, PhD; Lawrence A. DiDomenico, DPM; and Charles M. Zelen, DPM, FACFAS. The paper is now available in the Wiley Online Library at https://onlinelibrary.wiley.com/doi/full/10.1111/iwj.13715 … In a 40-patient, prospective, randomized, controlled multicenter clinical trial comparing a purified reconstituted bilayer matrix (PRBM, Geistlich Derma-Gide) vs. Standard of Care (SOC – collagen alginate dressing), Geistlich Derma-Gide was found to be superior relative to healing rates and time to wound closure … read more

Moisture-Associated Skin Damage | A Historic Step Forward

Every WOC nurse is aware of how often we encounter patients with conditions that are prevalent and clinically relevant but their management falls outside of available guidelines that provide direction for the care of we provide. As a result, we sometimes find ourselves managing disorders supported by scant evidence regarding epidemiology, etiology, pathophysiology, prevention, and treatment. Fortunately, WOC nurses and there are allies, along with the WOCN Society and its official journal, have a rich history of purposely drawing attention to these disorders, supporting and epidemiologic and clinical research expanding our knowledge of these conditions, and influencing public policies regulating care of these conditions … read more

What is the practice and understanding of podiatrists towards patient-centred consultations regarding diabetic foot care?

Background: Patient education is an integral part of diabetes management, yet research shows that increased knowledge alone does not translate into behaviour change. Behaviour change techniques (BCTs) have the potential to increase foot self-care and reduce the incidence of diabetic foot disease. Aims: The aim of this study was to explore the practice and understanding of podiatrists towards patient-centred support versus prescriptive instruction in consultations regarding diabetic foot care. Methods: The study was a cross-sectional design with a web-based questionnaire distributed to members of the College of Podiatry in the UK. Descriptive statistics, conceptual content analysis and the Pearson product-moment correlation coefficient were used to analyse the data. Results: Most respondents reported using BCTs in their consultations “often” or “very often” and that they “strongly agree” or “agree” that their consultations were patient-led … read more

Physician Coaching Explained

Did I choose the right path? How can I accomplish my professional goals? Do I have any career options outside of clinical practice? How can I decrease stress? I’m sure many reading this blog have asked one or more of these questions of themselves. The work we do as physicians is unique, and often many do not completely “get it,” except fellow physicians. So, whether one desires to be happier or advance in their current professional path, or seeks an entirely different trajectory, physician coaching could be a vital tool to pursue … Coaching has no definitive definition, but the concepts it entails are empowering. Thinking, listening, and verbalizing … read more

Skin Manifestations with COVID-19

The Purple Skin and Toes that you are seeing may not be Deep Tissue Pressure Injury
Many reports are occurring concerning areas of purpuric/purple skin and purple toe lesions in patients diagnosed with COVID-19 (SARS-CoV-2). Wound care providers are being asked if these skin lesions are forms of Deep Tissue Pressure Injury and/or “skin failure”. Early reports of COVID-19 related skin changes included rashes, acral areas of erythema with vesicles or pustules (pseudo-chilblain), other vesicular eruptions, urticarial lesions, maculopapular eruptions, and livedo or necrosis.1-4 The pattern and presentation of skin manifestations with COVID-19 is more than rashes … read more (PDF)

No Surprises Act – What it Means for Your Practice

Bob Jasak, VP of Coverage and Payment Policy with Hart Health Strategies will present on the recently implemented No Surprises Act and address recently released rules related to it and what it means for your practice.

This content is available to APMA members only. If you are a member, please log in to see the full content

Periwound health: new definition, new recommendations

I’m delighted to have been invited to present the best practice recommendations on the Prevention and Management of Periwound Skin Complications at this year’s Wounds UK conference (LeBlanc et al, 2020). These recommendations were devised by the International Skin Tear Advisory Panel (ISTAP) based on existing evidence and reviewed externally by 14 health professionals from seven different countries including Canada, UK, Brazil, Republic of Ireland, Switzerland, South Africa, and Indonesia. Consensus statements, of which there are 13, had to reach a level of 80% agreement to be included. The statements are summarised and discussed here for information … read more (PDF)

Custom-Molded Offloading Footwear Effectively Prevents Recurrence and Amputation …

and Lowers Mortality Rates in High-Risk Diabetic Foot Patients: A Multicenter, Prospective Observational Study
Recurrence of high-risk diabetic feet, after wound, healing is a common challenge among diabetic patients. Continuous use of an offloading device significantly prevents recurrence of high-risk diabetic feet, although patient adherence is imperative to ensuring this therapy’s clinical efficacy. In this study, we explored clinical outcomes of patients with a high-risk diabetic foot who had been prescribed with custom-molded offloading footwear under different adherence conditions … read more

Scientists map skin cells that contribute to diabetic foot ulcers

Diabetic foot ulcerations—open sores or wounds that refuse to heal—are a devastating complication affecting more than 15 percent of people with diabetes and resulting in more than 70,000 lower extremity amputations per year in the United States alone. Notably, more than half of patients undergoing amputations due to diabetic foot ulcerations are expected to die within five years—a mortality rate higher than most cancers. Yet, the biological processes at work in diabetic foot ulcerations are poorly understood … read more

Wound Care Research & the Imperative for Funding

Though wound care is a robust evidence-driven field with a broad variety of treatments for chronic wounds that have been proven safe and effective, more research must be done to determine how to best optimize healing for painful, life-threatening wounds. With the anticipated rise in chronic wounds, the Federal government needs to provide more funding for wound care research so patients can get back on their feet, literally, as quickly as possible. The longer a patient suffers from a chronic wound, the more likely they are to contract potentially fatal infections … read more

Molecular Biomarkers of Oxygen Therapy in Patients with Diabetic Foot Ulcers

Alisha R. Oropallo 1,*, Thomas E. Serena 2, David G. Armstrong 3 and Mark Q. Niederauer 4
1 Comprehensive Wound Healing Center and Hyperbarics, Department of Vascular Surgery, Zucker School of Medicine Hofstra/Northwell, Hempstead, NY 11549, USA
2 Serena Group Research Foundation, Cambridge, MA 02140, USA; serena@serenagroups.com
3 Limb Preservation Program, Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA; armstrong@usa.net
4 EO2 Concepts, San Antonio, TX 78249, USA; m.niederauer@eo2.com
* Correspondence: aoropallo@northwell.edu; Tel.: +1-516-233-3780

 

Hyperbaric oxygen therapy (HBOT) and topical oxygen therapy (TOT) including continuous diffuse oxygen therapy (CDOT) are often utilized to enhance wound healing in patients with diabetic foot ulcerations. High pressure pure oxygen assists in the oxygenation of hypoxic wounds to increase perfusion. Although oxygen therapy provides wound healing benefits to some patients with diabetic foot ulcers, it is currently performed from clinical examination and imaging. Data suggest that oxygen therapy promotes wound healing via angiogenesis, the creation of new blood vessels. Molecular biomarkers relating to tissue inflammation, repair, and healing have been identified. Predictive biomarkers can be used to identify patients who will most likely benefit from this specialized treatment. In diabetic foot ulcerations, specifically, certain biomarkers have been linked to factors involving angiogenesis and inflammation, two crucial aspects of wound healing. In this review, the mechanism of how oxygen works in wound healing on a physiological basis, such as cell metabolism and growth factor signaling transduction is detailed. Additionally, observable clinical … read more

Diabetes-Related Amputations Kept at Bay During Pandemic in Canada

Shift to virtual care and prioritization of certain procedures key, researchers say
Despite delays in screening and care during the COVID-19 pandemic, there wasn’t a spike in diabetes-related foot amputations, a Canadian study found … In an analysis of nearly 1.5 million adults with diabetes living in Ontario, rates for nearly all diabetes-related services took quite a nosedive in 2020, noted Charles de Mestral, MDCM, PhD, of St. Michael’s Hospital in Toronto, and colleagues … For starters, comprehensive in-person diabetes care assessment immediately dropped down from March to May, averaging only 28% of the 2019 level, they reported in JAMA Network Open … read more

Battling ‘the Pandemic within the Pandemic’

RedDress Addresses Wound Care Challenges in the COVID-19 Pandemic

Ponte Vedra Beach, FL, Jan. 05, 2022 (GLOBE NEWSWIRE) — Patients suffering with non-healing wounds continue to experience challenges accessing treatment two years after the onset of the COVID-19 pandemic … As new variants of COVID-19 emerge, wound care providers across the United States are reporting a more than 50 percent increase in the severity of wounds. If left unaddressed, these non-healing wounds can have severe consequences including infection, sepsis, amputation, and even death. RedDress is battling this compounding issue researchers have dubbed “the pandemic within the pandemic” utilizing cutting-edge technology … read more

Anastassia Johnson Tapped as Senior Manager at The Wound Pros

LOS ANGELES, Jan. 6, 2022 /PRNewswire/ — The Wound Pros (https://thewoundpros.com/) today announced Anastassia Johnson as a Senior Manager at the company. The Wound Pros specializes in the treatment and management of chronic non-healing wounds at long-term care facilities. It also partners with facilities to provide advanced wound care dressings for acute and chronic wounds as well as education for staff … Anastassia Johnson joined The Wound Pros in December 2020. She holds a Diploma and an Associate of Science Degree in Computer Systems Technology and a Bachelor of Science Degree in Information and Communication Technology. As senior manager at The Wound Pros, she brings over a decade of experience in project management, administration, customer support, quality assurance, training, and analytical decision-making … read more

Can we go from scarface to scarless?

Researchers examined skin regeneration over two years in various body parts of the adult newt, Cynops pyrrhogaster. Their wounds were very quickly healed over several days without prolonged inflammation. Because of this rapid healing, granulation/dermal fibrosis, and therefore scarring, did not occur. The skin was able to fully regenerate. These findings provide evidence that this newt species may be an ideal model system to study and prevent scar formation in human skin … read more

Newly developed injectable, adhesive surgical gel to prevent scar tissue

Up to 90% of patients who undergo open abdominal or pelvic surgery develop postoperative adhesions, or scar tissue. Minimally invasive laparoscopic surgical approaches can reduce the severity of the adhesions, but the scar tissue still forms. The cellular response to injury—even intentional injury, such as surgery to repair a problem—results in a cascade of molecules pouring to the site to heal the tissue. But the molecules, working quickly to close the wound, often go too far and bind the wound to nearby healthy tissue. Depending on the location, the resulting scar tissue can cause chronic pain, bowel obstruction and even death … read more

Wound Dehiscence After Achilles Tendon Trauma and Repair

Treatment With Ultraportable Negative Pressure Wound Therapy and Compression Therapy
Achilles tendon rupture is a common injury requiring surgical repair. Re-ruptures, infections, delayed wound healing, and hematomas have been reported postoperatively. Objective. This case series described the use of ultraportable negative pressure wound therapy (NPWT) and compression bandaging following postoperative dehiscence of Achilles tendon repair. Materials and Methods. Retrospective records were reviewed to identify patients who underwent wound management for Achilles tendon dehiscence between January 2014 and January 2018. Patient demographics, wound size at first and last visit, number of visits, and previous treatment data were extracted. Wound management included wound irrigation, surgical debridement, and application of silver dressings, as needed. Therapy was transitioned to ultraportable NPWT with twice-weekly dressing changes. When possible, patients with an ankle-brachial index greater than 0.8 received multilayer, multicomponent compression … read more

Mechanical Negative Pressure Wound Therapy: Real-World Effectiveness in Challenging Patient Presentations

When used for wound management, negative pressure wound therapy (NPWT) delivers subatmospheric pressure at the wound site, exerting multiple beneficial effects, including microstrain, macrostrain, edema management, granulation tissue formation, drainage management, and wound stabilization. Comparative effectiveness research has demonstrated similar wound healing and adverse event outcomes between traditional NPWT (tNPWT) and mechanical NPWT (mNPWT). Therefore, considerations for patient selection for mNPWT vs tNPWT are in alignment with current recommendations, including therapeutic goals, wound-related factors, patient satisfaction, quality of life, care setting, economic-related factors, and product design. Case Reports. The 3 complex patient cases in the present report describe the routine use of mNPWT between December 18, 2020, and June 7, 2021 … read more

Reflections on the Extraordinary Life of Norma N. Gill-Thompson, ET

In June 1986, I was a relatively new certified enterostomal therapy (ET) nurse. I was standing in line for an industry-sponsored lunch at my first International Association of Enterostomal Therapy (now the Wound, Ostomy, and Continence Nurses Society) meeting at Caesar’s Palace in Las Vegas, NV, when someone around me said, “Look, there’s Norma Gill!” Sure enough, she was a few spots ahead of me in line. I got so excited—it felt like I was in the presence of Florence Nightingale! I went over and introduced myself as a new ET nurse, saying how honored I was to meet her. In her down-home, humble way, she threw her arm around my shoulder and said, “Honey, come sit next to me at lunch.” So began my long and special relationship with this extraordinary pioneer of ET/wound ostomy continence … read more

INTERNATIONAL ALLIANCE OF WOUND CARE SCHOLARSHIP FOUNDATION AND HEALIANT …

Announces partnership to award wound care scholarships
The International Alliance of Wound Care Scholarship Foundation® is proud to announce a partnership with Healiant Training Solutions™ to bring hundreds of wound care scholarships to the nurse community. It is the purpose of IAWCSF® to provide financial aid in the form of scholarships to those individuals pursuing an education and certification in wound care. Healiant Training Solutions™ will match up to 100 scholarships that will be donated by sponsors from the wound care product community to be awarded to deserving healthcare providers. Accordingly, the funds will be used specifically for advanced education and subsequent certification in wound care. Our passion is wound care and our mission is to help decrease the rising costs and loss of limbs and life throughout the world. We cannot accomplish this without the help from benefactors such has Healiant. “Partnering with Healiant Training Solutions is just the beginning of what is to come for the future of wound care education and certification,” said Angela Weathersby, Ph.D., Executive Director of IAWCSF … read more

DIAGNOSTIC ACCURACY OF POINT-OF-CARE FLUORESCENCE IMAGING FOR THE DETECTION OF ….

bacterial burden in wounds

This excellent work from Le and coworkers strongly suggests that using a point of care diagnostic device (Moleculight) can identify elevated bacterial load and influence medical decision making … High bacterial load contributes to chronicity of wounds and is diagnosed based on assessment of clinical signs and symptoms (CSS) of infection, but these characteristics are poor predictors of bacterial burden. Point-of-care fluorescence imaging (FL) can improve identification of wounds with high bacterial burden (>104 CFU/g). FL detects bacteria, whether planktonic or in biofilm, but does not distinguish between the two … read more

 

The Role of Internal Offloading and Rotational Flap Closure of Charcot Arthropathy-Related Midfoot Ulcers

The patient with Charcot foot is seldom studied for their body’s ability to heal an open diabetic foot ulcer. These patients are usually excluded from all prospective randomized trials. Over a 5-year period, patients with Charcot arthropathy (CA) have been shown to have a 63% chance of developing a CA foot ulcer (CAFU), and those with a foot ulcer have a 37% mortality within the same timeframe.¹ To the authors’ knowledge, a correlation between healing a CAFU and mortality reduction has not been indicated. It is well-known that healing such ulcers improves quality of life and reduces the chance of hospitalization. The primary modality to heal such an ulcer is maintaining or creating a plantar grade foot.1 In a retrospective study of 106 patients with CAFU, Schmidt and Holmes² reported that 44% of the patients’ ulcers had healed, 11% had received a minor amputation, and only 9% had undergone major amputation … read more

Paracrine to Present at Biotech Showcase™ 2022

Paracrine, Inc. announced today that it is presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation which is now accessible. This year, registered attendees to Biotech Showcase can access Paracrine’s recorded company presentation on-demand.

Paracrine is an emerging biotechnology company developing a first-in-class, device-based, autologous cell therapy. Paracrine’s cell therapy platform bears the promise of cost-effectively addressing common, underlying pathology of several debilitating chronic diseases due to its unique multi-prong mechanisms of action. The company has an FDA approved IDE for the pivotal ASCEND Trial in patients with non-healing diabetic foot ulcers, the STAR II pivotal trial IDE is currently under review at FDA for hand dysfunction due to scleroderma and an IDE is being prepared for submission later this year for the ATHENA III trial in patients with chronic heart failure … read more

Safe and effective wound healing preparation reaches Clinical Phase II

APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells. APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore recommended continuation into a Phase II clinical trial. This represents a major success for the wound healing preparation developed at MedUni Vienna … read more

The Disconnect with Diabetic Foot Ulcers | Video

During the last 10 years, the United States FDA has approved only a few new treatments for diabetic foot ulcer (DFU). Amarex’s Kazem Kazempour, PhD, believes careful study design is required to demonstrate efficacy of new wound healing treatments. In this video, Kazempour explains the disconnect between the FDA’s definition of wound healing and the reality of DFUs … watch

New Technology in Identifying Wound Infections Helping to Deprescribe Antibiotics with Martha Kelso

In this podcast, Amy Stewart, MSN, RN, DNS-MT, QCP-MT, RAC-MT, RAC-MTA, vice president of education and certification strategy for AAPACN (American Association of Post-Acute Care Nursing) and Martha Kelso, RN, LNC, HBOT, CEO of Wound Care Plus, a mobile wound care provider, discuss new point-of-care technology (MolecuLight i:X) to help identify wound infections and the impact this has on deprescribing antibiotics

Adding Wound Care Specialist to Proning Team Reduces Pressure Injury Risks

Newswise — The addition of a certified wound and skin care nurse to a multiprofessional prone-positioning team at Penn Medicine Princeton Health significantly reduced the odds of patients with COVID-19 developing pressure injuries, according to a study published in American Journal of Critical Care … The development of healthcare-associated pressure injuries is a significant complication of placing patients prone, and prolonged prone positioning for patients with acute respiratory distress syndrome (ARDS) is associated with higher rates of new pressure injuries, specifically on the face, cheekbones and thorax and over bony prominences … Although many studies have reported the development of pressure injuries in patients with ARDS who are placed prone for prolonged periods, “Pressure Injury Outcomes of a Prone-Positioning Protocol in Patients with COVID and ARDS” is one of the first to explore specific treatment-related strategies for preventing pressure injuries … read more

Prioritizing Diabetic Foot Care During Pandemic Pays Off

The COVID-19 pandemic was not associated with increased limb loss among people with diabetes in Ontario, Canada, new research suggests.

The findings, which contrast with those from several other locales worldwide, were published online January 5 in JAMA Network Open by Charles de Mestral, MDCM, PhD, of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Ontario, and colleagues.

Despite limited in-person visits with physicians, hospital avoidance, and non-emergency surgical procedure restrictions, excess leg amputations were not seen among people with diabetes during the first 11 months of the COVID-19 pandemic. The authors postulate several reasons for this, including prioritization of foot care … read more

UK MP highlights efforts to improve care landscape for lower limb wound patients

This country is facing a crisis in vascular disease made worse by the effects of the COVID-19 pandemic. However, there is a potential answer in the recommendations of the National Wound Care Strategy Programme, being implemented in places like Hull University Teaching Hospitals Trust, but for it to succeed it needs the full commitment and backing of government … read more

Foot Sparing Amputations in Diabetics

These techniques can save limbs and lives.
The recent global SarsCoV-2 (COVID-19) pandemic significantly disrupted the delivery of healthcare across many disciplines and the effect of the pandemic has had an especially detrimental effect on people with diabetes-related foot complications, resulting in more amputations. Major level lower extremity amputation is one of the most feared complications of diabetes. One study found that patients with diabetes and lower extremity complications were more in fear of major amputation than death.1 In many cases, major level amputations can result in loss of function, decline in quality of life, and even death … read more

Hope for Health and Healing in 2022

One year ago, this page contained a message of hope and a wish that 2021 would bring an increased appreciation for the science we desperately need.1 That wish remains as heartfelt now as it was then because the end of this pandemic remains elusive and because the millions of health care providers who have worked behind a mask to provide care deserve all the help they can get. When we think about science, our minds usually ponder new technologies, medications, or expansive, expensive, or complicated treatments or interventions. However, some of the most critical and enduring innovations to help us help patients are neither high-tech nor fancy and expensive … read more

Welcome to APWH: The Academy of Physicians in Wound Healing

APWH, the Academy of Physicians in Wound Healing, originally formed in 2011 specifically for physicians (MD,DO,DPM) now includes advanced practice providers (Nurse Practitioners-NP and Physician Assistants-PA). The organization provides information and support in three subject areas: clinical and operations-focused education, compensation advocacy, and legislative action on healthcare issues. Additionally, the organization provides this information specifically to and for the benefit of providers that are responsible for diagnosis and management of patient care which defines the demographic of our membership … read more

3D Printed Skin? Potential New Treatment For Chronic Wounds

Wounds come in many shapes and sizes. Some are small and heal quickly, causing few problems. Others are larger and slower to heal. Deep wounds that take especially long to go through the normal healing process, called chronic wounds, are of particular concern; these have a tendency to reopen and are often accompanied by infection and, eventually, scarring. Add to this the fact that chronic wounds are difficult to treat with currently available therapies, and you end up with a serious healthcare challenge … read more

Combined Regenerative Approach for a Complex Lower Extremity Wound: A Case Report

More than 400 million patients worldwide are affected by diabetes; over their lifetime, at least 25% will develop foot ulcers that often result in high rates of nonhealing wounds and amputation. The authors present the case of a 43-year-old female patient with multiple comorbidities who presented with a large (8 cm x 4 cm), noninfected, hindfoot plantar ulcer that extended down to the bone and calcaneus. Over 2 weeks, the patient was successfully treated using a combination of an acellular dermal matrix, nanofat grafting, and negative pressure wound therapy, lessening the effects of the ulcer on the patient’s quality of life and achieving limb salvage … read more

The Scientist: Robert Kirsner, MD, PhD

Dr. Kirsner is Chairman and the endowed Harvey Blank Professor in the Dr. Phillip Frost Dermatology in the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine. He is Chief of Dermatology at the University of Miami Hospital and Clinics and Jackson Memorial Hospital and directs the University of Miami Hospital Wound Center. Dr. Kirsner received his undergraduate degree from Texas A&M University, his medical degree from the University of Miami and a PhD in epidemiology from the University of Miami, after he completed his clinical training. His clinical training included internal medicine, a clinical and research fellowship in wound healing and dermatology at the University of Miami … listen

Retrospective Analysis Using Viable Placental Membrane Allografts in Chronic Wounds

Introduction. Viable placental membrane (vPM) has been shown to decrease time to healing, adverse wound events, and wound-related infections. Wound research exclusion criteria commonly exclude wound types other than diabetic foot ulcers and venous leg ulcers (VLUs), comorbidities including peripheral arterial disease (PAD) and uncontrolled diabetes mellitus (DM), and wounds with exposed bone or tendon. Objective. This retrospective research study evaluated the clinical use and outcomes of the vPM with living mesenchymal stem cells used in chronic wound management in the community hospital outpatient department setting with the goal of comparing real-world use and outcomes of the product with use and outcomes described in the chronic wound literature … read more

Silver in Wound Care: Clinical Outcomes | Webinar

Since as early as ancient (1850 BCE) Egypt, silver has been used in wound care owing to its antimicrobial properties. Although its popularity dwindled in 1928 with the discovery of penicillin, medicinal silver has recaptured wound care professionals’ attention with the rise of antimicrobial-resistant microbes. In modern dressings, the incorporation of silver nanoparticles decreases the risk of infection while allowing the dressing to continue the facilitation of a moist wound bed environment. In nanoparticle form, silver deconstructs the cell membrane of microbes, passes into their cell body, and causes internal damage … Register

All Edema Is Lymphedema: Progressing Lymphedema and Wound Management to an Integrated Model of Care

Chronic edema affects millions of people in the United States and worldwide. Edema can result from a variety of diseases, trauma, medications, and other contributing factors; however, all edema is related to lymphatic fluid dysregulation. Additionally, lymphatic impairment and integumentary dysfunction are interrelated, leading to complex clinical presentations that require an integrated medical model of care to maximize outcomes. PURPOSE: This narrative review article will highlight the current evidence that details lymphatic physiology, fluid regulation by the endothelial glycocalyx layer, and the interconnectedness of the vascular and integumentary systems leading to a paradigm shift in our understanding of edema, lymphedema, and chronic wounds. Traditional pedagogy remains siloed with respect to the body systems, whereas current evidence indicates a certain interdependence, particularly between and among the venous, lymphatic, and integumentary systems … read more

Is Weight Loss or Physical Activity More Important for Preventing Type 2 Diabetes?

Ever since the US Diabetes Prevention Program (DPP) multicenter trial was completed nearly two decades ago (1), we have known that it is possible to prevent, or at least delay, prediabetes (an insulin–resistant state) from progressing into full-blown type 2 diabetes. Why? Diabetes risk was reduced by 58% in the “intensive lifestyle“ (ILS) participant group and by 31% in the metformin (an oral glucose-lowering medication) participants compared to no intervention (“placebo“ group). For 60 years or older participants, lifestyle changes worked much better to prevent diabetes than taking metformin … read more

Moisture Management in Neonatal Pressure Injury Prevention: A Survey

Neonates are widely known as a vulnerable patient population—especially critically ill and premature infants. This vulnerability has limited clinicians’ knowledge of moisture management products in the neonatal population that prevent pressure injuries. Recently, a survey of neonatal nurses from across the United States was conducted to find out what is being used for moisture management … This study was designed as a cross-sectional survey with a convenience sample of neonatal intensive care unit (NICU) nurses. A survey link was distributed electronically through websites, listservs, discussion boards, and newsletters to the National Association of Neonatal Nurses (NANN), the Academy of Neonatal Nurses (AAN), and WoundSource. There were 252 NICU nurses who completed the survey … read more

Cost-Effectiveness Analysis for the Treatment of Diabetic Foot Ulcer in France

Platelet-Rich Plasma vs Standard of Care
Introduction: Diabetic chronic foot ulcers (DFU) lead to pain, reduced quality of life and represent a severe economic burden for patients and health systems. The clinical results of PRP effectiveness in the treatment of DFU are promising; on the other hand, the costs associated with treating DFUs with PRP are higher than those using standard therapy. Therefore, this study aims to determine the cost-effectiveness of platelet-rich plasma (PRP) therapy compared to standard therapy from the French healthcare system perspective.
Methods: A cost-effectiveness analysis (CEA) was performed using a decision Markov model with a cohort of patients with chronic DFU (duration of > 3 weeks) with high orthopaedic risk and with ulcers graded 3A according to University of Texas classification … read more

Chronic Wounds: Innovations in Diagnostics and Therapeutics

A major global health issue is the existence of chronic wounds. Appropriate diagnosis and treatment is essential to promote wound healing and prevent further complications. Traditional methods for treatment and diagnosis of chronic wounds have shown to be of limited effectiveness. Therefore, there is a need for the development of diagnostic and therapeutic innovations in chronic wound care.

Objective: This mini-review aims to provide insight in the current knowledge of the wound healing process and the deficiencies encountered in chronic wounds, which provides a basis for the development of innovations in chronic wound care. Furthermore, promising diagnostic and therapeutic innovations will be highlighted … read more

Wound hygiene survey: awareness, implementation, barriers and outcomes

In light of the COVID-19 pandemic, which has resulted in changes to caseload management, access to training and education, and other additional pressures, a survey was developed to understand current awareness and implementation of the wound hygiene concept into practice one year on from its dissemination. Barriers to implementation and outcomes were also surveyed … read more

Prevalence of and Factors Associated with Diabetic Retinopathy in Patients with Diabetes Mellitus

at Siriraj Hospital – Thailand’s Largest National Tertiary Referral Center
Diabetic retinopathy (DR) is one of the most common chronic complications of diabetes mellitus (DM). DR is characterized by gradually progressive alterations in the retinal microvasculature, leading to areas of retinal non-perfusion, increased vascular permeability, and pathologic intraocular proliferation of retinal vessels. The complications are associated with macular edema, and uncontrolled neovascularization, termed proliferative diabetic retinopathy (PDR), resulting in severe and permanent vision loss if not treated in a timely and appropriate manner. DR is the leading cause of blindness among working-aged adults worldwide. However, with appropriate medical and ophthalmologic care, more than 90% of vision loss from PDR can be prevented.1 Unfortunately, in many cases, presenting symptoms may go unnoticed or unheeded and the damage caused by the disease becomes irreparable … By 2045, it is estimated that approximately 700 million people worldwide will have diabetes2 and that approximately 103 millions of those will have DR … read more

Theories of Skin Aging and Wound Care

Theories of Aging

One theory of aging is the free radical theory and mitochondrial DNA damage. Mitochondria are organelles within cells that are responsible for respiration, which promotes energy production using oxygen and simple sugars to produce adenosine triphosphate, the article explains. The DNA is located in a place with little protection and cannot repair itself which can lead to aging skin. The free radicals are atoms or molecules containing unpaired electrons that initiate a damaging chain reaction resulting in DNA crosslinking that leads to aging and may contribute to cancer genesis, the article continues … read more

Expanding horizons to upskill wound practice and research

With our horizons limited by Covid-related travel restrictions, it is more important than ever to experience and learn about our multicultural world through reading about wound-related research and practice in other jurisdictions and countries. Two such articles provide this important international insight and are included in this issue of the journal. The first by Obilor and colleagues describes the assessment of nurses’ knowledge, attitude and competence in wound assessment in a tertiary healthcare facility in southwest Nigeria. Here they found that many of the nurses surveyed were lacking in wound assessment competence, suggesting an important continuing need for education and skills development. The second internationally focused paper, by Yigit and Tas, describes the demography and injuries related to chemical burns in the southeastern Anatolia region of Turkey. The burn centre at the core of this study serves 10 million people in Diyarbakir and the surrounding 300km and is the only centre with an intensive care unit in southeast Turkey, a very different experience from what we would see in an Australian context … read more

AAN Updates Painful Diabetic Neuropathy Guidance

Four medication classes have been shown to help, plus topical and other treatments Gabapentinoids, serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, and sodium channel blockers were more likely than placebo to improve diabetic neuropathy pain, according to a new practice guideline from the American Academy of Neurology (AAN). Those classes typically had comparable effect sizes…

Therapy Delayed is Therapy Denied: A Case Report of Melanoma Misdiagnosed as Diabetic Foot Ulcer

Malignant melanoma is a deadly form of skin cancer, and prompt diagnosis is a key factor in providing adequate, life-saving therapy. A 75-year-old man, with long-standing type 2 diabetes mellitus, presented with a 2- to 3-year history of right heel ulcer. He had received various therapies for a diagnosis of diabetic foot ulcer, to no avail. Physical examination showed a black, fungating ulcerated lesion on his right heel, with minimal bleeding. No inguinal lymphadenopathy was palpated. A biopsy was done, which revealed BRAF-negative malignant melanoma, with a vertical growth phase, Breslow 3.1 mm, ulceration, 11 mitoses/mm2, Clark level IV, no lymphatic or vascular invasion observed. Right inguinal lymph node sampling suggested no involvement, but PET-CT suggested pulmonary, right inguinal lymph node and bone involvement. The patient was referred to the oncologists. Written informed consent for publication was given by the patient. Diabetic foot ulcers are a frequently encountered, but serious complication of diabetes mellitus. Delayed healing is often seen, despite adequate therapy. The differential diagnosis of diabetic foot ulcers is vast and includes neoplasia. When a foot ulcer fails to heal, other differential diagnoses must be considered, in order for the patient to receive adequate therapy. Here specialist consultations, including dermatology consultations, could improve chances of delivering the right therapy promptly. This is a factor underlying the emphasis on a multidisciplinary approach to foot ulcer therapy. Our presentation – reported according to the CARE guidelines – also illustrates the fact that failure to reach a timely diagnosis may deny the patient the opportunity to receive adequate treatment … read more

Advances in Skin & Wound Care | January 2022 – Volume 35 – Issue 1

EDITORIAL


Ready, Set, Go

Advances in Skin & Wound Care. 35(1):7, January 2022.

 

PAYMENT STRATEGIES


 

PRACTICE REFLECTIONS


 

PRACTICE POINTS


Xerosis in Older Adults

Dalgleish, Lizanne; Campbell, Jill

Advances in Skin & Wound Care. 35(1):62-63, January 2022.

BIDE-NADEP-PWGDF collaborates with Ferozsons Laboratories to end avoidable foot amputations

The Country wide health initiative “Fast Track Pathway” was launched at a simple but dignified ceremony held at a local Hotel in Lahore on Dec 20, 2021 … An MOU signing ceremony was held between BIDE and Ferozsons Laboratories Limited for the implementation of this project … Addressing the ceremony, the Project Director, Dr ZahidMiyan, from Baqai Institute of Diabetology and Endocrinology, told that; Foot involvement is one of the major and devastating complications of diabetes. It is estimated that approximately 3,000,000 people with diabetes in Pakistan have foot ulcers while approximately 300,000 people loose their limbs to diabetes, every year, he told further … The huge burden of diabetic foot and the high frequency of avoidable amputations strongly necessitate consolidated and unified efforts. Dr Zahid highly appreciated the leading role of Prof Abdul Basit, the Director of BIDE, who always emphasized on nationwide improvement in diabetic foot care. In that context the “Fast Track pathway” has been launched in Pakistan, Dr Zahid declared … read more

International Alliance of Wound Care Scholarship Foundation® & Healiant™️

to award hundreds of Wound Care Scholarships
Healiant Training Solutions™ and IAWCSF® partner to make 100+ scholarships available to clinicians who desire to become wound care trained and certified.

TAMPA, FL, UNITED STATES, December 21, 2021 /EINPresswire.com/ — Healiant Training Solutions™ and the International Alliance of Wound Care Scholarship Foundation® (IAWCSF®) come together to make scholarships available to passionate clinicians who desire to become wound care trained and certified. Healiant Training Solutions™ will match up to 100 scholarships that will be donated by sponsors from the wound care product community to be awarded to deserving healthcare providers … read more

New Screening Tool to Prevent Mortality from Complications of Foot Ulcers

Individuals with diabetes have around a 34% chance of developing a diabetic foot ulcer (DFU). This debilitating condition may lead to severe complications, including hospitalization, infection, and amputation. A recent study reported grim data on DFU, finding a five-year survival rate of just 29%. Any delay in treatment has been associated with worsened clinical outcomes. The researchers of this study were interested in identifying risk factors for DFU in patients with T2D. Early detection might one day reduce the number of diabetic foot ulcers … read more

Foot ulceration associated with increased risk for amputation or death

Using the Scottish Care Information – Diabetes database, Graham Leese (Ninewells Hospital, Dundee, UK) and co-authors observed that out of 23,395 individuals with type 1 diabetes and 210,064 with type 2 diabetes included in the study, a total of 13,093 had a previous foot ulceration and among these, 34.3% developed a further foot ulcer during the follow‑up period (2012–2017). In addition, a total of 9023 people developed a first ulcer during follow-up… read more

Biomechanical and musculoskeletal changes after flexor tenotomy to reduce the risk of diabetic

neuropathic toe ulcer recurrence

OBJECTIVE: To assess the effect of flexor tenotomy in patients with diabetes on barefoot plantar pressure, toe joint angles and ulcer recurrence during patient follow-up.

METHODS: Patients with a history of ulceration on the toe apex were included. They underwent minimally-invasive needle flexor tenotomy by an experienced musculoskeletal surgeon. Dynamic barefoot plantar pressure measurements and static weight-bearing radiographs were taken before and 2-4 weeks after the procedure … read more

History of Foot Ulcer & Risk for Limb Amputation or Death

Since care for diabetic foot ulcers is delivered by a wide range of healthcare professionals, from nurses working in primary care to specialized diabetes foot clinics, collecting population-based data on diabetic foot ulceration is notoriously difficult. Furthermore, epidemiological data on populations with diabetic foot ulceration collected from selected subpopulations is open to bias, hence the importance of unselected population-based data … To address this issue, my colleagues and I conducted a national, population-based, cohort study of people with diabetes, with the aim of describing the incidence of foot ulceration and amputation-free survival associated with foot ulceration status … read more

In Vitro and In Vivo Studies on the Antibacterial Activity and Safety

of a New Antimicrobial Peptide Dermaseptin-AC

Antimicrobial resistance has been an increasing public health threat in recent years. Antimicrobial peptides are considered as potential drugs against drug-resistant bacteria because they are mainly broad-spectrum and are unlikely to cause resistance. In this study, a novel peptide was obtained from the skin secretion of Agalychnis callidryas using the “shotgun” cloning method. The amino acid sequence, molecular weight, and secondary structure of Dermaseptin-AC were determined … The skin safety of Dermaseptin-AC was evaluated on wounds on the back skin of a rat … it was applied to skin wounds. Chronic wounds are often accompanied by high bacterial burdens and, at the same time, antimicrobial resistance is more likely to occur during repeated infections and treatments. Therefore, developing Dermaseptin-AC to treat chronic wound infection may be an … read more

Technology And Innovation Power Wound Care’s Ongoing Evolution – Marketplace Experts

Like all nurses who specialize in wound care, I have seen many changes in our profession over the years. Perhaps most significant are the influences that breakthrough technologies and products have had on our profession … In order to fully appreciate its scope, we must recall recent history. Not so long ago, a non-healing diabetic foot ulcer often resulted in complications and possible amputation. In addition, to follow the healing process of a wound, the measurements had to be taken manually with rulers, a subjective measurement process that is prone to variation between institutions and even individuals … read more

A year of international growth and product advancement

KEELE, England, Dec. 15, 2021 /PRNewswire/ — Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to provide the following business update … Enhanced approval for STIMULAN in Canada and Saudi Arabia … In 2021, STIMULAN® products gained a new approval in Canada for mixing with antibiotics: vancomycin, gentamicin and tobramycin, for use in treating bacterial infection in soft tissue surrounding bone. This was followed by a new approval in Saudi Arabia for STIMULAN® to be mixed with antibiotics for use in bone and soft tissue … STIMULAN® is the only calcium matrix antibiotic carrier with an EU approval for use in bone and soft tissue and offers surgeons the flexibility to apply broad spectrum ‘off-the-shelf’ antibiotics at concentrations that will support their patient-specific treatment plans – dramatically improving patient outcomes and redefining standard of care … read more

BioPhotonics Preview – March/April 2022

The measurement of oxygen levels in the blood commonly referred to as blood oxygen saturation (SpO2) is a critical medical diagnostic. The condition of below normal levels (<95%) is termed hypoxemia and is associated with patients who have asthma, heart disease, and chronic obstructive pulmonary disease … SpO2 levels are also of interest for brain and other surgical procedures (i.e. flap surgery), peripheral vascular disease (PVD), tumor development, the healing of wounds from conditions such as diabetic foot ulcer, systemic rheumatic disease, neuropathy and sepsis2–5. Pulse oximeters, a simple optical device that measures the ratios of two critical band-passes of light through an appendage … read more

Novel therapeutic targets for diabetes-related wounds: An update on pre-clinical and clinical research

Diabetes-related wounds, particularly diabetes-related foot ulceration, is mainly caused by lack of foot sensation and high plantar tissue stress secondary to peripheral neuropathy, ischemia secondary to peripheral artery disease and dysfunctional wound healing. Current management of diabetes-related wounds involves the offloading high foot pressures and the treatment of ischemia through revascularisation. Despite these treatments, the global burden of diabetes-related wounds is growing, and thus novel therapies are needed. The normal wound healing process is a coordinated remodelling process orchestrated by fibroblasts, endothelial cells, phagocytes and platelets, controlled by an array of growth factors. In diabetes-related wounds this coordinated process is dysfunctional. Past animal model and human research suggests that prolonged wound inflammation, failure to adequately correct ischemia and impaired wound maturation are key therapeutic targets to improve diabetes-related wound healing … read more

Extracellular Vesicles from HIF-1α-Overexpressing Adipose-Derived Stem Cells

Restore Diabetic Wounds Through Accelerated Fibroblast Proliferation and Migration
Inhibition of cellular adaptation to hypoxia can cause persistent inflammation, thereby increasing tissue damage and complicating wound healing in diabetes patients. Regulating cellular adaptation to hypoxic environments can help in effective wound repair. Hypoxia-inducible factor (HIF)-1α is a key regulator of cell hypoxia. Extracellular vesicles (EVs) regulate wound repair. This study investigated the mechanism of HIF-1α overexpression in adipose-derived stem cell extracellular vesicles (ADSCs-hEVs) in the repair of diabetic wounds … read more

What Is All This Swelling About? An Update on Lymphedema for Healthcare Providers and Patients

Swelling or edema is common. It can result from certain diseases, infections, conditions, trauma, or injury, and even medication.1 Typically, the swelling goes away on its own. Sometimes, however, the swelling continues and can worsen over time … This article serves as a guide to help patients and caregivers understand what swelling is and when medical help is necessary. We will educate patients and their caregivers about lymphedema including common risks and contributing factors. This article will also provide general treatment recommendations for lymphedema and provide general and disease-specific resources for individuals affected by lymphedema … read more

Get Up to Speed With Recent Wound Care Policy Updates

The Fall is a busy time in the policy world, as government agencies such as the Centers for Medicare and Medicaid Services (CMS) finalize policies for the fiscal year ahead such as the CY 2022 Physician Fee Schedule and more. Get up to speed on the latest payment and coverage policies that can impact wound care with this update from the Alliance of Wound Care Stakeholders … Real world evidence: The Food and Drug Administration (FDA) is opening up the door to more real-world evidence (RWE) in 2022 and beyond with two new draft guidance documents issued: Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support … read more

Frank & Lizzie Show: Episode 010, Dr. Mark Melin, Wound Week 2022

Frank & Lizzie host Dr. Mark Melin on this episode as they discuss Dr. Melin’s sessions during Wound Week 2022. This includes their courses Diagnosing & Treating Chronic Venous Insufficiency (Friday, February 25 2:45 PM – 3:45 PM EST) and Management of Lower Extremity Edema (Saturday, February 26 2:30 PM – 3:30 PM EST). To find out more information about Wound Week 2022 in Philadelphia February 24-27, go to WoundWeek.com! We hope to see you there.

From baker to wound care innovator – my HS story

Suzanne Moloney, the founder of HidraWear, first experienced the painful symptoms of Hidradenitis suppurativa as a young teen … At the time was a Suzanne a typical teenager who loved sports and running. She kept quiet about what was happening – she was embarrassed, as any 13-year-old would be. By her mid-teens, the lumps were bigger and harder to manage. Suzanne finally mustered up the courage to speak to a GP when they became infected … Suzanne was prescribed antibiotics every time new lumps flared up, which helped but didn’t stop the painful growths coming back. This cycle continued for years as more lumps appeared under her arms and at the tops of her legs … read more

sanaFactur – An Innovative Player in Wound Care Launches a ….

Novel Food Supplement to Support Tissue Regeneration

GRÄFELFING, Germany–(BUSINESS WIRE)– suppliDerm, a new brand by sanaFactur, represents a science based range of food supplements supporting tissue regeneration the immune system, and energy metabolism. All of these are critical for wound patients. ‘Our team of pharmacists, biochemists and nutritional specialists have combined carefully selected micro- and macro nutrients to support the body’s regenerative processes. Many older people and wound patients are suffering from nutritional deficiencies, also impacting their wound healing.’ says Dr. Alexander Maassen, CEO Scientific. A patent has been filed.

sanaFactur is an established brand in Wound Care, currently focusing on antimicrobial products. ‘suppliDerm will perfectly complement our existing portfolio, enabling patients to actively support wound therapy by supporting their regenerative metabolism. We do look forward to launch our food supplement with several flavors internationally, like the US and UK as leading markets for wound care.’ says Olaf Ohm CEO Commercial … read more

A 57-Year-Old Man with Type 1 Diabetes Mellitus and a Chronic Foot Ulcer Successfully Managed

with a Remote Patient-Facing Wound Care Smartphone Application
BACKGROUND Wounds affect millions of people world-wide, with care being costly and difficult to deliver remotely. The ongoing COVID-19 pandemic highlights the urgent need for telehealth solutions to play a larger role as part of remote care strategies for patient monitoring and care. We describe our findings on the use of a patient-facing wound care app (Swift Patient Connect App, Swift Medical, Canada) as an innovative solution in remote wound assessment and management of a diabetic patient’s wound. CASE REPORT In February 2020, a 57-year-old man with type I diabetes and peripheral arterial disease presented with osteomyelitis in the left foot at the fifth metatarsal, arising from a chronic ulcer … read more

Skin Bioprinter for Wound Care on Latest NASA SpaceX Resupply Mission

a German Aerospace Center study centers on bioprinting—using viable cells and biological molecules to print tissue structures. The German Aerospace Center study Bioprint FirstAid demonstrates a portable, handheld bioprinter that uses a patient’s own skin cells to create a tissue-forming patch to cover a wound and accelerate the healing process. On future missions to the Moon and Mars, bioprinting such customized patches could help address changes in wound healing that can occur in space and complicate treatment. Personalized healing patches also have potential benefits on Earth, providing safer and more flexible treatment anywhere needed … read more

Related:
The 3D bioprinting process in the Bioprint FirstAid Handheld Bioprinter

MediWound offers hope for chronic wound treatment – study

In a phase II study, EscharEx demonstrated safe and effective debridement of diabetic foot ulcers and venous leg ulcers.
A phase II pharmacology study has found positive initial data of EscharEx, a bioactive therapy for rapid debridement in chronic and hard-to-heal wounds, Israeli biopharmaceutical company MediWound announced on Monday … The US-based study, which is ongoing, examined the treatment of seven patients with either diabetic foot ulcers (DFUs) or venous leg ulcers (VLUs) … read more

Biogenic Nanoparticles Synthesized from African Medicinal Plants for Wound Healing

Wounds are described as damage to living tissue that disrupts its normal anatomical structure and function. They develop as a result of tissue damage caused by physical, chemical, thermal, microbiological, or immunological factors … The damage can compromise the skin’s epithelial surface and spread into the surrounding tissues, disturbing other systems such as ligaments, muscles, and nerves … Chronic wounds develop when wounds fail to heal properly and claim the lives of countless people around the world … read more

Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes

and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus

BACKGROUND AND AIMS: The ankle-brachial index (ABI) is an efficient tool for objectively documenting the presence of lower-extremity peripheral arterial disease (PAD). The predictive factors of cardiovascular events and diabetic foot ulcer were not clear from the ABI examination in Taiwanese patients with type 2 diabetes mellitus (DM).

METHODS: We enrolled 482 patients with type 2 DM who regularly visited the outpatient department of Chang Gung Memorial Hospital and received ABI as well as brachial-ankle pulse wave velocity … read more

Nano-Silver Medical Antibacterial Dressing Combined with High-Flow Oxygen

Therapy Facilitates Ulcer Wound Healing of Superficial Malignant Tumors
Malignant tumors (cancer cells) are metastatic and invasive, and cancer cells can spread throughout the body through hematogenous, lymphatic and implantation metastases. Clinically, the most common tumor metastasis sites are lung, liver, brain, bone, etc. Some patients will have metastasis on the body surface, while in some cases, the tumor directly spreads or invades the body surface.1 The appearance of superficial malignant tumor usually indicates that the tumor is in the middle and late stage. However, many patients seek medical treatment only after the superficial tumor has grown, ruptured, and become infected. The ulceration of superficial malignant tumors can lead to wound bleeding, exudation, pain, infection, and scar hyperplasia, which makes the wound unhealed for a long time, greatly reducing the quality of life of patients.2 At present, surgical resection, chemotherapy and radiotherapy are the mainstays of treatment for superficial malignant tumors.3 Clinically, such patients are required to maintain local dryness of the wound, but frequent dressing changes and large surgical wound make it difficult to keep the wound dry; Moreover, chemotherapy is easy to cause a large amount of exudate in the wound to be in a moist state, coupled with the skin damage aggravation resulted from radiotherapy, leading to the susceptible to wound bleeding and infection and consequently delayed wound healing … read more

Is Your Wound Bioburdened? Case 1

CASE

• 22-year-old male with paraplegia following a fall from a balcony presented with large presacral and buttock pressure injuries that continued to increase in size since last visit >3 months prior. Click here for photo.
• Although the ulcers were large with areas of increased depth, there were minimal clinical signs of bioburden.
• A fluorescence scan revealed red fluorescence indicative of significant bioburden that could not be removed with cleansing or debridement.
• A point-of-care fluorescence scan (MolecuLight i:X) revealed a pattern of scattered red fluorescence (white arrows) indicating elevated bacterial burden (>104 CFU/g) extending beyond … read more

EWMA Podcasts Season 1

  • EP07: Personal protective equipment
    This podcast episode will provide you with a comprehensive overview of the prevention and management of skin injuries related to the use of personal protective equipment (PPE).This is a follow-up to the EWMA webinar we ran on the 30th April devoted to this topic. Due to a high volume of questions and level of interest that we have received during the webinar we have decided to follow-up with this podcast.  In this episode we will be answering some of the questions raised from the webinar.
  •  

  • EP06: Wound Care Essentials during COVID-19
    In this short special edition of the EWMA podcasts, Julie Jordan O’Brien talks about how to help wound care patients during COVID-19 and how a healthcare professional (HCP) can change a dressing in a home care setting.
  •  

  • EP05: AMS in Wound Management
    In this episode, Samantha Holloway, Chair of the EWMA Education Committee and Teacher Network, speaks to Karen Ousey, Professor of Skin Integrity and Director for the Institute of Skin Integrity and Infection Prevention at the University of Huddersfield, about antimicroabial stewardship in wound management.
  •  

  • EP04: Atypical Wounds
    In this episode, Samantha Holloway and Kirsi Isoherranen briefly discuss the best clinical practices and challenges related to the management of atypical wounds. By listening to this podcast you can learn more about how to suspect an atypical wound and will get more information about the diagnostic criteria and available tools
  •  

  • EP03: Person-centred Wound Care
    Georgina Gethin discusses with the podcast’s host, Julie Jordan O’Brien, what person-centred care is and why it is so important in wound management. By listening to this episode, you can learn more about the benefits of shared decision-making between the patient and clinicians in wound management and get some practical support in implementing it
  •  

  • EP02: Standardisation Wound Education in EU
    Samantha Holloway, Chair of the EWMA Education Committee and Teacher Network, speaks to Sebastian Probst and Ida Verheyen-Cronau about the standardisation of the wound education in Europe. Both podcast guests shares their experience in implementation of the EWMA level 5 and 6 post-registration curricula for nurses in Switzerland and Germany
  •  

  • EP01: Understanding Diabetic Foot
    In this episode of the EWMA podcasts, Julie Jordan O’Brien and David G. Armstrong discuss current challenges and opportunities in the management and prevention of diabetic foot ulcers. Jordan O’Brien is a former EWMA Council member who works as anadvanced nurse practitioner in plastic surgery at Beaumont Hospital, in Ireland. Armstrong is Professor of Surgery and Director of the Southwestern Academic Limb Salvage Alliance (SALSA) at the Keck School of Medicine at the University of Southern California

Evidence for Person-centred Care in Chronic Wound Care

Chronic wounds affect an estimated 2.21 per 1000 population. They are a significant source of morbidity and affect individuals physically, psychologically, socially and financially. Person-centered care is one approach to improve patient outcomes in wound care as it values patients’ perspectives, beliefs and autonomy and considers the person as a whole within the cultural context in which care is provided … read more

Best Practice Statement – Addressing complexities in the management of venous leg ulcers

This document builds on the Best Practice Statement: Holistic Management of Venous Leg Ulcers to address complexities in the management of venous leg ulcers.

The aim of this document is to help ensure consistent clinical practices in relation to the assessment and management of people with VLUs who are outside the scope of the leg ulcer treatment pathway developed by Atkin and Tickle (2016). It will provide guidance based on relevant evidence and the experiences and opinions of clinicians, with a focus on practical, holistic and patient-centred strategies … read more

Researchers develop novel 3D printing technique to engineer biofilms

Anne S. Meyer, an associate professor of biology at the University of Rochester, and her collaborators at Delft University of Technology in the Netherlands recently developed a 3D printing technique to engineer and study biofilms—three-dimensional communities of microorganisms, such as bacteria, that adhere to surfaces. The research provides important information for creating synthetic materials and in developing drugs to fight the negative effects of biofilms … read more

Anti-biofilm Wound Dressing Market: High Prevalence of Diabetes to Drive Growth of the Market in Near Future

The rise in the occurrence of chronic illnesses such as diabetes and cancer throughout the world is driving expansion of the global anti-biofilm wound dressing market. Non-communicable illnesses are becoming more prevalent due to various factors such as smoking, alcohol usage, antibiotic resistance, and unhealthy and sedentary lifestyles.

Healthcare facilities, such as hospitals, have been overburdened as a result of the COVID-19 pandemic … read more

Payers Continue to Release Pertinent Coverage Policies

At the 2021 SAWC Fall, this reimbursement consultant/educator/author was honored to provide a main session reimbursement presentation, as well as a 3-hour interactive reimbursement post-conference workshop. The attendees at both venues were very attentive and asked many excellent questions. On the plane ride home, this author reflected on the questions that were asked at both sessions and came to the conclusion that many wound/ulcer management professionals either 1) have not implemented a process for monitoring and reviewing pertinent payers’ coverage policies or 2) have not incorporated these important “playbook guidelines” into their wound/ulcer management assessments, care plans, coding selections (diagnosis, evaluation & management, procedure, and product), and documentation … read more

Wound Care Technology: Advanced Tissue Therapeutics

Human knowledge is growing exponentially. This explosion is clearly evident in the field of Medicine. We hear almost daily about advances in cardiovascular and oncologic treatments. Medicine appears to be on the verge of extending human life well beyond 100 years. Fortunately, Wound Care physicians and their patients are also reaping the benefits of this rapid knowledge advancement. In the last decade, key elements in the body’s cellular healing processes have been elucidated. A major thrust has been in the development of human tissue therapies … read more

Expecting The Unexpected: When A Small Wound Has Big Implications

Acral lentiginous melanoma only accounts for only two to 10 percent of all reported melanoma types.1 Although the term “lentiginous” often refers to the typical dark coloration of the pathology, the dark coloration is not always a clinical finding, as multiple studies report amelanotic lesions, as well.2,3,4 Therefore, it is pertinent for every practitioner to give due diligence to any suspicious lesion and to know the key findings that may help differentiate a serious lesion from one that is more benign … read more

Compassionate and Versatile Brush-Biopsy for Histologic Wound Sampling

Soft K-Biopsy® – SFT-1000

 

SoftBiopsy® is a sterile single-use brush-curette is designed to be both minimally invasive and clinically effective for tissue sampling. The plastic applicator tip is coated with Kylon®, a patented medical fabric which dislodges and collects wound base tissue post-debridement, efficiently and effectively.

 

The SoftBiopsy® is designed with a trumpet shaped brush tip to easily press into the wound base surface and remove and trap a biopsy sample for anatomic pathology as curettings (tangential biopsy sample). When used post-debridement, it is optimal for molecular (PCR) or microbiological culture.

 

Organism ID Sampling Method

Once the biopsy is obtained, tissue samples for analysis are easily collected in the KYLON® hook tapered tip head and snapped off and placed into the vial to preserve tissue for organism (culture, PCR) or anatomic pathology lab analysis.

 

Request that your pathology lab that performs wound related tests contact us to become a Kylon® device “Center of Excellence”.

 

Brochure

 

Benefits:

  • Fabric pad on tapered applicator tip is designed for visible surface wounds that are visible on the body surface
  • Versatile use, Ergonomic, and minimally invasive design facilitates user tactile control for targeting and guiding the brushing, sweeping and rotational movements – modulating tactile pressure and method allows for tissue. removal and trapping using a pressure-twisting motion of the wound surface
  • Kylon® medical fabric hooks gently, yet substantially obtain abundant tissue samples that are trapped in the hook array, snapped free from the handle, and transported for laboratory analysis
  • Designed for compassionate patient experience and compliance

Clinical Scenarios: (Refer to Instructions for Use)

The SoftBiopsy® is indicated for tangential biopsy of wounds on visual surfaces in order to obtain a sterile biopsy sample. Once the tissue filled tip is detached and placed in a vial, it is transported for histological analyses and further laboratory evaluation regarding infection or other pathology

 

Contraindications: 

SoftBiopsy® is contraindicated for use with patients with known bleeding disorders or those on anticoagulant therapy, patients with an acute wound infection or condition that is not amenable to biopsy, patients with a known allergy to nylon or acrylic plastic, or patients who are pregnant or suspected to be pregnant when a wound biopsy would not be indicated

 

Warnings and Precautions: 

Federal law restricts this device to sale by or on the order of a physician or other licensed practitioner.

 

Storage Requirements: 

Consult manufacturer on special storage requirements outside of normal room temperatures.

 

How Supplied/Sizing: 

Box of 25 minimum order

 

Recommended Use: 

 

  • Burns
  • Chronic Wounds
  • Diabetic Foot
  • Graft Bed Preparation
  • Non/Minimally Exudating Wounds
  • Palliative Wounds
  • Pressure Ulcers
  • Non-Eschar/Solid/Fibrotic Wounds
  • Sloughy Wounds
  • Surgical Wounds
  • Venous Ulcers

Mode of Use/Application:

See manufacturer’s website for detailed instructions for use (IFU)

 

Clinically Tested: 

Latex-friendly

 

Product features: 

  • Single Use
  • Disposable
  • Instrument
  • Sterile

 

Other features: 

  • Educational Material Available
  • Free Samples/Trials Available
  • Published Clinical Study Available

 

Manufacturer: Histologics LLC – www.histologicswc.com

Histologics LLC’s primary objective is to advance a compassionate approach to debridement and wound biopsy sampling with devices using Kylon®, a medical fabric enabling biopsy with tissue capture, or frictional tissue cleaning, and debridement.

Website: 

www.histologicswc.com

Email: 

support@histologicswc.com

 

Phone: 

(888) 235-2275

Toll-free: 

(888) 235-2275

Fax: 

(888) 738-9757

A Challenging Case Of Limb Preservation For A Patient With Neuropathic Pedal Dislocation

In the summer of 2020, an 82-year-old male presented to the emergency department to evaluate right foot pain and swelling over the past week. He saw his primary care physician earlier in the morning, who referred him for more emergent evaluation. He states he fell at home one week ago, injuring his right foot. This initially resulted in minimal pain, but over one week, the pain and swelling continued to worsen. He notes that he had no open wounds or active bleeding at the time of the initial injury. However, over that week, in addition to the escalating pain and swelling, he developed a bleeding ulcer on the dorsal aspect of the right foot. He could stand and ambulate … read more

Impact of repeated remote ischemic conditioning on diabetic foot ulcers: A proof-of-concept study

 
The WHS Communications Committee is pleased to launch the WRR Fireside Chat video series to feature groundbreaking research in Wound Repair and Regeneration (WRR).

 

Each video Drs. Mitch Sanders, PhD and Kyle Quinn, PhD will feature a recent article in WRR.

 

Impact of repeated remote ischemic conditioning on diabetic foot ulcers: A proof-of-concept study
Author: Matthew Regulski, DPM

 View Article

Technology in Wound Care

In all fields of medicine, technology is changing and improving how we treat our patients. Wound care is no exception. From improved charting with electronic medical records to new treatment options to expanding access with the use of telemedicine, in wound care offices, technology plays an increasing role in our day to day interactions with patients.

The majority of physicians use an electronic medical record (EMR) for documentation, and in wound care, the way we use EMR’s to document is changing. New imaging technologies improve the accuracy of documentation and facilitate the process. For example, many wound centers still measure wounds with a ruler to document the length x width x depth and describe the type of tissue present in the wound. This opens up the possibility of user error, which may ultimately affect the way the wound is treated and the healing outcome overall. With newer imaging systems like the one from Tissue Analytics, the provider can picture, measure, and analyze the wound in one step, allowing for faster and more accurate documentation … read more

Is There An Optimal Metatarsal Length To Prevent Reulceration After Ray Amputations?

The podiatric surgeon frequently utilizes partial ray amputations aiming to remove infection while preserving bipedal ambulatory status and preventing further morbidity or mortality. An estimated 50 to 70 percent of lower extremity amputations take place due to diabetic complications, most commonly diabetic foot ulcers (DFUs) formed in the setting of peripheral neuropathy. Patients with diabetes often face additional comorbidities, including peripheral vascular disease and a diminished immune response, both of which increase the risk for ulcer development and complicate healing potential. Although amputation is an effective method of eradicating osseous infection, removing pedal anatomy will alter normal biomechanics and increase pressure distribution to surrounding structures. Furthermore, amputation of pedal structures involved in the gait cycle will require increased metabolic expenditure during ambulation. One hypothesis … read more

Roles of Oxidative Stress and Raftlin in Wound Healing Under Negative-Pressure Wound Therapy

Negative-pressure wound therapy (NPWT) is an effective way to promote wound healing. However, its mechanisms have not been investigated thoroughly. Growing evidence suggests that oxidative stress and Raftlin levels play important roles in wound healing. However, whether NPWT promotes wound healing through this mechanism remains unclear.
Purpose: Our study focuses on the different levels of oxidative stress and antioxidant response between wounds treated by NPWT and routine dressing change. The objective of this study was to measure the differences in Raftlin levels between the two groups, which is a new biomarker related to wound healing … read more

Preventing complications at wound dressing changes

This module aims to make clinicians aware of:

  • The importance of skin health and what makes it vulnerable to damage.
  • The damage that can occur when using medical adhesives and improper removal techniques.
  • The impact that MARSIs (medical adhesive-related skin injuries) can have on patients.
  • Ways to reduce the risk of MARSIs by providing appropriate treatment for at-risk patients groups.

read more

Executive Summary: Debridement

Canadian Best Practice Recommendations for Nurses Developed by Nurses Specialized in Wound, Ostomy and Continence Canada (NSWOCC)
Debridement is described in the literature as having a high level of clinical risk and may result in patient harm when performed by untrained nurses. As a result, specialized knowledge, skills, and competencies are required to initiate, direct, and perform safe and effective debridement. This executive summary provides an overview of Debridement: Canadian Best Practice Recommendations for Nurses from the Nurses Specialized in Wound, Ostomy and Continence Canada (NSWOCC). The primary objective of these recommendations is to positively influence patient outcomes and enhance safety. The 12 recommendations place the safety of the patient and nurse at the forefront and highlight the educational, competency, certification, preceptor/mentorship, and legal requirements for nurses to initiate, direct, and perform all methods of debridement. We designed these recommendations to be circulated and implemented widely by … read more

Determining Amputation Level To Optimize Functional Outcomes

Diabetes is the leading cause of non-traumatic amputations in the lower extremity.1 Around 15 percent of all patients with diabetes will develop a lower extremity ulceration, with these patients being 17 to 40 times more likely to require an amputation.1 Unfortunately for most, the decision to amputate is not always clear cut and the determination of where to make a definitive amputation is not always as it seems on plain films or advanced imaging, such as magnetic resonance imaging (MRI) or computed tomography (CT). There are several factors to consider when performing limb salvage procedures for these patients with diabetes … read more

APMA’s 2021 Diabetes Campaign, “Es Hora,” Focuses on Hispanic Males

November is Diabetes Awareness Month, and APMA’s Communications Committee is launching a new public education campaign designed to reach one of our most at-risk patient populations: Hispanic males. The campaign, “Es Hora,” offers a wealth of educational materials for you to use in your practice.

This content is available to APMA members only. If you are a member, please log in to see the full content … read more

Coding and Billing for the Foot and Ankle Surgeon

Take the first few steps to coding and billing by joining us for a comprehensive workshop covering the fundamentals of coding and billing for foot and ankle surgeons. Learn the foundation of the coding and billing process from expert colleagues before taking the ACFAS Coding and Billing for the Foot and Ankle Surgeon course. This course is for residents, fellows, new practitioners, office staff of foot and ankle surgeons or anyone who wants to learn more of the basic coding and billing terminology and process. Plus, if you’re a resident and attending Residents Day in the morning the day of the event, this course is a great next step to learning more about coding and billing for your future practice and can be bundled in your pricing … read more

Getting Back to Basic Wound Care

Author: Bill Richlen PT, WCC, DWC

My 25 years in the wound care field has been an incredible journey. Over the years I have been witness to better understanding of wound healing, better research and improved products and technology that has changed the way wounds are managed. At the same time, I regularly hear my students and colleagues share some of the practices being implemented today, along with many myths still being perpetuated, and it makes me wonder “what happened to the basics?”. I once learned from a colleague and now include it my teaching that there are 2 fundamentals to heal all wounds: 1) healthy patient; and 2) healthy wound. As long as those fundamentals are achieved, a wound is likely going to heal despite what you do it … read more

Evidence in wound care

There is an ever-growing variety of products and devices available to practitioners to improve healing rates and patient outcomes, but practitioners should be able to critically appraise evidence to make appropriate evidence-based changes to practice. This position document reviews the available evidence in wound care, looking especially at the critical appraisal of level 1 evidence, before considering the steps required to translate evidence to practice … read more

Printing technique creates effective skin equivalent, heals wounds

Chronic wounds are deep and difficult to repair. Often, the top of the injury heals before the bottom, so the wound collapses in on itself. Over time, this can result in scar tissue and reduced skin function … The technique is the first of its kind to simulate three layers of skin: the hypodermis, or fatty layer, the dermis, and the epidermis … “You effectively have three different cell types. They all grow at different speeds,” said author Alan Smith. “If you try to produce tri-layered structures … read more

MolecuLight Announces Availability of its MolecuLight i:X® Platform on Epic’s App Orchard

Save MolecuLight i:X fluorescence wound images and measurements in Epic
Toronto, CANADA – (August 12, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform on the Epic App Orchard Marketplace and the integration of its platform with Epic’s leading EMR (electronic medical record) platform.

Users who use Epic for the treatment of wounds can upload standard and fluorescence images, and measurements captured with the MolecuLight i:X device at the point-of-care to the patient’s record. The integrated platforms allow clinicians to optimize their workflow and document their patients’ wounds digitally. The MolecuLight i:X application – iX Imaging – is available on the App Orchard.

“We are proud to announce the inclusion of our MolecuLight i:X platform in the Epic App Orchard Marketplace to allow customers to generate and access documentation of patients’ wounds”, says Anil Amlani, MolecuLight’s CEO. “The MolecuLight i:X is the only point-of-care device enabling clinicians to capture wound images showing clinically significant bacteria, information that improves clinical decision making to ensure the fastest path to healing. The integration of this additional information into existing documentation protocols will provide clinicians with a more complete wound dataset.” … read more

NHS Resolution reviews medical negligence claims by patients with diabetes and lower limb complications

The NHS’s defence organisation, NHS Resolution, are reviewing past medical negligence claims against the NHS by patients with diabetes who suffered lower limb complications. Most of these cases relate to patients with non-healing foot ulcers, who then needed major lower limb amputations. The aim of the review is to identify and report on the themes which are common in these cases to help the NHS learn from its mistakes. NHS Resolution hope that by raising awareness of the risks and need for consistent, correct treatment of diabetes-related lower limb problems, both the number of amputations and the cost to the NHS can be reduced. The key message of the review will be that lower limb amputations are often preventable, but this requires NHS organisations to work together to improve care for these patients. The review will be published within the next few months … read more

Wound Healing Gets a Boost from 3D Printed Platelet-Rich Plasma

Researchers from RCSI University of Medicine and Health Sciences report replicating a crucial component of our blood may aid wound healing … The findings are published in the journal Advanced Functional Materials in a paper titled, “3D Printed Scaffolds Incorporated with Platelet-Rich Plasma Show Enhanced Angiogenic Potential while not Inducing Fibrosis,” and led by researchers at the Tissue Engineering Research Group (TERG) and SFI AMBER Centre based at RCSI’s department of anatomy and regenerative medicine … read more

3 Steps For Turning Wound Care Into Staff Inspiration

Staffing was a challenge in skilled nursing care prior to the COVID-19 pandemic, and like all segments of health care, the problem has only worsened for SNFs since March 2020. But new figures from the Bureau of Labor Statistics are nevertheless a shock to the system … Since the start of the pandemic, the industry lost a startling 221,000 jobs — or 14% of its workforce — from March 2020 to October 2021. This is a significantly greater loss than any other health care segment, well ahead of the 8.2% drop in assisted living staff … read more

ZZ Biotech Announces First Patients Dosed in Phase 2 Clinical Trial of 3K3A-APC for

Treatment of Amyotrophic Lateral Sclerosis (ALS)
HOUSTON–(BUSINESS WIRE)–ZZ Biotech, a clinical stage biopharmaceutical company developing the experimental drug 3K3A-APC for some of the biggest unmet needs in stroke, neurodegenerative disease and chronic wound healing, today announced that the first patients have been dosed in a Phase 2 clinical trial evaluating 3K3A-APC for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The study is being conducted at Macquarie University, in Sydney, Australia, and seeks to investigate whether 3K3A-APC is safe and potentially effective in patients with ALS. The Firies Climb for Motor Neurone Disease provided an AU$1 million donation to support this clinical trial … The Phase 2 open label trial (NCT05039268) will enroll a total of 16 patients with ALS into two dose cohorts. The primary study outcomes are to ensure the safety and tolerability of 3K3A-APC in ALS patients and to determine whether 3K3A-APC is able to reduce the pathological changes that are thought to cause ALS. The study will evaluate biomarkers of microglial and monocyte activation and should provide evidence as to whether microglial activation is a major pathogenic contributor to ALS … read more

Singapore tests out ‘smart bandage’ for remote recovery

SINGAPORE – Researchers in Singapore have developed a smart bandage to enable patients to have chronic wounds monitored remotely via an app on a mobile device, potentially saving them visits to the doctor … A research team at the National University of Singapore has created a wearable sensor attached to a transparent bandage to track progress in healing, using information like temperature, bacteria type, and levels of pH and inflammation … “Traditionally when someone has a wound or ulcer, if it’s infected, the only way to examine it is through looking at the wound itself, through visual inspection … read more

Stem cell memories may drive wound repair, and also chronic disease

A trifling paper cut is a site of frenzied activity. Within it, a squad of epidermal stem cells briskly regenerate to patch up the wound. A closer inspection of this war-torn swath of epidermis will reveal that while some of the stem cells are native to the area, others are newcomers—former hair-producing stem cells, that—upon sensing nearby injury—migrated from the hair follicle to the wound bed, where they transformed to resemble indigenous epidermal stem cells … read more

A Comparative Study of Efficacy of Povidone Iodine Versus Super Oxidized Solution in Lower Limb Ulcers

BACKGROUND Wounds and their management are important in the practice of surgery. Super oxidised solution is a recent concept in wound management. It is an aqueous solution which is electrochemically processed which is non-toxic, non-irrigating and is having a neutral pH. Povidone iodine is the most common topical wound care product used in surgical practice. Both are affordable solutions for the patients. There are very few studies comparing the efficacy. In this study, we wanted to compare the efficacy of super oxidised solution and povidone iodine in the management of lower limb ulcers. METHODS A prospective study was conducted on 100 patients who were randomized into two groups. Group A was treated with super oxidized solution and Group B were treated with povidone iodine. Assessments of wounds were done on various days (1, 3, 5, 7, 9, 12, 15, 18, 21). Various outcomes of data were analysed using statistical analysis. RESULTS The average percentage reduction in wound size on day 21 was 47 % in Group A compared to 24 % in Group B. Early appearance of granulation tissue, disinfection, decrease in wound size, and less duration of hospital stay was achieved in Group A. CONCLUSIONS The results were more favourable towards super oxidised solution than povidone iodine. In this comparative study, super oxidized solution had faster efficacy and wound healing … read more

Diversity and Pressure Injury Prevention: Important Terms to Know

 

Erythema: A result of injury or irritation that causes dilation of blood capillaries and manifests as patchy reddening of the skin. Occurs after a patient/resident is exposed to unrelieved pressure for 2 hours. It can be identified as a deep, localized redness; can also be blue or purple.

 

Hyperemia: The condition of having excess blood in vessels that supply an organ or area of the body. Occurs after patient/resident is exposed to 30 minutes of unrelieved pressure. It can be identified as a localized, non-blanchable redness.

 

Perfusion: The passage of blood through arteries and capillaries into tissues or organs. When insufficient, there is an increased chance that the patient may have complications.

more

Wound Care Search Engine

Beyond being a great source for news, Wound Care Weekly is also an effective search engine for wound care related content. Google searching will reflect results targeted toward the general public where our search results will be derived from thousands of articles written almost exclusively for medical professionals.

 

Use italics for more focused search results “foot ulcer”

Smart wound dressing provides suture-free closure of surgical incisions

It is a staple of science fiction to mock sutures as outdated. The technique has, after all, been in use for at least 5,000 years. Surely medicine should have advanced since ancient Egypt. Professor Hossam Haick from the Wolfson Department of Chemical Engineering at the Technion has finally turned science fiction into reality. His lab succeeded in creating a smart sutureless dressing that binds the wound together, wards off infection … read more

Research holds promise of new information about skin injuries

Biomedical engineering professor Kyle Quinn has received a four-year, $1.6 million grant from the National Institutes of Health to develop non-invasive, real-time “optical biopsies” of chronic skin wounds.

The goal of Quinn and researchers in his lab is to provide digital histopathology images — the microscopic examination of tissue to study the manifestation and progression of disease — and other quantitative information without the need for an invasive biopsy, tissue processing and staining with histology dyes … read more

‘Death is a greater risk’ than amputation after diabetic foot ulcer

People with diabetes and a history of foot ulcer are more likely to die than undergo amputation during 6 years of follow-up, a potential measure of effectiveness of diabetes care, registry data from Scotland show.

In an analysis of real-world data comparing people with diabetes with and without foot ulcer, researchers also found amputation or death occurred for approximately one in two of those with a prior foot ulcer … read more

Frank & Lizzie Show: Episode 009, Dr. Jeffrey Lehrman and Moira Sykstus, Wound Week 2022

On this episode, Frank & Lizzie’s guests Dr. Jeffrey Lehrman and Moira Sykstus share insight on their upcoming “Coding, Compliance, and Documentation in Wound Care” course held during the American Professional Wound Care Association’ s (APWCA) Wound Week 2022 conference in Philadelphia. This course will be held on Thursday, February 24, 2022 at the Loews Hotel. The conference will be held Feb 24-27, 2022. For more information about Early Bird Discounts, New Member deals, and more, visit woundweek.com.

The role of non-medicated dressings for the management of wound infection

There is growing concern regarding the treatment of infection, caused by the rise of antimicrobial resistance. This position document looks at current treatment approaches to identifying and treating biofilm in wounds, focusing on the mechanism of action and role of non-medicated wound dressings (NMWDs) within antimicrobial stewardship practices and evidence that supports their effectiveness … read more

Strategies to reduce practice variation in wound assessment and management

The T.I.M.E. Clinical Decision Support Tool
This document seeks to help clinicians support those who do not have specialist wound training to accurately assess patients and their wounds and arrive at a broad-based, systematic rationale that will ultimately help reduce variations in clinical decision-making. The T.I.M.E. Clinical Decision Support Tool provides a structured approach to wound bed preparation … read more

Development and Implementation of an Individualized Turning Program for Pressure Injury Prevention

Using Sensor Technology in Nursing Homes: A Quality Improvement ProgramA Quality Improvement Program
Turning nursing home residents every 2 hours has been a long-held standard for pressure injury (PrI) prevention in individuals with mobility impairments although evidence to substantiate this practice is limited. New guidelines recommend personalizing turning schedules to support person-centered care but lack specific recommendations about which turning frequencies are appropriate for various risk levels. PURPOSE: This quality improvement program aimed to determine the feasibility and outcomes of using individualized turn schedules for newly admitted nursing home residents. METHODS: An expert panel of wound clinicians developed, tested, and implemented a turn frequency tool that allowed staff in 2 nursing homes to select a turning schedule of 1, 2, 3, or 4 hours based on resident risk factors. Turning schedules were operationalized using a wearable sensor-based visual cueing technology that alerted staff to resident repositioning needs. Nonparticipating resident data were collected for comparison of PrI incidence. Descriptive statistics were calculated for all covariates. Significance of differences tests were performed as … read more

A Review: Matrix Metallopeptidase-9 Nanoparticles Targeted for the Treatment of Diabetic Foot Ulcers

Diabetes foot ulcers are a leading cause of death in diabetic individuals. There are very few medicines and treatments that have received regulatory clearance for this indication, and numerous compounds from various pharmacological classes are now in various stages of clinical studies for diabetic foot ulcers treatment. Multiple risk factors contribute to diabetic foot ulcers, including neuropathy, peripheral artery disease, infection, gender, cigarette smoking, and age. The present difficulties in diabetic foot ulcers treatment are related to bacterial resistance to currently utilized antibiotics. Inhibition of the quorum sensing (QS) system and targeting matrix metallopeptidase-9 (MMP-9) are promising. This study focuses on the difficulties of existing treatment, current treatment technique, and novel pharmacological targets for diabetic foot ulcer. The electronic data base search diabetic for literature on foot ulcers treatment was carried out using Science Direct, PubMed, Google-Scholar, Springer Link, Scopus, and Wiley up to 2021. Becaplermin, a medication that targets MMP-9, glyceryl trinitrate, which inhibits the bacterial quorum sensing system, probiotic therapy, and nano technological solutions are just a few of the novel pharmaceuticals being developed for diabetic foot ulcers … read more

Study shows how management of serious diabetic foot ulcers was possible during the COVID-19 lockdown

New research being presented at the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct), reveals how Belgium’s efforts to maintain a diabetic foot care program during the COVID-19 pandemic can offer valuable lessons to the rest of the world … “Thanks to the great efforts of diabetic foot clinics, continued availability of diabetic foot ulcer services during lockdown, although in a limited capacity, were really helpful, and may be the reason why we didn’t see late presentation and the impact on the severity of ulcers was limited to slightly larger wounds”, says lead author Dr. An-Sofie Vanherwegen from Sciensano … read more

WoundSource Upcoming Webinars

December 01, 2021 2:00 pm to 3:00 pm EST

Presenter: Robert J. Klein, DPM, FACFAS, CWS; Catherine T. Milne, MSN, APRN, CWOCN-AP and Dot Weir, RN, CWON, CWS

December 09, 2021 12:00 pm to 12:45 pm EST

Presenter: Naz Wahab, MD, FAAFP, FAWPCA

December 17, 2021 11:00 am to 12:00 pm EST

Presenter: Neesha Oozageer Gunowa MSc, PGCert, BSc, SPT, DN, RN, QN

Efficacy of Hydromechanical Therapy in Nonhealing, Chronic Wounds

as a Cost- and Clinically Effective Wound Care Modality

Chronic wounds pose a widespread challenge to health care, with many new, costly wound care modalities introduced in recent years with varying degrees of success. Bacterial biofilms have been postulated as one of the main culprits of the stagnation of chronic wound healing. For years, surgical fields have used pressurized irrigation for cleansing surgical wounds, but its utility in managing nonhealing chronic wounds has often been overlooked. Objective. In this case series, the authors aimed to demonstrate that hydromechanical therapy with pressurized irrigation can be a cost-effective and clinically effective wound care modality … read more

Trends in Wound Care Audits & Denials, with Dr. Caroline Fife and Dr. Helen Gelly

Last week I (Dr. Caroline Fife) enjoyed a relaxed, unscripted conversation with Dr. Helen Gelly about trends in wound care audits and charge denials, with a live audience Q&A. You can watch the recording of the conversation and Q&A below.

You can also find the audio of this event on Google Podcasts by searching for the Intellicure Wound Care Podcast.

Cold plasma ionised gas as new treatment for diabetic foot ulcers could also kill COVID-19 virus indoors

A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems … Enhancing cold plasma ionized gas with peracetic acid eradicates bacteria in wounds and substantially reduces SARS-CoV-2 viral loads, Australian and UK scientists claim in a paper published in Applied Physics Letters … read more

The FDA’s Take on Diabetic Foot Ulcer Treatments

This is fairly complex issue. There are many factors in responding to your question. Really, it’s multi-factor issue. Part of the challenge is that the regulatory agency, FDA, has a very clear, and at the same time, very narrow definition of wound healing. That is 100% wound closure with no drainage or no need for any dressing … read more

Embedding Predictive Analytics Into Your Wound Care Workflow Webinar

This webinar, presented by Matt Berezo, Joshua Budman, Abbey Cooper, and Cathy Thomas Hess will discuss how wound care-specific analytics can impact a practice’s workflow. Specifically, the presenters will discuss several clinical analytics models, how they are validated, and how clinicians can use them to improve their clinical and operational outcomes … register

Resolving Patient and Provider Concerns: Overcoming Another Year of Disruption

As 2021 comes to a close, it marks 2 full years that the US, Canada, and other parts of the world have endured the effects of COVID-19 on our personal and professional lives. The pandemic continues to force our hands in so many ways that were unimaginable just a short time ago and has had innumerable unforeseen consequences for patients and providers. In this issue, articles on provider- and patient-centered concerns speak to the social, psychological, and physical components that determine quality-of-life scores and impact activities of daily living … read more

Hyperbaric oxygen therapy reduces thermal wound complications and length of stay in hospitals, study finds

Hyperbaric oxygen therapy (HBOT) can reduce thermal wound complications, length of stay in hospitals due to thermal burns, intercellular adhesion molecule 1 (ICAM-1) mRNA gene expression, and ICAM-1 serum level, a case-control study published in Annals of Medicine and Surgery concludes.

“The damaging effects of thermal burns need to be managed holistically in order to create a suitable environment for wound healing,” study author Mendy Hatibie Oley (University Sam Ratulangi; R D Kandou Hospital; Hyperbaric Centre Siloam Hospital; all Manado, Indonesia) et al write … read more

Workflow Strategy Snapshots: Fresh Focus for the New Year

Kicking off any new year allows us to pause and reflect on the previous year’s actions and results. When you work within wound care, perhaps your first action this year was to review your schedule of patients to ensure they were provided the proper time to be seen, or review your staffing matrix to ensure you are you are meeting the needs of the scheduled patients, or dig into your supply cabinets to ensure inventory is abundant. Each action is vital to maintain your business and is interconnected to your unique process … read more

Where Are We With Point-Of-Care Testing For PAD In Patients With Diabetes?

How reliable are our screening tools for peripheral arterial disease (PAD)? A recently published meta-analysis suggests that while our current diagnostic testing measures are promising, one should be wary of relying upon any one tool in isolation in patients with diabetes.

In their 2020 study in the Journal of Vascular Surgery, Normahani and coworkers reviewed and analyzed studies to evaluate the accuracy of bedside testing for PAD in patients with diabetes.1 In examining the diagnostic accuracy of the ankle-brachial pressure index (ABPI), the toe brachial pressure index (TBPI) and the tibial waveform assessment, these authors reviewed 11 studies (including a total of 1,543 limbs) … read more

Delayed Care During the COVID-19 Pandemic: Effects on Chronic Wound Therapy

Chronic wound care is challenging for the entire healthcare ecosystem, from clinicians to patients, and COVID-19 has only exacerbated those challenges. Patients are delaying primary care provider and wound clinician visits for ongoing guidance and therapy to reduce possible exposure to the virus. This is understandable, as many chronic wound patients are in the high-risk category if they become ill with COVID-19.1 They are also putting off elective surgeries, annual physicals, and basic preventive care, which can negatively affect long-term outcomes. A survey of wound care clinicians in March 2021 reported a decrease in patient visits from pre-pandemic numbers, and 57% of respondents stated that “wound severity has either increased or significantly increased since the start of the pandemic.”2 At the same time, the pandemic has accelerated patient-driven care and increased usage of interactive devices for care administered at home, rapidly increasing the use of telemedicine across demographics … read more

Safe and effective wound healing preparation reaches Clinical Phase II

APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells. APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore recommended continuation into a Phase II clinical trial. This represents a major success for the wound healing preparation developed at MedUni Vienna … read more

Cleveland Clinic surgeon helps draft Amputation Reduction and Compassion Act

But there is legislation moving through Congress that seeks funding to improve public awareness and early detection.

Vascular surgen Dr. Lee Kirksey of the Cleveland Clinic said there is no disease that ravages the body quite like diabetes. The complications can be serious: heart attacks, strokes, kidney failure and the most worrisome and drastic of all, limb loss.

“When I talk to diabetics, their greatest fear and they know that they can have a heart attack or stroke, their greatest fear is having to have an amputation,” said Dr. Kirksey.

According to Dr. Kirksey, as many as 25% of patients with diabetes at some point will develop a foot ulcer and if left untreated, that ulcer can lead to infection and amputation … read more

Chronic Venous Leg Ulcer in Klinefelter Syndrome Treated with Platelet-Rich Fibrin: A Case Report

Venous leg ulcers (VLUs) are the most common causes of leg ulcers due to venous insufficiency. Most cases persist for more than 6 weeks, referred to as chronic VLUs. These chronic ulcers have been described as a manifestation of Klinefelter syndrome (KS). Platelet-rich fibrin (PRF) is a second-generation platelet concentrate, which contains growth factors required for chronic wound healing. The use of PRF in the management of VLUs in KS has not been reported, to the best of our knowledge. We report a case of chronic VLU associated with KS in a 41-year-old man treated with PRF. Dermatological examination showed a tender, shallow, irregular ulcer partly covered with hard, yellow necrotic tissue on the anterior side of the lower-left leg and hyperpigmented indurated skin on both lower legs. The diagnosis of venous ulcer was established based on clinical manifestation and supported by the result of Doppler ultrasound showed chronic venous insufficiency. Histopathological examination, which showed epidermal acanthosis … read more

Malaysian Diabetics Develop Complications After Delayed Screening, Treatment

A medical doctor says the proportion of diabetes cases that developed complications may have risen by roughly 15 to 20 per cent.
KUALA LUMPUR, Nov 25 — Late detection and interruptions to clinic visits for diabetic treatments during the Covid-19 pandemic have led to complications in some patients … Many had their appointments deferred as the government imposed a nationwide lockdown in March last year … “Because of the first movement control order (MCO 1.0), there is a higher chance for us to see patients who are coming in, not only with diabetic foot ulcers, but some may have rot their toes and limbs,” the doctor said … read more

Lower Extremity Wounds: Differential Assessment and Management

Determining Wound Etiology:
Predominant pain pattern, ulcer location, ulcer appearance, type and amount of wound exudate, and vascular and sensorimotor assessment are some key factors used to determine the primary etiology of lower extremity ulcers.1

Etiology Guides Treatment:
Certain patients will have a clear presentation of wound etiology, whereas others may present with a mixed wound appearance. The certified wound specialist will complete a thorough history and physical assessment when determining wound etiology. From there, an individualized plan of care will be created, implemented, and continuously evaluated. For example … read more

Overcoming Health Inequities In Wound Care

Q: What resources do you use and/or recommend for physicians to educate themselves on health inequities, especially in the field of wound care?
A:
Babajide Ogunlana, DPM, FACFAS, encourages physician to learn first-hand by engaging in community outreach-type programs that seek to improve access to care.

“The field of wound care has a lot of cost implications that tend to tilt the services offered and/or available to the patient in the direction of who can afford it or whose insurance company … read more

DDI holds course on managing diabetic foot complications

KUWAIT: Dasman Diabetes Institute (DDI), a leading diabetes research Institute established by the Kuwait Foundation for the Advancement of Sciences, held recently its specialized three-day course on the ‘Prevention and Management of Diabetic Foot Complications’.

This program was held at the Institute and attended by healthcare professionals. Trainees learned to assess and treat the feet in people with diabetes using evidence-based assessment and treatment methods, aimed at reduction of diabetic foot ulceration and amputation. This program was organized and delivered by Kay Scarsbrook Khan, Chief Podiatrist and Dr Abdullah Al-Ajmi … read more

Wound Care and Healing for Neonates

A study published in the Advances in Skin & Wound Care Journal examined wound care information to help educate about care for the specific physiology of newborns.

A group of researchers aimed to help physicians differentiate the use of hydrocolloids, hydrogels, foam dressings, and barrier creams in the neonatal population and identify issues related to the use of solvents, alginates, collagen dressings, and negative pressure wound therapy (NPWT) in neonates, according to an article in the Advances in Skin & Wound Care journal.1

PubMed, Google Scholar, and other journals/textbooks were used to help collect data on wound healing in newborn patients. With this data, the authors of the study aimed to discuss what is already known about wound milieu in premature and full-term neonates, including the unique challenges pediatric clinicians face, the therapies that have proven effective, and the therapies … read more

The Burden of Wound Care

A study investigated the clinical and economic burdens of wound care in the Tropics during a 5-year institutional review.

In an article published in the International Wound Journal, researchers evaluated the clinical and economic burden of wound care in the Tropics during a 5-year institutional population health review that occurred from 2013 to 2017.1

The 55,583 wounds included in the study were classified into different subtypes: neuro-ischaemic ulcers (NIUs), venous leg ulcers (VLUs), pressure injuries (PIs), and surgical site infections (SSIs). There were 41,461 patients admitted during that time with a 95.1% increase in wound episodes per 1000 inpatient admissions during this period (142 and 277 wound episodes per 1000 inpatient admissions in 2013 and 2017, respectively).

In 2017, the average amount of time a patient had to stay in the hospital for wound care were 17.7 … read more

Promoting Pressure Injury Prevention Technology

Do you remember that cartoon from the 1960s (and later reproduced in the 1980s), The Jetsons? It was about a futuristic family that had all kinds of amazing robot helpers and automatic appliances. Rosie the Robot was the wonderbot that would whisk about the house, frantically preforming housekeeping duties, monitoring the security of the home, and generally making sure that everything was online and functioning. Do you ever feel like this as a clinician? Rushing about, multitasking, being pulled in what seems like a hundred different directions, all while expected to perform with “Rosie-like” perfect, machine-like efficiency. Wouldn’t it be wonderful to have Rosie’s artificial intelligence technology … read more

 

Related: Pressure Injuries and Disparities in Health Care: Important Terms to Know

Pressure Injury Monitoring: Using Technology in a Time of Hospital Overcrowding

In the last 2 years, hospitals and skilled nursing facilities have seen unprecedented surges in admissions attributed to the COVID-19 pandemic sweeping across the world. Just in the United States, we saw a high of 116,243 weekly hospital admissions in mid-January of 2021. This dropped to a low of 13, 424 in mid-June of 2021 and then bumped up again to 86,871 in August of 2021.1 With this fluctuation of numbers, along with staffing shortages and burnout, wound care professionals have seen significant overcrowding in many hospitals and facilities. Caregivers and clinicians are stretched thin. They are taking on more patients, who tend to be sicker and with more acute needs on a global scale. These patients tend to be at higher risk of developing a pressure injury … read more

Cellphones Help MDs Monitor Surgical Patients for Infections

The crystalline clarity with which smartphones can now capture images has been put to another innovative use: monitoring patients who’ve undergone emergency abdominal surgery for surgical-site infections (SSIs) and allowing physicians to diagnose them earlier in the postoperative period before they morph into a much bigger problem.

“Since the COVID-19 pandemic started, there have been big changes in how care after surgery is delivered,” Kenneth McLean, MBChB, University of Edinburgh, Scotland, observed in a statement.

“Patients and staff have become used to having remote consultations and we’ve shown we can effectively and safely monitor wounds … read more

Pressure Injury Prevention: Recognizing the Early Signs of Injury

Here’s a question for you: How long does it take for a pressure injury (PI) to form? Do you think it happens in 30 minutes? 2 hours? 8 hours? The answer is actually all of the above. The time it takes for a PI to develop depends on a number of different factors, which we will discuss here. This blog will describe how a PI forms, some signs that a PI is forming, and how to assess a patient’s skin for a PI. It will then look at some types of intervention and assessment that help in the prevention and treatment of a PI, as well as track its healing or declination … read more

Gel-Based Sensor Continuously Monitors Wounds for Infection

When bacteria make their way into wounds, they literally threaten life and limb—unless they are detected as quickly as possible. A new sensor can nestle in bandages and alert a nearby smartphone when the bacterial population tips over into dangerous territory.

Healthy human skin is covered with bacteria such as Staphylococcus aureus and Escherichia coli, which are quick to colonize an open wound. To prevent the bacteria from spreading through the body, which can permanently injure or kill a person, the infected wound may need to be cleaned and treated with antibiotics or—in the most extreme situations—the affected limb may require amputation … read more

Building a Pressure Injury Prevention Plan in a Low-Resource Facility

A nurse recently shared some of her experiences as a charge nurse in a skilled facility during the COVID-19 pandemic. She worked evenings (3-11:30 pm) at a local facility and was overwhelmed by the high number of patients she was responsible for. She typically worked on a 26-bed floor with just one nurse assistant for the shift. She later transferred to the night shift, where she was the only person on a 16-bed unit for the 8 hours. When asked how she was able to reposition patients as frequently as was recommended, the nurse said that she did “the best I could.” She is, unfortunately, not alone … read more

Imcivree Considered for Expanded Label; Semglee Hits Shelves; Buphenyl for T2D?

The FDA accepted a priority review of a supplemental new drug application for setmelanotide (Imcivree), a melanocortin-4 receptor agonist, for the treatment of Bardet-Biedl syndrome and Alström syndrome, Rhythm Pharmaceuticals announced. The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 16, 2022 … After getting the green light from the FDA, Paracrine announced plans to initiate its pivotal ASCEND trial testing its Celution System for diabetic foot ulcers … read more

ProgenaCare Global announces effective applications of novel keratin matrix technology, ProgenaMatrix

ProgenaCare Global, formerly Cell Constructs, has developed innovative products for wound healing that provide excellent outcomes for patients, while advancing the use of renewable materials. The company’s wound care technology, ProgenaMatrix™, incorporates human keratin as a major component of the highly effective and affordable wound therapy.

The all-natural robust human keratin protein option that constitutes this specialized biomaterial offers a completely unique solution to wound care clinicians. The human keratin technology in ProgenaMatrix is hydrated, non-cellular (not tissue-based), non-resorbing and supports the body’s own healing process. The bio-inspired design makes ProgenaMatrix the next generation of advanced wound therapy in the CMS skin substitute category … read more

Help support Wound Care Weekly


Help support non-profit medical journalism. If you find WoundCareWeekly.com of value please consider a monthly donation to help cover expenses and keep this website going.
 

ProgenaCare Global Announces Effective Applications Of Novel Keratin Matrix Technology, ProgenaMatrix

ATLANTA, November 17, 2021 / PRNewswire / – ProgenaCare Global, formerly Cell Constructs, has developed innovative wound healing products that deliver great patient outcomes while advancing the use of renewable materials. The company’s wound care technology, ProgenaMatrix™, contains human keratin as the main component of highly effective and inexpensive wound therapy.

The all-natural, rugged human keratin protein option that makes up this specialized biomaterial offers surgeons a completely unique solution. The human keratin technology in ProgenaMatrix is ​​hydrated, non-cellular (non-tissue-based), non-resorbing and supports the body’s own healing process. The bio-inspired design makes ProgenaMatrix the next generation of advanced wound therapy in the CMS skin replacement category.

Keratin technology has been in the published literature for over a century with applications in wound healing, drug delivery, tissue engineering, trauma and medical devices … read more

In South L.A., a legacy of limbs lost to diabetes tells a larger story

Her small toe was turning purple, and the pain was excruciating. Glory Paschal knew how fast this could spiral. She just had to look around her neighborhood in Watts to see how many residents were missing feet and legs.

She fought for a referral to a podiatrist, but by the time she saw one, it was too late.

On Feb. 10, 2011, doctors at Harbor-UCLA Medical Center had no option but to amputate her left leg below the knee.

This summer, the now 53-year-old Black grandmother was back in the hospital, this time with two infections particularly lethal for a diabetic: severe COVID-19 had her gasping for breath and gangrene was eating away at her remaining foot … read more

Paracrine Receives Full FDA Approval of Investigational Device Exemption (IDE) to Launch a

U.S. Pivotal Trial in Patients With Diabetic Foot Ulcers
Paracrine, Inc. announced today that the FDA has granted full approval of its Investigational Device Exemption (IDE) to conduct a new pivotal trial titled Adipose Derived Regenerative Cells (ADRCs) in the Treatment of Diabetic Foot Ulcers (DFUs): A Prospective, Double-blind, Multi-center, Randomized, Parallel-group Study – The “ASCEND Trial.”

The ASCEND Trial is a Pivotal Trial designed to provide a robust data set on the safety and efficacy of ADRCs in the treatment of patients with DFUs. The trial will include up to 291 patients at 25 clinical sites in the U.S. Trial results will be submitted in a Premarket Approval (PMA) application to the FDA to support regulatory approval.

Dr. Robert G. Frykberg, Co-Principal Investigator for The ASCEND Trial and past Foot Care Council Chair of the American Diabetes Association, stated: “Despite recent advancements in wound care and pharmacotherapy techniques, up to one quarter of patients with diabetes will develop diabetic foot ulcers – a leading cause of disability worldwide. The goal of this pivotal study is to compare the use of ADRCs against the current standard of care and determine if ADRCs can improve clinical outcomes in this challenging patient population.” … read more

Compassionate Debridement at your Fingertips®

Soft K-Cot® brush-curette is designed to be both minimally invasive and clinically effective for wound hygiene, debridement, and optional tissue sampling. The nitrile finger cot tip is coated with Kylon®, a patented medical fabric which dislodges and collects wound debris efficiently and effectively.

 

Histologics LLC’s primary objective is to advance a compassionate approach to debridement and wound sampling with devices using Kylon®, a medical fabric enabling frictional tissue cleaning, and debridement with optional specimen capture.

 

Benefits:

  • Fabric disk on finger cot tip is designed for flat or curved wounds that are visible on the body surface
  • Versatile use, Ergonomic, and minimally invasive design facilitates user tactile control for targeting and guiding the brushing, sweeping and rotational movements – modulating tactile pressure and method allows for light brushing away of debris versus pressure twisting motion curettage of the wound surface.
  • Kylon® medical fabric hooks gently, yet substantially excavates the wound surface, dislodging debris and necrotic tissue, which can be easily wiped off the wound surface with gauze
  • Designed for compassionate patient experience and compliance
  • Promotes the efficiency of a debriding procedure
  • Abundant tissue samples can be collected, stored and transported for laboratory analysis

Indications:
The Soft K-Cot® is indicated for patients with small to moderate sized (no larger than 6cmx6cm), non-fibrotic surfaces of wounds requiring cleansing or debridement in order to remove non-viable tissue and debris. Debridement may stimulate blood flow to encourage tissue regrowth. It is also indicated for scraping or debriding and then transporting tissue requiring histological analyses for further laboratory evaluation regarding infection or other pathology.

 

Contraindications:
Soft K-Cot® is contraindicated for use with patients with known bleeding disorders or those on anticoagulant therapy, patients with an acute wound infection or condition that is not amenable to debridement, patients with a known allergy to nylon or acrylic plastic, or patients who are pregnant or suspected to be pregnant when a wound biopsy would not be indicated.

 

Warnings and Precautions:
Federal law restricts this device to sale by or on the order of a physician or other licensed practitioner.

 

Storage Requirements:
Consult manufacturer on special storage requirements outside of normal room temperatures.

 

How Supplied/Sizing:
Box of 25 minimum order

 

Recommended Use:

  • Burns
  • Chronic Wounds
  • Diabetic Foot
  • Graft Bed Preparation
  • Non/Minimally Exudating Wounds
  • Palliative Wounds
  • Pressure Ulcers
  • Sloughy Wounds
  • Surgical Wounds
  • Venous Ulcers

 

Mode of Use/Application:
See manufacturer’s website for detailed instructions for use (IFU):
Instructions for use

 

Clinically Tested:
Latex-friendly

 

Product features:

  • Single Use
  • Disposable
  • Instrument
  • Sterile
  • Variety of sizes

 

Other features:

  • Educational Material Available
  • Free Samples/Trials Available
  • Published Clinical Study Available

 

Free Sample Kit Available on Request to:
support@histologicswc.com

 

Histologics LLC, 4095 E. LaPalma Ave, St N, Anaheim, CA 92807, (888) 235-2275
www.histologicswc.com
support@histologicswc.com

A Review of the Skin Failure Concept

My colleagues, Barbara Delmore PhD, RN, CWCN, MAPWCA and Jill Cox PhD, RN, APN-c, CWOCN, and I have written a paper,1 available electronically ahead of print, that reviews the skin failure concept, defines related controversies, and proposes a model for its pathogenesis. Like all other organs, skin can fail; however, experts continue to grapple with definitions, causative factors, and manifestations. By defining contributing factors that apply to other organ systems, providers establish skin failure as an entity and thus are able to recognize and address it in practice. This also enables providers to assist regulators by incorporating these pathophysiologic factors into modification of quality measurement criteria. Unifying the concept across the health care continuum … read more

Kent Imaging named #15 on the list of “The 20 Most Promising Businesses to Watch in 2021”

Global Business Leaders magazine features Kent Imaging: Setting A New Global Standard in Advanced Tissue Assessment.

CALGARY, ALBERTA, CANADA, November 16, 2021 /EINPresswire.com/ — Kent Imaging Inc., a leading innovator in oxygenation imaging is pleased to report that the company has been named #15 on the list of “The 20 Most Promising Businesses to Watch in 2021” by Global Business Leaders magazine.

Kent Imaging’s flagship product is SnapshotNIR, a handheld and lightweight point-of-care device that can capture tissue oxygenation in superficial tissue with a single click of its camera-like structure. Using multiple wavelengths of near-infrared (NIR) light, SnapshotNIR non-invasively measures relative amounts of oxygenated and deoxygenated hemoglobin in the microcirculation of tissue where oxygen exchange is happening.

With the innovative SnapshotNIR device, Kent is focused on delivering improved usability to enhance workflow integration … read more

Wound dressing releases silver nanoparticles when infections occur

Although silver is highly effective at killing bacteria, it can also be toxic to humans in large amounts. That’s where a new wound dressing is intended to come in, as it only releases its silver payload when infections are present.

Currently being developed at the University of South Australia, the dressing is intended mainly for use on children with burn injuries, as they are particularly at risk of serious infections and sepsis. It’s made up of a topically applied hydrogel that contains silver nanoparticles along with proprietary ingredients which are sensitive to changes in pH and temperature … read more

American CryoStem to Study New Standardized Treatment Protocols for Wound Healing

EATONTOWN, NJ / ACCESSWIRE / November 16, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has completed the development of a new standardized wound healing protocol utilizing its tissue based technologies with Advanced Regenerative Associates (Tinton Falls, NJ). The Company’s wound healing technologies rely on exemptions from FDA clinical study and approval for the use of human tissue and cell products (PHS 361 and 21CFR1271.10) and is incorporated into the current standards of care protocols currently in use. The new protocol is focusing on realigning the microenvironment of the treatment area to achieve greater healing support during the treatment period utilizing current standard of care protocols. The initial rollout is fashioned as a study to collect additional information about the wound environment and healing progress. The Company intends to obtain informed consent from each participant for the collection, analysis and potential publication of the assessment data as required under current regulations … read more

CūtisCare Increasing Awareness This National Diabetes Month To Save Limbs and Lives

BOCA RATON, Fla., Nov. 14, 2021 /PRNewswire/ — CūtisCare, a leading provider of wound care management services to hospitals and physicians, is continuing our fight this month to raise awareness regarding diabetes and the available treatment options to help save limbs and lives. According to the CDC, diabetes currently adversely impacts the lives of approximately 34 million Americans, and that number is continuing to increase each year. About 25% of people with diabetes will develop foot ulcers, and 1% end up with an amputation in their lifetime. However, as many as 85% of potential amputations can be avoided when advanced modalities, such as hyperbaric oxygen therapy, or HBOT, are added to a treatment plan.

There is good news on the horizon though. Many of these amputations are preventable. HBOT is one therapy that is showing great promise. Louis Pilati MD, CutisCare’s Medical Advisory Board Member, expounds on the manifold benefits of HBOT for patients with Wagner Grade 3 or higher … read more

New tech wound healing

Safe and effective – wound healing preparation reaches clinical phase II: APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells.

APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore recommended continuation into a Phase II clinical trial. This represents a major success for the wound healing preparation developed at MedUni Vienna. APO-2 contains the secretome … read more

Diabetes & Speaking In “Tongues”

I have on several occasions had the unpleasant duty of telling family, friends and clients about a medical condition that they may be challenged with; heart disease, stroke, HIV, COVID-19, cancer etc. but none of them seem to have the same impact as DIABETES. Many people who have never seen the inside of a church building will break out into uncontrollable “tongues” that will amaze even the Apostles at Pentecost. That is how much diabetes is feared and it can cause havoc if not managed properly.

Diabetes on its own will not kill even if it wipes your bank account dry BUT the organ complications that come with poor management or no management is the killer … read more

Power to control bleeding Power to heal | LifeScience PLUS

LifeScience PLUS is a leader in advanced wound care technology. We are committed to developing and marketing innovative total wound care solutions: hemostasis (bleeding control), sealant, moist dressing, contamination prevention, and fast tissue growth generation. Our patented, best-in-class flagship product—BloodSTOP® iX Advanced Hemostat with WoundHEAL®—utilizes our revolutionary technology for both acute and chronic wound care.

BloodSTOP iX can be applied in many different specialty care areas with successful and positive outcomes. Our primary focus is to provide medical professionals an innovative product for EMS prehospital point-of-care treatment of traumatic wounds; for surgical procedures, including burn and trauma surgeries; and for treatment of diabetic ulcer and decubitus wounds … learn more

2021 Desert Foot Virtual Conference

Desert Foot Virtual Multi-Disciplinary Limb Salvage and Wound Care Conference is accredited for 35.5 CE/CME/CECH for all podiatric surgeons, surgical residents, MDs, DOs, WOCNs along with the VA, DOD, IHS and AAWC Healthcare Professionals (www.desertfoot.org). Conference Co-Chairmen are Drs Charles Andersen, Matthew Garoufalis and Thomas Serena (Past-President AAWC). The Desert Foot Virtual Conference provides a great opportunity for you to meet and share your scientific leadership with a large part of the federal service wound care and surgical community, as well as hundreds of healthcare professionals in acute care, home care and the private sector. The conference brings together six groups involved with limb salvage preservation of the lower extremity, from healthcare clinicians in the private sector, the Veterans Administration, VA Podiatric Residency Directors, Association for the Advancement of Wound Care (AAWC), Arizona Podiatric Medical Association, and the Department of Defense from across the country to a virtual conference to best meet their educational needs. This important conference will be live streamed, and the education will be taught by our nation’s top key opinion leaders focused on evidence-based and best practices to improve limb salvage techniques, advanced wound care skills, and treat surgical and medical disorders of the lower limb … read more

Hymed: Facilitating Effective Wound Care

Delayed wound healing and the resulting impact to the cost of care impacts both patients and facilities across the healthcare continuum. When it comes to wound care, no one is comfortable choosing a service provider with only a basic understanding of the subject. Thus, a product specialist with a historical legacy of providing effective products will invariably gain market traction due to its reliability. Founded in 1995, Hymed has been a renowned name in the healthcare industry for over two decades, offering safe and efficacious, natural wound care products. The company is the developer of innovative wound care products that utilize collagen (the chief structural protein of the body), hyaluronic acid (HA) and glycosaminogly can chemistry for human and animal use. In addition to wound care, these products find varied applications in joint/tissue support, surgery, eye care, dental, and dermatology, and the cosmetic industry … read more

Africa diabetes cases to soar: WHO

Africa is set to see diabetes cases more than double to 55 million by 2045, the biggest increase across the globe, the World Health Organization (WHO) warned Thursday.

“The COVID-19 pandemic will eventually subside, but Africa is projected in the coming years to experience the highest increase in diabetes globally,” said Dr. Matshidiso Moeti, WHO Regional Director for Africa.

Twenty-four million people are living with diabetes today in Africa, which is also the region with the “highest number of people who do not know their diagnosis,” the WHO statement said … read more

‘Foot Selfies’ May Improve Remote Diabetic Foot Monitoring

“Foot selfies” may be a simple solution to keeping tabs on patients at high risk for diabetic foot complications.

Patients with or at risk of foot ulcers are told to check their feet regularly at home, but doing so can be difficult for those who aren’t flexible or who have vision problems. Those who live alone may not be able to ask someone else to check their feet for them. Some use hand mirrors, but those can be difficult to manipulate and don’t offer feedback … read more

Diabetic foot ulcer treatment could kill COVID-19 virus, researchers say

A new foot ulcer formulation developed by scientists at the University of South Australia could be used to kill the COVID-19 virus, according to new research.

In a study published in the journal Applied Physics Letters, the team looked at the treatment of antimicrobial-resistant bacterial infections, experimenting to find an effective non-antibiotic antimicrobial strategy to combat the infections in diabetic foot ulcers.

The authors found that enhancing cold plasma ionized gas with peracetic acid was “highly effective” at eradicating common wound pathogenic bacteria and at inactivating SARS-Cov-2 … read more

Portfolio of hydrophilic PU foams and hydroactive nonwovens with sustainability credentials

Freudenberg Performance Materials will showcase its multi-layer material compositions of hydrophilic PU foams and hydroactive nonwovens for sustainable woundcare at Compamed in Düsseldorf from November 15-18 2021.

The Eco-Check label endorses particularly sustainable solutions for the design of wound plasters which use bio-based raw materials, allowing biodegradation in an industrial composting setting after the product has been used.

M 1701 for traditional woundcare plasters comprises 100% polylactid acid derived from natural resources and offers good woundcare characteristics, while M 1714 has superior absorption for more challenging wounds and consists of a mix of bio-based fibres. With a smooth wound contact layer, M 1714 has already been evaluated for industrial compostability and conforms with the ISO 13432 standard … read more

DIAGNOSTIC ACCURACY OF POINT-OF-CARE FLUORESCENCE IMAGING FOR THE DETECTION OF

BACTERIAL BURDEN IN WOUNDS

High bacterial load contributes to chronicity of wounds and is diagnosed based on assessment of clinical signs and symptoms (CSS) of infection, but these characteristics are poor predictors of bacterial burden. Point-of-care fluorescence imaging (FL) can improve identification of wounds with high bacterial burden (>104 CFU/g). FL detects bacteria, whether planktonic or in biofilm, but does not distinguish between the two. In this study, diagnostic accuracy of FL was compared to CSS during routine wound assessment … read more

Mechanosensor Plays Critical Key Role in Skin Wound Healing

PIEZO1, an ion channel mechanosensor found within cells, has been revealed to play a key role in regulating the speed of skin wound healing by researchers at the University of California, Irvine (UCI).

Published today in eLife, the study (“Spatiotemporal dynamics of PIEZO1 localization controls keratinocyte migration during wound healing”) found that in mice lacking the ion channel protein PIEZO1 in keratinocytes, skin wounds heal faster than in mice with increased PIEZO1 function in keratinocytes … read more

DCMH selected for Hyperbaric Oxygen Treatment Study for veterans

The Wound Care unit at Decatur County Memorial Hospital has been selected to participate in a new study on the uses of hyperbaric oxygen treatment in partnership with the Indiana Department of Health and the Department of Veterans Affairs.

The HBOT Pilot Program will study the effect that hyperbaric chamber treatments can have on PTSD and traumatic brain injuries in veterans.

The VA seeks to improve the lives and health of veterans, and they have seen significant anecdotal evidence of the symptoms of PTSD decreasing and traumatic brain injuries improving during hyperbaric therapy … read more

Ion channel mechanosensor plays a key role in regulating the speed of skin wound healing

an ion channel mechanosensor found within cells, has been revealed to play a key role in regulating the speed of skin wound healing by researchers at the University of California, Irvine (UCI).

Published today in eLife, the study, titled, “Spatiotemporal dynamics of PIEZO1 localization controls keratinocyte migration during wound healing,” found that in mice lacking the ion channel protein PIEZO1 in keratinocytes, skin wounds heal faster than in mice with increased PIEZO1 function in keratinocytes … read more

Sonoma Pharmaceuticals (SNOA) Announces Expanded Long-Term Partnership

with Dyamed Biotech for New Territories and Products in Southeast Asia
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its long-time partner, Dyamed Biotech Pte Ltd., announce a renewed and expanded long-term partnership for Singapore, Malaysia, Indonesia and Thailand for multiple indications using Sonoma’s patented Microcyn® Technology.

Dyamed Biotech Pte Ltd., one of Sonoma’s first international partners, successfully commercializes Dermacyn® Wound Care, Dermacyn® Scarless for Scar Reduction, and Dermacyn® Ezyma Spray for itch relief associated with atopic dermatitis. Dyamed expects to launch Ocucyn® Eye Care and Oracyn® Oral Care in 2022. The Dermacyn® line of products are widely used at many hospitals throughout Singapore and Malaysia … read more

An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (Natrox™) on the Rates of

Healing of Chronic Diabetic Foot Ulcers (OTONAL Trial)
Natrox™ topical oxygen therapy (TOT) (Inotec AMD Ltd, Hertfordshire, UK) employs a small battery-powered “oxygen generator” to concentrate atmospheric oxygen and feeds pure, moist, oxygen through a fine, soft tube to a dressing-like “oxygen distribution system”, which is placed over the wound and is held in place by a conventional dressing. The aim was to determine the effectiveness of Natrox™ for non-healing diabetic foot ulcers (DFU) over a 3-month period.Longitudinal, single-arm, open prospective registry study using 12 weeks of TOT using a 4 week run-in period. 20 patients recruited to OTONAL had chronic DFU greater than 3 months duration or minor amputation sites with less than 50% healing in 4 weeks.There were 13 (65%) males and the mean age was 65.7 (±11.6) years. The mean glycated haemoglobin (HbA1c) was 6.9 (±1.3) mmol mol-1 and mean wound duration before TOT was 114 (±79.1) days. 18/20 (90.0%) patients had concomitant lower limb revascularization angioplasty for chronic limb threatening ischaemia. The mean size … read more

Diabetic foot ulcers on the rise

November is Diabetes Awareness Month, a time to bring attention to this fast-growing, life-threatening epidemic. Currently more than 34 million Americans have diabetes and this number is expected to increase to 54.9 million by 2030. Increases have been attributed to a rise in obesity rates and an aging population, but new research shows that younger people are being diagnosed with the disease. From 2001 to 2017, the number of people under age 20 living with diabetes increased by 45 percent, and the number living with type 2 diabetes grew by 95 percent. This troubling development is expected to further challenge the healthcare system in the coming decades … read more

Healing skin ischemia-reperfusion injuries with interleukin-36 receptor antagonists

Skin wounds from ischemia-reperfusion injuries — tissue damage caused by blood returning to tissues after a period of oxygen deprivation — may not heal appropriately in some patients, owing to elusive underlying immunological mechanisms. Scientists from Japan have now succeeded in proposing a means to solve this medical conundrum by understanding the role of interleukin-36 receptor antagonists as they act to inhibit the effects of interleukin-36 cytokines, which could help identify new therapeutic targets for wound healing … read more

We Are Failing Our Patients With Diabetes

My career in medicine has spanned approximately 26 years. Nineteen-ninety-six was my first year of residency training as well as my first real exposure to the emerging specialty of wound care.

To put things into perspective, during my first year of training, there were approximately 300–500 wound care products on the market. That may seem like a lot, especially considering there are now thousands of products that wound providers and others may choose from. Consider, however, that when I began clinical practice, the resources available were considerably different when compared to what is available today … read more

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but risk factor management is usually suboptimal. This Joint Task Force from the European Atherosclerosis Society and the European Society of Vascular Medicine has updated evidence on the management on dyslipidaemia and thrombotic factors in patients with PAD. Guidelines recommend a low-density lipoprotein cholesterol (LDLC) goal of more than 50% reduction from baseline and <1.4 mmol/L (<55 mg/dL) in PAD patients. As demonstrated by randomized controlled trials, lowering LDL-C not only reduces cardiovascular events but also major adverse limb events (MALE), including amputations, of the order of 25%. Addition of ezetimibe or a PCSK9 inhibitor further decreases the risk of cardiovascular events, and PCSK9 inhibition has also been associated with reduction in the risk of MALE by up to 40%. Furthermore, statin- based treatment improved walking … read more

Talk on Malta’s first biomedicine experiment at the International Space Station

Joseph Borg, a lecturer and researcher in Applied Biomedical Science at the University of Malta’s Faculty of Health Sciences, will deliver a talk and presentation on Wednesday, November 10 at 7pm at Spazju Kreattiv, Valletta, regarding an experiment on diabetes he is conducting at the International Space Station (ISS) as part of Project Maleth.

Prof. Borg’s experiment is the first Maltese presence at the ISS, launching the nation into a new era of involvement in space … read more

Magnitude of Surgical Site Infections, Bacterial Etiologies, Associated Factors and Antimicrobial Susceptibility Patterns of

Isolates Among Post-Operative Patients in Harari Region Public Hospitals, Harar, Eastern Ethiopia
Surgical site infections (SSIs) are infections that occur one month after a surgical operation or one year after implant surgery and a surgical procedure, either at the injury site or near the injury site. Surgical site infections are still a major global problem, especially in developing countries, where they cause increased morbidity and mortality. There is a dearth of information regarding SSIs in the eastern Ethiopia, particularly in this study area … read more

Simple Color Change Test Identifies Wound Infections

Researchers at the University of Bath in the UK, along with outside collaborators, have developed a simple color change test that rapidly indicates whether a wound is infected with harmful bacteria. The test works by detecting virulence factors released by the bacteria, which prompt a simple color change in a solution. The test could help clinicians to determine whether to prescribe antibiotics, and may help to avoid unnecessary prescribing. As the test can be administered at the point of care, and does not require expensive and time-consuming laboratory analysis, it may be very useful in low-resource or remote regions … read more

The epidemic of diabetic limb amputation in poor communities and parts of Cleveland

Differences in outcomes across race, ethnicity and income exist for virtually every chronic health condition that Americans experience. Without exception, minority and poor white Americans die younger and suffer more preventable diseases.

November is diabetes awareness month. Few diseases impact every system of the body in the way that diabetes increases the risk for stroke, heart attack and kidney failure.

Of these devastating conditions, loss of limb, or amputation, is one of the most-dreaded complications of diabetes … read more

Advanced Tissue Technologies Provide Flexibility in Regenerative Medicine

Products derived from human and animal tissues, often referred to as tissue technologies, have offered outstanding results in medical care for decadesin the specific areas of soft tissue, nerve, and tendon repairs. These products are notable for aiding individual patients suffering from severe tissue damage, while also supporting large-scale reconstruction efforts for those who were injured in disasters, including 9/11, earthquakes and wars. Medical experts such as Ian Valerio, MD, MS, MBA, of Massachusetts General Hospital, have underscored the benefits and potential opportunities of regenerative therapies in managing complex wounds. One breakthrough product –Integra® Dermal Regeneration Template (Integra Template) — has paved the way for the continuing development of other regenerative medicine products … read more

Prestigious NSF grant awarded to FIU engineering professor for ‘smart’ bandages

In the future, a “smart” bandage being developed at FIU’s College of Engineering and Computing could remotely send real-time information directly to physicians to advise them how well a patient’s chronic wound is healing.

That’s the hope of the project’s mastermind, Satheesh Bojja Venkatakrishnan, a research assistant professor in the Department of Electrical and Computer Engineering.

Venkatakrishnan’s work in the development of a wireless, adhesive bandage to monitor wounds has led to a prestigious National Science Foundation (NSF) Research Initiation Initiative (CRII) grant, also known as a “mini CAREER” award. The highly competitive, $175,000 grant is awarded annually to support the promising research of a small number of principal investigators who are early career academicians … read more

Streaming Mon 6th – Fri 10th December 2021 | 6pm – 7pm (GMT)

With 10 hours of incredibly current topics, Wounds Week 3 will give a chance for the wound care community to come together in these difficult times, engaging in key education free of charge.

Each session has a live Q&A so participants can benefit from one-on-one interactions with the experts and engage in the event, no matter their COVID-19 situation. All our sessions are CPD-certified, and you will receive a certificate for watching on-demand too!
read more

It’s Time to #BreakTheSilence on Diabetic Foot Ulcers

RedDress is launching a nationwide public awareness campaign, “Break the Silence,” educating Americans about the prevalence and prevention methods of diabetic foot ulcers.

Diabetic foot ulcers are sometimes omitted from the national discussion about diabetes and its complications. “Break the Silence” aims to reduce the stigmas associated with diabetic foot ulcers, while promoting and educating Americans about the prevalence and risk factors associated with this complication of diabetes. “Break the Silence” will run through November and coincide with National Diabetes Awareness Month.

Approximately 25 percent of diabetics will suffer a diabetic foot ulcer in their lifetime, according to the Centers for Disease Control and Prevention (CDC). 1,2

“These ulcers are as serious as some cancers. We need to have a national conversation. Right now, we’re looking at diabetes in very broad strokes. I think we have to have a greater dialogue and more information about diabetic foot ulcers, in general,” expressed Dr. Robert Snyder, Dean of Barry University School of Podiatric Medicine in Miami, one of our partner physicians participating in the “Break the Silence ” campaign … read more

AI guides care of slow-healing wounds

Industry researchers have used machine learning to predict healing times for wounds based in part on patient data stored in electronic health records.

The team suggests its model can help clinicians make optimal decisions for treating slow-to-heal abrasions, lacerations and so on by knowing which new and preexisting patient traits are most likely to influence outcomes.

The study was conducted by staff members of Net Health, a supplier of software and analytics services, and is current in Advances in Wound Care.

The team trained AI prediction models on data from more than 1.2 million wounds … read more

Predicting Chronic Wound Healing Time Using Machine Learning

Chronic wounds have risen to epidemic proportions in the United States and can have an emotional, physical, and financial toll on patients. By leveraging data within the electronic health record (EHR), machine learning models offer the opportunity to facilitate earlier identification of wounds at risk of not healing or healing after an abnormally long time, which may improve treatment decisions and patient outcomes. Machine learning models in this study were built to predict chronic wound healing time … read more

Quinn Receives $1.6 Million NIH Grant for Research on Chronic Skin Wounds

Biomedical engineering professor Kyle Quinn has received a four-year, $1.6 million grant from the National Institutes of Health to develop non-invasive, real-time “optical biopsies” of chronic skin wounds.

The goal of Quinn and researchers in his lab is to provide digital histopathology images — the microscopic examination of tissue to study the manifestation and progression of disease — and other quantitative information without the need for an invasive biopsy, tissue processing and staining with histology dyes … read more

SKIN BACTERIA CAN HELP WOUNDS TO HEAL

Skin wounds heal by coordinated induction of inflammation and tissue repair, but the initiating events are poorly defined. Here we uncover a fundamental role of commensal skin microbiota in this process and show that it is mediated by the recruitment and the activation of type I interferon (IFN)-producing plasmacytoid DC (pDC). Commensal bacteria colonizing skin wounds trigger activation of neutrophils to express the chemokine CXCL10, which recruits pDC and acts as an antimicrobial protein to kill exposed microbiota, leading to the formation of CXCL10–bacterial DNA complexes … read more

Cuba inaugurates a biotechnological industrial complex

Cuba inaugurated this Monday the CIGB-Mariel Biotechnological Industrial Complex, the first high-tech industry located in the Mariel Special Development Zone (ZEDM), the island’s flagship megaproject for commerce and attracting foreign investment …Among the Cuban drugs that he will produce, he cited the anti-covid vaccine Abdala and the Jusvinza drugs -for the treatment of severe and critical patients with covid-19-, Heberprot P -employed to cure diabetic foot ulcers- and Heberferon, applied to patients with skin cancer, dengue and conjunctivitis … read more

University of Huddersfield and Regional Hospital Wiener Neustadt collaborate for wound management projects

The Institute of Skin Integrity and Infection Prevention (ISIaIP) at Huddersfield has signed a memorandum of understanding with the Regional Hospital Wiener Neustadt that will create a satellite office of the ISIaIP south of the Austrian capital Vienna. The alignment will enable joint research projects, international teaching and more publications.

The two institutions have collaborated for several years, with Professor Ojan Assadian having served as a Professor with the ISIaIP for more than four years before returning to Vienna, where he is Medical Director of the Regional Hospital Wiener Neustadt as well as … read more

Childhood Obesity Is Soaring to New Levels

Kids’ weight has spiked during the pandemic, but it’s part of a long-term trend
As a pediatric endocrinologist in a busy New York City hospital, I am acutely aware of the impact COVID-19 has had on my patients. The physical, emotional, social, and academic costs of the pandemic are evident every time I examine a child diagnosed with the virus. However, I am also deeply aware of another health risk that is threatening the well-being of my patients — the significant increase in obesity that we have seen in children and teenagers over the past 18 months.

Before COVID-19, obesity affected around 20% of American children 2 to 19 years of age. Now, the numbers are expected to rise much further, with modeling studies predicting at least a 3% to 4% weight gain in children during the pandemic … read more

The impact of the SARS-CoV-2 pandemic on the management of chronic limb-threatening ischemia and wound care

In the wake of the coronavirus pandemic, the critical limb ischemia (CLI) Global Society aims to develop improved clinical guidance that will inform better care standards to reduce tissue loss and amputations during and following the new SARS-CoV-2 era. This will include developing standards of practice, improve gaps in care, and design improved research protocols to study new chronic limb-threatening ischemia treatment and diagnostic options. Following a round table discussion that identified hypotheses and suppositions the wound care community had during the SARS-CoV-2 pandemic, the CLI Global Society undertook a critical review of literature using PubMed to confirm or rebut these hypotheses, identify knowledge gaps, and analyse the findings in terms of what in wound care has changed due to the pandemic and what wound care providers need to do differently as a result of these changes. Evidence was graded using the Oxford Centre for Evidence-Based Medicine scheme. The majority of hypotheses and related suppositions were confirmed, but there is noticeable heterogeneity, so the experiences reported herein are not universal for wound care providers and centres … read more

Innovative Israeli ‘copper’ dressing helps cure diabetic wounds

Herzliya-based MedCu’s product have already been approved by the US FDA.
An innovative Israeli-made wound dressing has been found to drastically stimulate the healing of diabetic wounds, a new study by physicians at the Rambam Health Care Campus in Haifa has found.
Copper Oxide Impregnated Wound Dressings, developed by Herzliya-based MedCu Technologies, have already received clearance by the major international regulatory bodies – including the United States’ FDA – for use in acute and chronic wounds.
“What is special about our dressing is that it contains particles of copper oxide,” said Dr. Gadi Borkow … read more

Vivex Biologics, Inc. to Attend the Symposium of Advanced Wound Care

Leading regenerative medicine company to participate in initiatives to further educate and improve patient care.

Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatment options, will be attending the Symposium on Advanced Wound Care (SAWC) in Las Vegas on October 29-31, 2021.

SAWC brings together wound care teams, including physicians, nurses, physical therapists, researchers, scientists, podiatrists and dietitians, to improve the overall outcome of patients through furthering wound care education. The event will be comprised of various presentations, case studies, clinical research and practice innovations on topics including wound healing and wound care issues.

VIVEX professionals will host booth #440 during the forum, showcasing VIVEX’s portfolio of wound care products and solutions. The inherent properties of VIVEX’s amniotic allograft products provide mechanical protection and act as a barrier for external wounds, such as diabetic foot ulcers, venous leg ulcers, pressure ulcers and burns while VIVEX’s Integrity Processing™ retains the nutrient-rich growth factors essential for signaling … read more

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the latest advanced wound care research on its PuraPly® AM, Affinity®, Apligraf®, and NuShield® product lines will be showcased at the 2021 Symposium on Advanced Wound Care (SAWC) Fall Conference held October 29-31 in Las Vegas, Nev.

Attendees of this year’s event are encouraged to visit the Organogenesis-supported lunch symposium, “New Scientific Data Supporting the Use of an Antimicrobial Native Collagen ECM and Real-World Case Studies Highlighting a Treatment Algorithm Approach​” held Friday, Oct. 29, from 11:40 a.m. – 1:10 p.m. PST in the Innovation Theatre … read more

Independence Blue Cross Taps Podimetrics to Prevent Diabetic Amputations Via RPM

Independence Blue Cross (Independence) and Podimetrics, a virtual care management company dedicated to preventing diabetic amputations, today announced an agreement for Podimetrics to remotely monitor Independence fully insured commercial members who have diabetes and a history of a diabetic foot ulcer with the use of the cellular-connected SmartMat … read more

Healogics 8th Annual Diabetes Awareness Campaign, Chronic Wound Healing through Specialized Care

Healogics, the nation’s leading provider of world-class wound care services, is proud to announce the eighth annual Diabetes Awareness Campaign throughout the month of November, which is National Diabetes Awareness Month. The Healogics wound care specialists, at the more than 600 Healogics Wound Care Centers® nationwide, will be raising awareness of the importance of early intervention and specialized care for diabetes-related chronic wounds, such as diabetic foot ulcers … Diabetic foot ulcers are a leading cause of lower-limb amputations and according to the American Diabetes Association, an average of 10 Americans will undergo an amputation due to diabetes every hour. Of the 34.2 million Americans currently living with diabetes, up to 25% may develop a diabetic foot ulcer. These hard-to-heal wounds often go undetected due to the lack of feeling in the lower extremities due to nerve damage caused by diabetes … read more

Scientists report new hydrogel to protect wounds from germs

RUDN University and Shahid Beheshti University (SBU) chemist together with colleagues from Iran created a hydrogel film for wound dressing. It protects the wound from germs and is harmless to healthy tissues. Moreover, its porous structure can hold antibiotic, which kills dangerous microorganisms and provide additional protection. The results are published in the International Journal of Biological Macromolecules.

The main aim in treating wounds is to prevent infection. With an open wound, microbes gain direct access inside the body. This significantly complicates wound healing and can cause more serious consequences, so it is important to develop antibacterial coatings for wounds. One of the modern approaches to this is hydrogel films. Unlike traditional remedies, hydrogels mimic healthy tissue and cover the wound, protecting it from germs. They also help to cool the wound and not over-dry it. In addition, hydrogels can contain … read more

NUS scientists develop a smart bandage to monitor chronic wounds

A research team led by Professor Lim Chwee Teck from the National University of Singapore’s (NUS) Department of Biomedical Engineering and Institute for Health Innovation & Technology (iHealthtech), in collaboration with clinical partners from Singapore General Hospital, has developed a smart wearable sensor that can conduct real-time, point-of-care assessment of chronic wounds wirelessly via an app. A world’s first, the novel sensor technology can detect temperature, pH, bacteria type and inflammatory factors specific to chronic wounds within 15 minutes, hence enabling fast and accurate wound assessment … read more

Utilizing Nanofibers for Treatment of Skin Infections

With the advancement in nanotechnology, its medical applications have provided a significant difference to the level of diagnosis and therapeutics. The use of nanotechnology for regenerative medicine, including wound healing, is an example of how this industry has advanced and developed novel treatments to provide better care to patients … read more

Assessing Oxygenation Status in the Management of Lower Extremity Wounds – webinar

Peripheral arterial disease (PAD), the narrowing or blockage of the vessels carrying blood from the heart to the legs, can have detrimental effects on lower limb health, and can lead to critical limb ischemia, limb loss, and even death. Patients with poor arterial health can develop hard-to-heal ulcers as the blood pools in the lower extremity, causing localized swelling and ulceration.

Transcutaneous monitors that measure tissue oxygen can assist with determining the health of the limb and the ability for a lower extremity wound to heal, and can detect the presence of vascular disease. Understanding these values is vital as it will help the provider to guide clinical decisions in in the plan of care, whether it involve curative measures such as compression therapy or advanced wound care interventions such as negative pressure wound therapy or skin grafts, or palliative or amputation, depending on the patient’s goals. Transcutaneous oxygen measurement can be used to determine amputation level in non-healable wounds … register

A Dual Celebration: Milestones in Diabetes Mellitus and Pressure Injury Research

This month we celebrate World Diabetes Day on November 14,1 which is the birthday of Dr Frederick G. Banting, one of four key collaborators in the discovery of insulin. He pursued the idea that an important element in the pancreas could help save the lives of persons with type 1 diabetes: insulin. It took the other members his team—collaborators at of the University of Toronto— to isolate insulin from the pancreas and formulate it into a lifesaving clinical reality. All of this happened 100 years ago this November, when the researchers demonstrated that insulin extract reduced blood sugar in laboratory animals.1 Because they felt so strongly that this medical breakthrough had to be available to all, they sold the patent for 100 cents ($1) so insulin could be affordable for everyone who needed … read more

How Might Protein Alteration From NPWT Affect Wound Healing?

Excellent continued efforts in elucidating the role that perturbation of the wound matrix (via negative pressure wound therapy (NPWT)) has on angiogenesis, healing and regeneration. A recent study in Molecular Medicine Reports used label‑free quantitative mass spectrometry to analyze differences in granulation tissue protein expression profiles before and after NPWT for patients with diabetic foot ulcers (DFUs).1 They aimed to take a closer look at how NPWT promotes DFU healing. As such, the study identified multiple novel proteins altered by NPWT, paving the way for future studies in this area … read more

Practice Management Education Opportunities Coding Fundamentals

Take the first few steps to coding and billing by joining us for a comprehensive workshop covering the fundamentals of coding and billing for foot and ankle surgeons. Learn the foundation of the coding and billing process from expert colleagues before taking the ACFAS Coding and Billing for the Foot and Ankle Surgeon course. This course is for residents, fellows, new practitioners, office staff of foot and ankle surgeons or anyone who wants to learn more of the basic coding and billing terminology and process. Plus, if you’re a resident and attending Residents Day in the morning the day of the event, this course is a great next step to learning more about coding and billing for your future practice and can be bundled in your pricing … read more

Lower Extremity Wounds: Is It Venous, Arterial, Neuropathic, or a Combination?

Lower extremity wounds manifest in a multitude of ways, with numerous causative or trigger factors. These types of wounds are often costly to treat, are frequently refractory, and have a high risk for recurrence. A comprehensive assessment and an evidence-based treatment plan, along with ongoing patient education and routine follow-up, are essential components of an effective plan of care … read more

Healing of a Chronic Pressure Injury in a Patient Treated With Medical Cannabis for Pain and Sleep Improvement

A Case Report
A small body of evidence suggests medical cannabis may facilitate wound healing, but the exact mechanism of this effect is unclear. PURPOSE: This case report describes a patient with a pressure injury (PI) who received cannabis oil treatment for pain management and sleep improvement. METHODS: A 37-year-old woman with multiminicore disease, scoliosis, short-chain acyl-CoA dehydrogenase deficiency, and epilepsy presented to the Neurology Centre of Toronto with chronic pain and sleep disturbance, including difficulty initiating and maintaining sleep. She also had a 5-year history of a PI between her right iliac crest and right rib cage that had progressively worsened. The patient received a medical cannabis oil protocol that used a combination of cannabidiol and tetrahydrocannabinol … read more

The Courage to Do the Right Thing by Caroline Fife

Nearly 200 years ago, the brilliant French historian Alexis de Tocqueville traveled the fledgling United States and observed that in lieu of hereditary wealth and aristocracy, we were building a society on individualism, market capitalism, and honoring the hard-working common man. However, in his 1835 book, he cautioned that laws could never be a substitute for public morality and that such a society was less endangered by “the great profligacy of a few”, but by the “laxity of morals amongst all.” Those words were prophetic. Individualism and market capitalism have enabled us to create the most technologically advanced healthcare system in the world, but Medicare will be bankrupt in less than 10 years. Although there are a lot of reasons for this dire situation, they include “a laxity of morals amongst all and the great profligacy of a few.” … read more

Treating Wounds in the Very Young

Through the years, I have been asked to see and treat neonates, infants, and children with wounds of various etiologies. These have included genetic problems, pressure injuries occurring in the hospital, operative wounds, and, as they aged, the full spectrum of trauma and burns. I have always been honored to do so, but it must be remembered that treating the young can present its own challenges. Many who treat infants and children look at them as just small adults and proceed to treat them the same way. I learned very early on that neonates, infants, and children should not be treated as just small adults, because they have issues related to their development, age, and genetics that may make adult treatments ineffective at best and harmful at worst. The selection of dressings and bandages must be carefully based on the … read more

The Alliance of Wound Care Stakeholders outlines how wound care may be affected by …

CMS CY 2021 hospital outpatient and physician fee schedule proposed rules
The Center for Medicare and Medicaid Services have released for comment its proposed CY 2021 updates to the Hospital Outpatient Prospective Payment System and Physician Fee Schedule. Below, verbatim, are several provisions the Alliance of Wound Care Stakeholders has identified as particularly impacting wound care clinicians, which the Alliance will be tracking and preparing comment on … read more

Extensive Type V Aplasia Cutis Congenita Without Fetus Papyraceus or Placental Infarction

Aplasia cutis congenita (ACC) is a congenital disorder characterized by the absence of epidermis, dermis, and sometimes subcutaneous tissue and bone. There are nine types of ACC based on the number and location of the lesions as well as the presence or absence of associated deformities, with type I ACC being the most common. Type V affects the trunk with a characteristic pattern resembling the “H” letter of the alphabet, generally accompanied by fetus papyraceus (death of one of the twin fetuses) or placental infarction. Type V ACC without fetus papyraceus and placental infarction is a rare case. We reported a case of type V ACC in a 3-day-old baby girl, with clinical manifestation of extensive ulcers on the scalp, back, buttocks, and both lower extremities, in an “H”-shaped pattern, with history of placenta accreta, but no fetus papyraceus or placental infarction was found. The patient received dialkyl carbamoyl chloride hydrophobic swab with hydrogel (Sorbact® gel dressing-BSN Medical) and hydrocolloid wound dressing with good response, as indicated by the wounds becoming dried up … read more

Latest Clinical Evidence Presented at SAWC 2021 Illustrates the Significant Clinical Utility of the MolecuLight Point-of-Care …

Imaging Platform
7 Clinical Posters and Presentations Highlight the Breadth of Clinical Benefits
of the MolecuLight Device for Wound Care Applications

TORONTO and LAS VEGASOct. 28, 2021 /PRNewswire/ – MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces the presentation of 7 clinical posters and presentations at the Symposium of Wound Care (SAWC) Fall 2021, held from October 29 – 31, 2021 in Las Vegas, Nevada. SAWC is one of the largest multidisciplinary meetings of wound care professionals.

“We are thrilled to have so many customers presenting their impressive clinical findings at this year’s SAWC Fall conference”, says Anil Amlani, MolecuLight’s CEO. “The clinical topics being presented span the wound care continuum, from improved wound assessment and treatment planning, to monitoring of wound cleaning and debridement efficacy, and the resulting improvement in wound healing rates. Presenters will also describe detection and treatment of wound-related cellulitis, and findings from the recently published Delphi consensus-based guidelines for the use of the MolecuLight platform. The outcomes presented in these studies illustrate the significant clinical improvements to wound care provided to clinicians by the MolecuLight i:X“.

A submission on MolecuLight by Dr. Charles A. Andersen was one of the top scoring abstracts out of more than 200 submissions. This is the fifth consecutive SAWC meeting at which an abstract on improved patient care achieved through use of the MolecuLight i:X has received this honour.

The 5 clinical posters and 2 presentations featuring the MolecuLight i:X from SAWC Fall 2021 are as follows:

Poster #CR-005
12-Week RCT Evaluating Impact of Routine Fluorescence Imaging of Bacteria on DFU Healing Rates
Alisha Oropallo, MD¹, Scott Gawlik DPM¹, Dean Vayser, MD²
¹Northwell Comprehensive Wound Health Center and Hyperbarics, Lake Success NY,
²ILD Research Centre, San Diego, CA
 Download poster

Poster #CR-006
Cleansing Techniques for Wound Hygiene: Which Are Most Effective?
Alisha Oropallo, MD1Amit Rao MD1Jai Joshi1
1Northwell Comprehensive Wound Health Center and Hyperbarics, Lake Success NY 
 Download poster

Poster #LR-025
Detection of bacterial fluorescence from in vivo wound biofilms using a point-of-care
fluorescence imaging device
Andrea J. Lopez1Laura M. Jones2, Landrye Reynolds1Rachel C. Diaz1Isaiah K. George1William Little1Derek Fleming3,4Anna D’souza2Kendra Rumbaugh3Allie Clinton Smith1Monique Y. Rennie2
1Department of Honors Studies, Texas Tech UniversityLubbock TX, USA; 2MolecuLight Inc. Toronto, ON Canada3Department of Surgery, Texas Tech University Health Sciences Center4Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA 
 Download poster

Poster #CR-020
Are Semi-quantitative Clinical Cultures Inadequate? Comparison to Quantitative Analysis of 1053 Bacterial Isolates from 350 Wounds
Thomas E. Serena1Phil Bowler2Gregory Schultz3Anna D’souza4Monique Rennie4
1
SerenaGroup Research Foundation, Cambridge MA USA; 2Phil Bowler Consulting, Warrington UK3Department of Obstetrics and Gynecology, University of Florida, FL, USA; 4MolecuLight Inc. Toronto 
 Download poster

Poster #PI-003
Guidelines for point-of-care fluorescence imaging for detection of wound bacterial burden based on Delphi consensus
Charles A. Andersen¹, Alisha R. Oropallo², Raymond Abdo³, Jenny Hurlow⁴, Martha R Kelso⁵, M. Mark Melin⁶ and Thomas E. Serena⁷
1Madigan Army Medical Center, Renton WA2. Zucker School of Medicine Hofstra/Northwell, Hempstead, NY3St. Louis Foot & Ankle LLC, St. Louis MO4Consultant Wound Care Practitioner, Memphis TN5Wound Care Plus LLC, Blue Springs MO6M Health Fairview, Edina MN7SerenaGroup Research Foundation, Cambridge MA
 
 Download poster

Oral Presentation & Poster #PI-002
Diagnosis and Treatment of the Invasive Extension of Bacteria (Cellulitis) from Chronic Wounds Utilizing Point-of-Care Fluorescence Imaging
Charles Andersen¹, Katherine McLeod¹, Rowena Steffan¹
¹Vascular/Endovascular/Limb Preservation Surgery Service, Madigan Army Medical Center, Joint base Lewis-McChord, WA USA
 Download poster

Podium Presentation
Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care
Charles Andersen¹
¹Vascular/Endovascular/Limb Preservation Surgery Service, Madigan Army Medical Center, Joint base Lewis-McChord, WA USA

In additional to the clinical posters and presentations at SAWC (Symposium on Advanced Wound Care) Fall 2021, the recently launched MolecuLightDX will be available for demonstration in the MolecuLight booth #439 in the Exhibit Hall at Caesars Palace in Las Vegas, Nevada.

About MolecuLight Inc.

MolecuLight Inc., a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i: and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden (when used with clinical signs and symptoms) and for digital wound measurement. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

Download for Image:

SOURCE MolecuLight

Related Links

www.moleculight.com

Probiotics accelerate wound healing in patients with diabetic foot ulcer

Patients with diabetic foot ulcer (DFU) who were given probiotic supplements for 12 weeks had faster wound healing and improved glycemic control compared with similar patients on placebo, according to researchers who recently published their results in Diabetes/Metabolism Research and Reviews.

ADMIN2-Probiotics pick up the pace

Diabetic foot ulcers healed faster in patients given probiotics.

“Due to the increasing global antimicrobial drug resistance issues, the idea of probiotic consumption is interesting and pertinent because probiotics have the ability to strengthen the immune system, have anti-inflammatory effects, and therefore, could increase the wound healing process,” wrote lead co-author Zatollah Asemi, PhD … read more

Does the Documented History Tell the Patient’s Wound Story Accurately?

Information regarding coding, coverage, and payment is provided as a service to our readers. Every effort has been made to ensure information accuracy. However, HMP Communications and the authors do not represent, guarantee, or warranty that coding, coverage, and payment information is error-free and/or that payment will be received. The ultimate responsibility for verifying information accuracy lies with the reader.

Welcome to the second article dedicated to documentation issues in wound care (click here for the first part). The intent of this article is to point out inconsistencies found in the documentation of a patient’s wound care history and provide possible suggestions on how to avoid creating those inconsistencies. Reviewing numerous wound care records has provided me with interesting findings that I would like to share with you … read more

Efficacy and Safety of a Hyaluronic Acid–Containing Cream in the Treatment of Chronic, Venous, or Mixed-Origin Leg Ulcers

A Prospective, Multicenter Randomized Controlled Trial
Topical applications of hyaluronic acid (HA)–containing formulations, based on the complex and vital role of HA in all stages of the wound-healing process, are routinely used with standard therapy to promote faster healing of chronic wounds. However, evidence to guide clinical decisions on the use of topical HA in the healing of vascular leg ulcers is limited. Objective. This study compared the efficacy and safety of topical application of a hyaluronic acid cream vs a neutral comparator (identical cream without HA) in treating subjects with chronic leg ulcers of vascular origin. Materials and Methods. This was a prospective, multicenter double-blind randomized controlled trial. One hundred sixty-eight subjects with chronic leg ulcers of venous or mixed (venous and arterial) origin were randomized to receive either topical applications of 0.2% HA cream or neutral comparator cream for a maximum of 20 weeks. The primary efficacy endpoint was complete ulcer healing (100% reepithelialization of the wound area centrally assessed at 20 weeks or before and confirmed 3 weeks later). In both groups, topical treatment was associated with standard therapy (ulcer cleansing and optimized compression) … read more

Valsartan nano-filaments alter mitochondrial energetics and promote faster healing in diabetic rat wounds

Chronic wounds are a common and debilitating condition associated with aging populations that impact more than 6.5 million patients in the United States. We have previously demonstrated the efficacy of daily topical 1% valsartan in treating wounds in diabetic mouse and pig models. Despite these promising results, there remains a need to develop an extended-release formulation that would reduce patient burden by decreasing the frequency of daily applications. Here, we used nanotechnology to self-assemble valsartan amphiphiles into a filamentous structure (val-filaments) that would serve as a scaffold in wound beds and allow for steady, localised and tunable release of valsartan amphiphiles over 24 days. Two topical treatments of this peptide-based hydrogel on full-thickness wounds in Zucker Diabetic Fatty rats resulted in faster rates of wound closure. By day 23, all val-filament treated wounds were completely closed, as compared to one wound closed in the placebo group. Mechanistically, we observed enrichment of proteins involved in cell adhesion and energetics pathways … read more

2nd Annual Virtual PRESENT Superbones Superwounds West Conference a Crowd Pleaser

The 2nd Annual Virtual PRESENT Superbones Superwounds West Conference took place October 9-10, 2021. For the past 13 years, since 2008, PRESENT has been running the Superbones Superwounds West each year as a live-in person event in Las Vegas. The pandemic situation has required us to deliver education virtually these past 2 years and this is the 9th full live virtual conference put on by the PRESENT e-Learning Team since March of 2020. The post-event survey for this event revealed that 100% of attendees are likely to return to this conference in its virtual format … read more

Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer

Diabetic foot ulcers (DFUs) are a severe complication associated with diabetes, a precursor for amputation, and a major cause of patient suffering and high health-care costs.1,2 While the continuous efforts of multidisci-plinary foot clinics and preventive activities in primary care have reduced the incidence of major lower limb amputations in most countries, the prevention of DFUs remains a major challenge.3- 5 Over the years several risk factors associated with the development of a DFU have been discovered, but despite this, little is known about the factors leading directly to the first ever ulceration.6 Therefore, the predictive power of even seasoned cli-nicians in our experience remains low, and combined with the poorly reported, but relatively low, incidence of first ever DFUs, the possibilities for primary prevention is extremely limited.7 These challenges have led to re-current DFUs being studied far more than the first ever DFUs, but despite continuous improvements in healing … read more

Hillrom | WatchCare™ Incontinence Management System | Customer Video

Explore how the WatchCare™ Incontinence Management System provides caregivers with real-time incontinence detection and is designed to protect patient’s skin, optimize caregiver efficiency and improve patient experience. The information contained in these videos is provided for educational purposes only and is not intended nor implied to be a substitute for professional medical advice. You assume full responsibility for how you choose to use this information. Please speak with your healthcare provider about any questions you may have regarding a medical condition. Hill-Rom retains all right, title, and interest in and to the video, and retains the right to demand that you immediately cease use of the video and unembed the video. Hill-Rom may discontinue or disable videos you have embedded at any time for any reason. You will not misrepresent the content contained in the video or use it in conjunction with price comparisons, in derogatory comparisons or in negative comparisons, with Hill-Rom’s competitor’s products, or in derogatory or negative commentaries about Hill-Rom’s products – doing so may subject you to liability. Any and all claims made by you regarding the use, operation, quality, etc. of Hill-Rom’s products are your own, and you shall be responsible for ensuring that all such claims comply fully with all applicable federal, state and local laws.

 

Joerns Healthcare Introduces Point-of-Care Imaging to Wound Care Portfolio Through MolecuLight Partnership

CHARLOTTE, N.C. and PITTSBURGH, Oct. 19, 2021 /PRNewswire/ — Joerns Healthcare, a healthcare technology and equipment services company, announces the addition of the MolecuLight i:X® and DX™ wound imaging platforms to its wound management portfolio through an exclusive agreement with MolecuLight Corp. to provide MolecuLight’s fluorescence imaging technology for point-of-care detection of the bacterial burden in wounds. The MolecuLight i:X and DX devices are the first-of-their-kind handheld imaging devices that help clinicians quickly and easily visualize the bioburden of wounds as part of the standard clinical examination. The device can be used on all wounds, in all care settings and provides invaluable information in real-time to inform and support clinician decision-making. The automated wound measurement and assessment platform simplifies wound management to maximize healing and patient satisfaction.

“The revolutionary MolecuLight i:X and DX devices are the first point-of-care devices that simplify wound management and put immediate decision-making data at the clinician’s fingertips. The addition of this bedside imaging tool to our Connexio™ platform creates the first holistic system designed to enable immediate, evidence-based decisions for wound management. The device also eliminates the manual, administrative burden clinicians traditionally face by automating the data flows to their EMR platform of choice. The result is improved healing rates, reduced wound management costs, improved patient satisfaction and increased clinician efficiencies,” says Doug Ferguson, Chief Strategy Officer of Joerns Healthcare … read more

Where Do You Get Your Information?

One of the rewarding and fun projects I have been involved with for the past 2 years has been the development of a YouTube video program called “Inside the Doctors” Lounge.”

“The Lounge” is part of a bigger project called MD Coaches and is a talk show–like forum that takes place in an imaginary doctors’ lounge within the YouTube universe. Anyone who has spent time in a doctors’ lounge understands it is a place of respite and where discussions with colleagues can cover a wide range of topics, but most importantly, there is no associated fear of violating HIPAA or other repercussion. Everyone in the Lounge has an opinion, and discussions can become spirited, whether in agreement or not.

My colleagues (Rhonda Crowe, Randy Cook, Rick Zollinger and Dael Waxman) and I recently … read more

Helixmith Announces Phase 3 Study Results of Novel Gene Therapy Treatment for Diabetic Foot Ulcers

at 2021 Annual Meeting of Diabetic Foot Ulcer Conference (DFCon)
Data indicate that gene therapy appears to be effective, particularly in neuroischemic ulcers
SAN DIEGO, Oct. 22, 2021 /PRNewswire/ — Helixmith, a gene therapy company based in Seoul, Korea and San Diego, CA, announced today the results of a Phase 3 study for the treatment of diabetic foot ulcers with their novel gene therapy VM202 (Engensis) at the 2021 annual meeting of the Diabetic Foot Conference (DFCon) held in San Francisco and virtually. The study, “Gene Therapy for Diabetic Foot Ulcers: Analysis of a Randomized, Placebo-Controlled Phase 3 Study of Engensis (VM202), a Plasmid DNA Expressing Two Isoforms of Human Hepatocyte Growth Factor (HGF),” demonstrated a positive trend toward wound closure, potential healing effects and an acceptable safety profile. This is the first study using gene therapy for the treatment of diabetic foot ulcers. DFCon is the premier international, interdisciplinary diabetic foot conference in North America.

The purpose of the un-prespecified interim analysis was to evaluate the status of a 7-month Phase 3 study conducted to test the effect of intramuscular injection of Engensis into the calf muscles of participants having chronic nonhealing diabetic foot ulcers (DFU) with concomitant peripheral artery disease. In the interim ITT population (n=44), there was a positive trend toward wound closure in the VM202 group from month 3 to month 7. Ulcer closure effects were prominent, particularly in neuroischemic ulcer. In 23 patients having this type of foot ulcers, the percentage of subjects reaching complete ulcer closure was significantly higher in the VM202 group at months 3, 4 and 5 (p = 0.0391, 0.0391, and 0.0361, respectively). Engensis seems to also improve hemodynamic features; a potentially clinically meaningful 0.15 increase in ABI was observed in the VM202 group at day 210 in ITT population (p=0.0776). The company believes that intramuscular injections of VM202 plasmid DNA to calf muscle may have promise in treatment of chronic neuroischemic DFUs … read more

A Comprehensive Review of the Pathogenesis, Diagnosis, and Management of Diabetic Foot Infections

GENERAL PURPOSE: To review an approach to diabetic foot infections (DFIs), including acute osteomyelitis, while also discussing current practices and the challenges in diagnosis and management.

TARGET AUDIENCE: This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care.

LEARNING OBJECTIVES/OUTCOMES: After participating in this educational activity, the participant will1. Identify the risk factors for developing DFIs.2. Outline diagnostic techniques for assessing DFIs.3. Select the assessment techniques that support a diagnosis of osteomyelitis.4. Choose the appropriate pharmacologic and nonpharmacologic treatment options for patients who have DFIs … read more

MicroVascular Tissues Announces Peer-Reviewed Publication of Positive HIFLO Clinical Trial Results Using mVASC® Graft

Data on Nonhealing Wagner 1 & 2 Neuropathic Diabetic Foot Ulcers Published in IWJ. Additional Data to be Presented at Upcoming 2021 SAWC and DFCon Meetings.
SAN DIEGO, CA, UNITED STATES, October 20, 2021 /EINPresswire.com/ — MicroVascular Tissues, Inc., (MVT), a regenerative tissue company, today announced that the results of its HIFLO Trial assessing patient outcomes after treatment with mVASC® Microvascular Tissue Graft product have been published in an article entitled, “Improved Healing of Chronic Diabetic Foot Wounds in a Prospective Randomized Controlled Multicenter Clinical Trial with a Microvascular Tissue Allograft” in the International Wound Journal (IWJ), one of the preeminent journals aimed at improving patient care in the wound care industry.

The HIFLO trial was a Level 1, prospective, single-blind, randomized clinical trial conducted at six U.S. sites that assessed outcomes in 100 subjects with nonhealing Wagner grade 1 and 2 neuropathic diabetic foot ulcers (DFUs). The primary endpoint was the percentage of ulcers healed within 12 weeks. Secondary and research endpoints included wound area percent reduction, time to healing, improvement in blood flow (perfusion) and peripheral neuropathy … read more

AiCuris Announces Expansion of its Collaboration with Lysando with a Focus on Diabetic Foot Infections

AiCuris Anti-infective Cures AG, a leading company in the discovery and development of drugs against infectious diseases, and the biotechnology company Lysando AG with its Regensburg-based subsidiary Lysando GmbH, today announced the expansion of their existing long-term collaboration for the development and optimization of Artilysin(R)-based drug candidates for the topical treatment of infected, chronic wounds such as diabetic foot infections.

AiCuris and Lysando joined forces in 2019 to drive the fight against antimicrobial resistance, with innovative approaches based on Lysando’s Artilysin(R) technology platform, a new class of phage-lysine derived artificial designer molecules with a novel mode of action and the potential to replace conventional antibiotics. Under the terms of the agreement … read more

Visceral Fat Associated With Increased Arterial Stiffness in Youth With Obesity

Data show In youth with obesity, but not healthy weight, visceral fat was positively associated with PWV and was predictive of PWV beyond BMI and waist circumference.

New research dove into associations between visceral fat and arterial stiffness in youth with healthy weight, obesity, and type 2 diabetes (T2D), in order to discover whether the relationships were independent of body fatness estimates as a predictor of cardiovascular events read more

WoundZipper Application to Distal Forearm Laceration

Application of WoundZipper to a patient with a laceration of distal forearm.

The procedure includes sterilizing affected area with betadine and alcohol prior to application of the WoundZipper. No local anesthetic is required as the procedure is painless. The total procedure time is less than 1 minute. The patient is more comfortable during the procedure and is able to go home in minutes.

The patient returned to clinic after five days for a wound check. The patient was left with a faint, linear scar after 5 days. No suture or staple marks are visible.

Please visit WoundZipper.com for more information about the product.

Case Presentation: Dr. Maher Arafa, MD
Narrator: Kyle Dickinson, PA-C
Video Production: Val Valgardson, MFA

Singapore researchers develop bandage that can wirelessly assess wounds

Researchers in Singapore say they have developed a bandage that can detect and wirelessly send medical information related to chronic wounds, such as temperature and bacteria type. With the ability to capture and transmit such data in under 15 minutes, the wearable sensor is touted to speed up assessment of such wounds and provide more timely treatment.

Called VeCare, the platform encompasses a “wound sensing bandage”, an electronic chip, and a mobile app through which data is transmitted, said the research team from the Department of Biomedical Engineering and Institute for Health Innovation & Technology (iHealthtech) at National University of Singapore (NUS). The researchers also worked with clinical partners from Singapore General Hospital (SGH) … read more

Journal of Wound Care – July issue available online

Research and best practice – all in one resource
Wound Central is a specialist publication from Journal of Wound Care, for healthcare professionals across North America involved in skin integrity and wound management. It shares the latest clinical best practice, peer-reviewed research and medical education, brought to you with the support of the following associations:

  • American Vein and Lymphatic Society (AVLS)
  • Association for the Advancement of Wound Care (AAWC)
  • Academy of Physicians in Wound Healing (APWH)
  • Wound Care Education Institute (WCEI)

July issue is available now. Register here to read the latest issue and more.

Vomaris Announces First Patient Enrollment in Study on Effects of Bioelectric Wound Care in Hidradenitis Suppurativa

TEMPE, Ariz., Oct. 18, 2021 /PRNewswire/ — Vomaris Innovations, Inc. announces the first patient enrollment in a study using its bioelectric antimicrobial wound care technology following surgical treatment for Hidradenitis Suppurativa (HS).

About HS
HS is a chronic inflammatory skin condition that affects 1-4% of the global population. It occurs more often in women than men and is characterized by recurring pus-filled skin abscesses that drain and can develop tunnels under the skin. This results in pain, scarring and suffering that is both physical and emotional. Because HS most commonly occurs in areas where skin rubs together, such as the armpits, groin, buttocks and breasts, it presents unique treatment challenges.

Current treatments are aimed at managing lesions and their symptoms, trying to reduce recurrence and scarring, and coping with the associated psychological impact. Unfortunately, no one treatment is universally effective and there is no cure for HS. When tunnels develop under the skin, a surgical procedure called deroofing is commonly done. While this removes painful lesions and preserves the surrounding tissue, it leaves large open wounds … read more

COVID in the ICU: Can Patients Be Too Obese for ECMO?

Published guidelines recommend against extracorporeal membrane oxygenation (ECMO) for morbidly obese COVID-19 patients in severe distress, but a Florida researcher said his center’s experience indicates that such advice needs another look.

At Orlando Regional Medical Center, mortality in COVID patients with acute respiratory distress syndrome (ARDS) and body mass index (BMI) values above 40, while not good, was no worse than previously reported for all critically ill COVID patients in a large database, said Sergio Ramirez, MD, a critical care fellow at the institution … read more

 


related:
2,000th ECMO patient

Decline in Diabetic Foot Ulcers Observed in Patients with Type 2 Diabetes (UK)

Although diabetic foot ulcers (DFU) are considered both a major cause of patient suffering and high healthcare costs in the treatment of diabetes, low predictive power of DFUs makes primary prevention practices extremely limited for clinicians and patients.

Stemming from this challenge, a recent study examined incidence rates (IR) and changes over time for the first DFU in patients with diabetes seen in primary care in the United Kingdom … read more

From Chronic to Curable? RHEACELL is Developing a Novel Cell-Therapy Agent for the Treatment of Chronic Venous Ulcers

Heidelberg-based biopharmaceutical company is conducting a follow-up study with highly purified stem cells (AMESANAR (R) ) for the treatment of previously incurable chronic ulcers.

Heidelberg, 19. October 2021 – More than 80,000 people in Germany suffer from chronic venous ulcers (CVU). Triggered by venous insufficiency, wounds and weeping ulcers can develop that may not heal for years. Severely affected patients experience intense pain every day. Until now, there has been no effective treatment – but this could change soon … read more

How a medieval ‘leechbook’ could be the latest cutting-edge treatment to beat superbugs

Could novel vaccines or even a medieval recipe for eye balm provide new ways to defeat the teeming armies of antibiotic-resistant superbugs?

There is no doubt we desperately need new solutions to tackle infectious bacteria: the World Health Organisation (WHO) lists antimicrobial resistance as a top ten global health threat, saying that by 2050 it will kill more people than cancer if resistance keeps rising at current rates … In April, the WHO warned that none of the 43 antibiotics now being developed can beat the world’s 13 most lethal bacteria, such as Acinetobacter baumannii and Pseudomonas aeruginosa, both of which cause blood infections and pneumonia … read more

Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers

GENEVA, SWITZERLAND / ACCESSWIRE / October 20, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB: RLFTF) (” Relief “), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that its wholly owned subsidiary, APR Applied Pharma Research SA (” APR “), reported two papers published in the peer reviewed Journal of Wound Care , concluding that the company’s Nexodyn(R) acid-oxidizing solution (AOS), developed with APR’s proprietary Tehclo(R) technology, may represent a valuable therapeutic addition to standard of care (SOC) for the management of hard-to-heal ulcers requiring long periods of treatment. The data also confirmed the safety of Nexodyn(R) AOS.

Conducted by Elia Ricci, M.D., Director of the Difficult Wound Healing Unit, St. Luca Clinic, Department of Surgery A, Pecetto Torinese (TO), Piedmont, Italy, the prospective case series evaluated the clinical impact of Nexodyn(R) AOS in addition to SOC. Between February 2015 and February 2017, a total of 60 patients with hard-to-heal ulcers of various etiologies took part in the study. Patients were treated for 70 days with Nexodyn(R) AOS and the usual SOC wound dressings. The follow-up study, also conducted by Dr. Ricci, included a subset of 31 patients (51.7%) whose wounds had not fully healed by day 70, who opted to continue with treatment for another 22 weeks (for a total treatment time of 32 weeks) … read more

Wound Care Today 2021 conference 19-20 October, Marshall Arena, Milton Keynes

Wound Care Today 2021 offers delegates a unique learning platform, FREE of charge, to enhance their delivery of care through clinical updates, personal development, practical learning zones and networking in a friendly, open and above all else safe environment … Due the huge popularity over the last three years, we’ll have the same mix of clinical and professional development themed sessions – with a host of expert speakers presenting at the conference … read more

Bionix® Introduces AlphaCleanse™ to Wound Care Line

New AlphaCleanse™ Antimicrobial Wound Care System Offers a More Efficient and Convenient Approach to Wound Care Treatment

TOLEDO, Ohio, Oct. 18, 2021 /PRNewswire/ — Bionix® is pleased to announce their new, single-use product—AlphaCleanse™ Antimicrobial Wound Care System with NovaGran™ Hypochlorous Acid.
The all-in-one kit is designed to provide healthcare professionals with the tools for efficient, effective treatment of chronic wounds … Contained in the AlphaCleanse™ Antimicrobial kit are the Bionix® Igloo® Shield and Probe Applicator, NovaGran™ Hypochlorous Acid, and a highly absorbent LiquidLock™ pad. Having all of the components in one kit saves time and protects against the cross contamination that is possible if the user has to search through various boxes for the tools to treat the wound … read more

Study of 236 patients reveals utility of MolecuLight i:X® in detection and management of wound-related cellulitis

Published results describe use of point-of-care imaging for the early detection and proactive management of wound-related cellulitis

 

TORONTOOct. 12, 2021 /PRNewswire/ – MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced the publication in International Wound Journalof an independent prospective observational study examining the impact of incorporating fluorescence imaging into standard care for the diagnosis and management of wound-related cellulitis. Dr. Charles Andersen, a surgeon at the Madigan Army Medical Center, led this study on wound-related cellulitis, defined as an invasion of bacteria from chronic wounds into the adjacent dermis.

“The results of this study show how MolecuLight point-of-care imaging presents an intriguing solution to revealing extension of bacteria into tissue, reducing misdiagnosis of wound-associated cellulitis, and enabling more proactive early treatment, particularly in patients lacking obvious symptoms”, says Dr. Charles A. Andersen, Chief, Vascular/ Endovascular and Limb Preservation Surgery Service (Emeritus), Chief Wound Care Service and Medical Director Wound Care Clinic at Madigan Army Medical Center, Tacoma, WA. “Given that at least 30% of cellulitis cases are misdiagnosed,6,5 the addition of consistent and objective information provided by fluorescence scans can significantly reduce the uncertainty associated with diagnosis of wound-related cellulitis. In addition, the use of fluorescence imaging to support earlier detection and proactive management of wound-related cellulitis can limit progression of infection and avoid the need for intravenous antibiotics and the high costs associated with inpatient admission”.

An example case of wound-related cellulitis from the study is shown (above) where the wound does not appear to have cellulitis or elevated bacterial burden upon assessment with standard-of-care clinical signs and symptoms (left). In contrast, when imaged with the MolecuLight i:(right), an irregular pattern of red (bacterial) fluorescence extending beyond the wound bed and periwound is visible, and could not be removed with vigorous cleansing, indicating that the bacteria are located subsurface. This pattern of red fluorescence, demonstrating invasive extension of bacteria into surrounding tissues, was consistent in all wounds in the study where wound-related cellulitis was diagnosed.

Dr. Andersen will present the findings of this publication in a talk titled, “Diagnosis and Treatment of the Invasive Extension of Bacteria (Cellulitis) from Chronic Wounds Utilizing Point-of-Care Fluorescence Imaging at the upcoming clinical conference, SAWC (Symposium on Advanced Wound Care) Fall 2021 on Sunday, October 31, 2021 at 9:00 am at Caesars Palace in Las Vegas, Nevada.

References

1

Andersen, C.A. et al, “Diagnosis and Treatment of the Invasive Extension of Bacteria (Cellulitis) from Chronic Wounds Utilizing Point-of-Care Fluorescence Imaging“, International Wound Journal 2021: 1-13

2

Lazzarini L et al, J Infect. 2005;51(5):383-389.

3

Raff AB et al, JAMA. 2016;316(3): 325-337.

4

Pasternack MS. Mandell, Douglas, & Bennett’s Principles & Practice of Infectious Diseases. Vol 1; Phil., PA: Churchill Livingstone/Elsevier; 2010:1289-1312.

5

Weng QY et al, JAMA Dermatol. 2017;153(2):141-146.

6

Levell NJ et al, Br J Dermatol. 2011;164(6):1326-1328.

About MolecuLight Inc.

MolecuLight Inc., a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s first commercially released device, the MolecuLight i:X fluorescence imaging system and its accessories provide a point-of-care handheld imaging device for the global wound care market for the detection of wounds containing elevated bacterial burden (when used with clinical signs and symptoms) and for digital wound measurement. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

Image:
Download at: https://moleculight.box.com/s/oab22c1vi8ud1j8oymylbfogp2lg12bk

SOURCE MolecuLight

Related Links

www.moleculight.com

The Polymath: Lee Rogers, DPM, RCPS, FFPM

Dr. Lee Rogers is a fellowship-trained podiatrist in diabetic limb salvage.  Dr. Rogers is the Chief of Podiatry and Associate Professor of Orthopedics at University of Texas Health Science Center at San Antonio. He has authored over 150 published papers, books, and book chapters on limb salvage and policy and practice and he has delivered more than 500 lectures around the world:

Mesenchymal Stem Cell Secretome for Dermatology Application: A Review

Secretome, also known as conditioned medium, is a secreted molecule from mesenchymal stem cells (MSCs) that has a variety of biological activities that can be used in various therapies, especially on the skin applications. A lack of conventional therapies makes secretome as a promising alternative therapy. The presence of growth factors, cytokines, and extracellular vesicles including microvesicles and exosomes in secretome has been widely reported, which serves in improving the proliferation and migration of cells to help in skin regeneration. Therefore, we were able to optimize the use of this secretome in a well-needed special review related to its work in addressing various skin problems. So, in this article, we discussed the benefits and biological activity of secretome on the skin application. This review was compiled based on the approval of several sites, such as Scopus, PubMed, Science Direct, and Google Scholar with the terms “MSC secretome for skin,“ “secretome for skin,“ “secretome dermatology,“ “secretome conditioned medium for skin,” ”secretome conditioned medium for skin wound … read more

Fireside Chat with Dr. Breanne Everett

Dr. Breanne Everett is the CEO, President and Co-Founder of Orpyx Medical Technologies Inc., a company which creates medical-grade wearable technologies with unique pressure sensors to help prevent diabetic foot ulcers often caused by peripheral neuropathy, and to aid athletic performance. Dr. Everett was recognized as Graduate of the Last Decade from the University of Calgary, has been named one of the top 100 most powerful women in Canada, and has received the Governor General’s Innovation Award. Dr. Everett is a Loran Scholar, and sits on the CMA’s Joule Innovation Council, the Governor General’s Innovation Award Assessment Committee, and the Rideau Hall Innovation Advisory Council.

Orpyx high-tech insoles a step toward a better future for diabetics

During her studies at the University of Calgary, medical doctor Breanne Everett became interested in plastic and reconstructive surgery, concerned about the burden that diabetic foot complications posed to patients and our health-care system … Orpyx sensory insoles are helping people with diabetes to maintain mobility by helping prevent diabetic foot ulcers and possible limb loss, using advanced pressure, temperature and movement sensor technology and analytics … read more

Join the AAWC Sunday, October 24 online for a live replay encore presentation of the OUTSTANDING PrU EDUCATION, at no cost!

AAWC is delighted to be able to offer a live online replay of a select number of presentations from our Pressure Ulcer Summit.

The PrU Summit, themed Reducing Health Disparities in Pressure Ulcer/Injury (PU/PI) Detection & Management, took place on October 7-9, 2021. As part of the AAWC’s commitment to educating health care professionals on this important topic and as a thank you to the generous support from our sponsors and exhibitors, a live online replay conference will be aired globally, at no cost. More information.

The Role of Nutritional Inventions in Wound Care

A study in the Plastic and Reconstructive Surgery journal investigated the role of nutritional intervention in wound care.

The nutritional intervention and its role in wound care has been a controversial topic, according to authors of a review recently published in the Plastic and Reconstructive Surgery journal.1 This is the first literature review of mineral and vitamin wound intervention using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines by wound type, according to the review’s authors.

The authors of this review sought to outline the nutrients and delivery methods used in identified relevant studies, analyze treatment outcomes, and summarize the nutrient effectiveness. They also proposed evidence-based conclusions to improve outcomes of wound healing and increase the consistency of nutritional intervention in wound care … read more

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

From deep-vein arterialization to a 3D stent, data presented at VIVA 2021 encourage novel thinking about peripheral vascular management.

New technologies that divert or improve blood flow offer promising options for patients with chronic limb-threatening ischemia (CLTI), according to two presentations this week at VIVA 2021 … We know there are a group of these patients who are nonrevascularizable with standard means, either percutaneous angioplasty or surgical bypass, and it’s in this group of patients where we’d like to divert the blood flow into the venous system to try and deliver that oxygenated blood to the foot and allow their wounds to heal,” noted Daniel Clair, MD (Vanderbilt University Medical Center, Nashville, TN) … read more

Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease

Peripheral artery disease (PAD) stems from atherosclerosis of lower extremity arteries with resultant arterial narrowing or occlusion. The most severe form of PAD is termed chronic limb-threatening ischemia and carries a significant risk of limb loss and cardiovascular mortality. Diabetes mellitus is known to increase the incidence of PAD, accelerate disease progression, and increase disease severity. Patients with concomitant diabetes mellitus and PAD are at high risk for major complications, such as amputation. Despite a decrease in the overall number of amputations performed annually in the United States, amputation rates among those with both diabetes mellitus and PAD have remained stable or even increased in high-risk subgroups. Within this cohort, there is significant regional, racial/ethnic, and socioeconomic variation in amputation risk. Specifically, residents of rural areas, African-American and Native American patients, and those of low socioeconomic status carry the highest risk of amputation … read more

Unsalvageable: Preventable Amputations Rise During COVID

Leafer Miller didn’t hear much after the doctor told him they had to “sacrifice the leg.”

Lying on the emergency room gurney, the self-proclaimed video game nerd and former athlete struggled to comprehend life without the leg that had propelled him on the track and to the turf for tackles on the soccer field.

“It was always in the back of my mind as a worst-case scenario,” the 35-year-old Fresno, CA, native says. “But I wasn’t expecting that to be the case.”

The amputation was the result of a recurring American narrative: A diabetes diagnosis in his early 20s; a sequence of layoffs and hirings that left his insurance status in flux; missed primary care visits when providers went out of network; and skipped insulin doses due to unaffordable price tags.

“Sometimes, it would come down to insulin or rent,” Miller says, “I felt like my hands were tied.” … read more

Prioritizing Foot Ulcers During Lockdown Paid Off in Belgium

Belgium’s efforts to prioritize care at its diabetic foot ulcer clinics during the COVID-19 pandemic lockdown minimized both delays in care and adverse outcomes, new data suggest … The country has had a national diabetic foot care program in place since 2005, with 34 multidisciplinary clinics recognized by the Belgium Ministry of Health for the treatment of diabetic foot ulcers (DFUs) … The system has resulted in a decline in lower-limb amputations in the country … And while all nonurgent medical care in Belgium was postponed during the national COVID-19 lockdown period March 14-May 3, 2020, the clinics followed advice from professional associations to consider all active DFUs as urgent … read more

Maggots used to clean wounds in NHS as antibiotics fail some patients

Live maggots are being increasingly used to clean wounds by the NHS amid the threat of antibiotic resistance threatening patients’ well-being … According to a report in The Daily Telegraph, the treatment – which involves applying sterilised fly larvae to wounds to eat dead tissue – was common practice in the first half of the 20th century, but faded with the use of antibiotics in the 1940s … However, thanks to antibiotic resistance, maggots are again being used in the NHS and overseas. The paper reports that superbugs kill around 700,000 people a year, a figure predicted to reach 10 million by 2050 … read more

New wound gel to treat foot ulcers

An international research team, led by the University of Canterbury‘s Professor Rudi Marquez, has developed a new wound gel that promises horses and humans. This new wound gel will be used to treat foot ulcers and kick-starts tissue regeneration.

As scientists noted, it could have a significant impact on healing horses and humans alike.

To create this gel, scientists used a protein that helps the skin inside the human mouth to heal quickly … read more

A single center’s 15-year experience with palliative limb care for chronic limb threatening ischemia in frail patients

Our institution’s multidisciplinary Prevention of Amputation in Veterans Everywhere (PAVE) program allocates veterans with critical limb threatening ischemia (CLTI) to immediate revascularization, conservative, primary amputation or palliative limb care based on previously published criteria. These four groups align with the approaches outlined by the Global Guidelines for management of CLTI. The current study delineates the natural history of the palliative limb care group of patients and quantifies procedural risks and outcomes … read more

Launch of New MolecuLightDX™ Device to Enable Point-of-Care Imaging of Wounds in New Expanding Market Segments

MolecuLight Platform is Becoming the Standard-of-Care for Real-Time Imaging of Elevated Bacterial Burden in Wounds Across All Wound Care Settings

TORONTO, CANADA – (October 14, 2021) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced the launch of the MolecuLightDX™, a new point-of-care device model targeted at the unique needs of new expanding wound care market segments in the USA. The DX is an expansion of MolecuLight’s product line and compliments the MolecuLight i:X®, the “workhorse” wound imaging device that has quickly become a standard in wound care practices worldwide, with over 2,000 units sold.

“The i:X and DX are the only commercially-available point-of-care devices to enable real-time detection of elevated bacterial burden in wounds. With the introduction of the MolecuLightDX, we are thrilled to expand our product line and provide added functionality for these wound care market segments,” says Anil Amlani, MolecuLight’s CEO.

Specifically, the MolecuLightDX has the following new features frequently required in these segments:

  • Comprehensive EMR (electronic medical record) integration options for multiple EMR environments,
  • Patient-centric user interface and workflow to allow for easy patient and wound tracking,
  • An Administrator workflow and system configuration capability, and
  • Docking system for easier charging of the devive.

As with the i:X, the DX has the same accurate, rapid digital wound measurement for documentation of procedures and of wound progression. Newly available on the DX is a stickerless measurement capability which automatically measures wound area without the need for wound stickers.

Photo Legend: Select new features of the MolecuLightDX include a larger screen (top left), new Stickerless digital wound area measurement for documentation and monitoring of wound progression (top right), and integrated docking station (bottom right). As with the i:X, the DX is used for point-of-care imaging of elevated bacterial burden in wound to help inform clinical decision-making (bottom left).

“With the expansion of our product line, we can now offer clinicians in any care setting the unmatched capabilities of the MolecuLight platform, with a feature set and price point that matches their specific needs”, says Amlani. “MolecuLight customers will continue to receive our comprehensive activation and training support on both platforms, including on-site training with patients, e-Learning courses and certification and ongoing in-person and remote support by our Clinical Applications team.”

In addition, all MolecuLight procedures will be able to benefit from the reimbursement pathway available in the United States for the MolecuLight procedure, which is applicable to both the MolecuLight i:andDX devices. The reimbursement pathway includes two CPT® codes for physician work to perform “fluorescence wound imaging for bacterial presence, location, and load” and facility payment for Hospital Outpatient Department (HOPD) and Ambulatory Surgical Center (ASC) settings through an Ambulatory Payment Classification (APC) assignment.

The MolecuLightDX has received FDA clearance for sale in the USA, as well as the CE Mark and Health Canada approval for commercial availability in Europe and Canada.

The MolecuLightDX will be displayed in the MolecuLight exhibit booth at the upcoming clinical conference, SAWC (Symposium on Advanced Wound Care) Fall 2021, on Sunday, October 31, 2021 at 9:00 am at Caesars Palace in Las Vegas, Nevada. To request an on-site clinical demonstration of the MolecuLightDX, please go to www.moleculight.com, or email info@moleculight.com.

 

About MolecuLight Inc.

MolecuLight Inc., a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i: and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden (when used with clinical signs and symptoms) and for digital wound measurement. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

 

Rob Sandler
Chief Marketing Officer
MolecuLight Inc.
M. +1.647.362.4684
rsandler@moleculight.com
www.moleculight.com

Wound Care Advantage Launches National Awards Program Honoring The Unsung Hero Of Wound Healing: The Patient

Wound Care Advantage (WCA), the leading provider of consulting and digital services for wound care programs, is pleased to announce a new awards program honoring inspirational patients who demonstrate exceptional strength and fortitude during treatment. Sponsored by WCA, the Wound Care Hero Awards are designed to give special recognition to patients treated by wound care programs in the WCA Network, which comprises programs across 20 states.

The award was inspired by LaVonna Tipton, a cancer survivor who was treated for non-healing wounds at Clark Regional Medical Center, a WCA Luvo Network partner in Winchester, Kentucky. Despite the ongoing COVID-19 pandemic, she attended every session of her hyperbaric oxygen therapy, which involved daily sessions, five days a week for one month. Her wounds, caused by previous cancer treatments, were fully healed, thanks to her diligence and the work of the Clark Regional team … read more

Treatment of Non-Healing Diabetic Foot Wounds with Vaporous Hyperoxia Therapy in Conjunction with Standard Wound Care

Vaporous Hyperoxia Therapy (VHTTM), a patented FDA-510 (k) cleared technology, is an adjunct therapy used in conjunction with standard wound care (SWC). VHT is said to improve the health of wounded tissue by administering a low-frequency, non-contact, non-thermal ionic anti-microbial hydrating mist alternating with concentrated topical oxygen therapy (TOT). VHT was used to treat 36 subjects with chronic diabetic foot ulcers (DFUs) that were previously treated unsuccessfully with SWC. The average age of DFU in the study was 11 months old and the average size was over 3 cm2. Wounds were either Wagner Grade 2 or 3 and most commonly on the plantar surface around the midfoot … read more